Patient risk assessment based on data from multiple sources in a healthcare facility

0001The present disclosure relates to assessing patient risk in a healthcare facility and particularly, to assessing patient risk based on data obtained from medical equipment. More particularly, the present disclosure relates to assessing multiple risks of a patient in a healthcare facility and notifying caregivers of the patient's multiple risks.

0002Patients in healthcare facilities are susceptible to multiple risks during their stays. For example, there is a risk of developing sepsis, a risk of developing pressure injuries such as pressure sores or decubitus ulcers, and a risk of falling while exiting a bed or after having exited the bed. Risk assessments of patients oftentimes take place on a sporadic basis with prolonged periods transpiring between the assessments. For example, vital signs may be charted into a patient's electronic medical record (EMR) once or twice per shift and so, four to eight hours or more may transpire between vitals charting. Furthermore, the results of risk assessments are sometimes only available at a limited number of locations in the healthcare facility such as at an EMR computer or at a computer of a master nurse station. Accordingly, there is a need in the healthcare field to have more timely information regarding risk assessments of patients and there is a need for the risk assessment information to be more readily available to caregivers.

0003An apparatus, system, or method may comprise one or more of the following features alone or in any combination.

0004According to a first aspect of the present disclosure, a system for use in a healthcare facility may be provided. The system may include an analytics engine and a plurality of equipment that may provide data to the analytics engine. The data may pertain to a patient in the healthcare facility. The plurality of equipment may include at least one of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The analytics engine may analyze the data from the plurality of equipment to determine in substantially real time at least one of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury. The system may further include a computer that may be coupled to the analytics engine and that may coordinate a caregiver rounding interval at which at least one caregiver assigned to the patient may be required to check in on the patient. The computer may automatically decrease the caregiver rounding interval in response to the at least one of the first, second, or third scores increasing from a first value to a second value and the computer may automatically increase the caregiver rounding interval in response to the at least one of the first, second, or third scores decreasing from the second value to the first value.

0005In some embodiments, the system of the first aspect may further include a plurality of displays that may be communicatively coupled to the analytics engine and that may be operable to display the at least two first, second, and third scores. For example, the plurality of displays may include at least two of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver that may be assigned to the patient.

0006If desired, the plurality of equipment of the first aspect may include at least three of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. Alternatively, the plurality of equipment of the first aspect may include at least four of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. Further alternatively, the plurality of equipment of the fist aspect may include at least five of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. Still further alternatively, the plurality of equipment of the first aspect may include all six of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

0007Optionally, each of the first, second, and third scores of the first aspect may be normalized by the analytics engine so as to have a minimum value and a maximum value that may be common to each of the other first, second, and third scores. For example, the minimum value may be 0 for each of the first, second, and third scores. Alternatively, the minimum value may be 1 for each of the first, second, and third scores. Also, the maximum value may be 5 for each of the first, second, and third scores. It is within the scope of this disclosure for other minimum values, less than 0 (e.g., negative numbers), and greater than 5, to be used in connection with the first, second, and third scores.

0008In some embodiments of the first aspect, the analytics engine also may receive additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and may analyze the additional data in connection with determining at least one of the first, second, and third scores. The analytics engine may communicate the at least two first, second, and third scores to at least one piece of equipment of the plurality of equipment. Optionally, the at least one piece of equipment of the plurality of equipment may include a device display and, if desired, steps for lowering at least one of the first, second, and third scores may be displayed on the device display.

0009According to the system of the first aspect, data from the patient support apparatus may include at least one patient vital sign that may be sensed by at least one vital sign sensor that may be integrated into the patient support apparatus. For example, the at least one patient vital sign that may be sensed by the at least one vital sign sensor may include heart rate or respiration rate. Data from the patient support apparatus further may include patient weight. Alternatively or additionally, data from the patient support apparatus may include patient weight and a position of the patient on the patient support apparatus. Further alternatively or additionally, data from the patient support apparatus may include data indicative of an amount of motion by the patient while supported on the patient support apparatus.

0010In some embodiments of the first aspect, data from the physiological monitor may include one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data. The system of the first aspect may be configured such that the first score may be at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.

0011If desired, the analytics engine of the first aspect may initiate a message to a mobile device of the at least one caregiver assigned to the patient if the first, second, or third score increases from a previous value. Alternatively or additionally, the analytics engine of the first aspect may initiate a message to a mobile device of the at least one caregiver assigned to the patient if the first, second, or third score reaches a threshold value. Optionally, the analytics engine of the also may receive additional data relating to at least one wound of the patient and may analyze the additional data in connection with determining at least one of the first, second, and third scores. For example, the additional data relating to the at least one wound may include an image of the at least one wound.

0012In some embodiments, the patient support apparatus of the first aspect may include a patient bed or a stretcher. The analytics engine also may receive additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and wherein the analytics engine may analyze the additional data in connection with determining at least one of the first, second, and third scores. The physiological monitor of the first aspect may include at least one of the following: a wireless patch sensor that may be attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer. The plurality of equipment of the first aspect may further include a chair monitor to monitor patient movement while the patient is seated on a chair. Alternatively or additionally, the plurality of equipment of the first aspect may further include a toilet monitor to monitor patient movement while the patient is seated on a toilet.

0013According to a second aspect of the present disclosure, apparatus for assessing medical risks of a patient may include an analytics engine and a plurality of equipment that may provide data to the analytics engine. The plurality of equipment may include at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The analytics engine may analyze the data from the plurality of equipment to determine at least two of the following: a first score that may relate to a risk of the patient developing sepsis, a second score that may relate to a risk of the patient falling, and a third score that may relate to a risk of the patient developing a pressure injury. The apparatus may further include a plurality of displays that may be communicatively coupled to the analytics engine and that may be operable to display the at least two first, second, and third scores. The plurality of displays may include at least two of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver that may be assigned to the patient.

0014In some embodiments, the plurality of equipment may include at least three of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In further embodiments, the plurality of equipment may include at least four of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In additional embodiments, the plurality of equipment may include at least five of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In still other embodiments, the plurality of equipment includes all six of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

0015Optionally, each of the first, second, and third scores may be normalized so as to have a minimum value and a maximum value that may be common to each of the other first, second, and third scores. For example, the minimum value may be 0 for each of the first, second, and third scores. Alternatively, the minimum value may be 1 for each of the first, second, and third scores. Similarly, the maximum value may be 5 for each of the first, second, and third scores. It is within the scope of this disclosure for other minimum values, less than 0 (e.g., negative numbers), and greater than 5, to be used in connection with the first, second, and third scores.

0016It is contemplated by this disclosure that a rounding protocol relating to caregiver rounds may be adjusted based on at least one of the first, second and third scores. For example, the rounding protocol that may be adjusted includes a rounding time interval relating to when the caregiver may be required to check on the patient.

0017If desired, the analytics engine also may receive additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and may analyze the additional data in connection with determining at least one of the first, second, and third scores.

0018In some embodiments, the analytics engine may communicate the at least two first, second, and third scores to the plurality of equipment. At least one piece of equipment of the plurality of equipment may include a device display and steps for lowering at least one of the first, second, and third scores may be displayed on the device display.

0019Data from the patient support apparatus may include at least one patient vital sign that may be sensed by at least one vital sign sensor that may be integrated into the patient support apparatus. For example, the at least one patient vital sign that may be sensed by the at least one vital sign sensor may include heart rate or respiration rate. Alternatively or additionally, data from the patient support apparatus may include patient weight. Further alternatively or additionally, data from the patient support apparatus may include patient weight and a position of the patient on the patient support apparatus. Optionally, data from the patient support apparatus may include data indicative of an amount of motion by the patient while supported on the patient support apparatus.

0020The analytics engine may analyze the data from the plurality of equipment in substantially real time and may update the at least two first, second, and third scores in substantially real time. It is contemplated by this disclosure that data from the physiological monitor may include one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data.

0021In some embodiments, the first score may be at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.

0022Optionally, the analytics engine may initiate a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score increases from a previous value. Alternatively or additionally, the analytics engine may initiate a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score reaches a threshold value.

0023In some embodiments, the analytics engine also may receive additional data relating to at least one wound of the patient and may analyze the additional data in connection with determining at least one of the first, second, and third scores. The additional data relating to the at least one wound may include an image of the at least one wound, for example.

0024The patient support apparatus may include a patient bed or a stretcher, for example. If desired, the analytics engine also may receive additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork. The analytics engine may analyze the additional data in connection with determining at least one of the first, second, and third scores.

0025In some embodiments, the physiological monitor may include at least one of the following: a wireless patch sensor that may be attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer. Alternatively or additionally, the plurality of equipment also may include a chair monitor to monitor patient movement while the patient is seated on a chair. Further alternatively or additionally, the plurality of equipment further may include a toilet monitor to monitor patient movement while the patient is seated on a toilet.

0026According to a third aspect of the present disclosure, apparatus for assessing medical risks of a patient may include an analytics engine and a plurality of equipment that may provide data to the analytics engine. The plurality of equipment may include at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The analytics engine may analyze the data from the plurality of equipment to determine each of the following: a first score that may relate to a risk of the patient developing sepsis, a second score that may relate to a risk of the patient falling, and a third score that may relate to a risk of the patient developing a pressure injury. The apparatus may further include a plurality of displays that may be communicatively coupled to the analytics engine. At least one display of the plurality of displays may be operable to display the first, second, and third scores.

0027In some embodiments, the at least one display may include at least one of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In additional embodiments, the at least one display may include at least two of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In further embodiments, the at least one display may include at least three of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In still other embodiments, the at least one display may include all four of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.

0028In some embodiments, the apparatus of the third aspect set forth above in paragraph [0027] may be provided in combination with any one or more of the features set forth above in the various sentences of paragraphs [0015] through [0026].

0029According to a fourth aspect of the present disclosure, a method for assessing medical risks of a patient may include receiving at an analytics engine data from a plurality of equipment. The plurality of equipment may include at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The method may further include analyzing with the analytics engine the data from the plurality of equipment to determine at least two of the following: a first score that may relate to a risk of the patient developing sepsis, a second score that may relate to a risk of the patient falling, and a third score that may relate to a risk of the patient developing a pressure injury. The method also may include displaying at a plurality of displays that may be communicatively coupled to the analytics engine the at least two of the first, second, and third scores. The plurality of displays may include at least two of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.

0030In some embodiments, the plurality of equipment may include at least three of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In further embodiments, the plurality of equipment may include at least four of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In additional embodiments, the plurality of equipment may include at least five of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad. In still other embodiments, the plurality of equipment may include all six of the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

0031Optionally, the method may further include, with the analytics engine, normalizing each of the first, second, and third scores so as to have a minimum value and a maximum value that may be common to each of the other first, second, and third scores. For example, the minimum value may be 0 for each of the first, second, and third scores. Alternatively, the minimum value may be 1 for each of the first, second, and third scores. If desired, the maximum value may be 5 for each of the first, second, and third scores. It is within the scope of this disclosure for other minimum values, less than 0 (e.g., negative numbers), and greater than 5, to be used in connection with the first, second, and third scores.

0032In some embodiments, the method may further include adjusting a rounding protocol that may relate to caregiver rounds based on at least one of the first, second and third scores. For example, the rounding protocol that may be adjusted may include a rounding time interval that may relate to when the caregiver is required to check on the patient.

0033If desired, the method may further include receiving at the analytics engine additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and analyzing with the analytics engine the additional data in connection with determining at least one of the first, second, and third scores. The method may also include communicating the at least two first, second, and third scores from the analytics engine to the plurality of equipment. At least one piece of equipment of the plurality of equipment may include a device display and the method may further include displaying on the device display steps for lowering at least one of the first, second, and third scores.

0034In some embodiments of the method, data from the patient support apparatus may include at least one patient vital sign that may be sensed by at least one vital sign sensor that may be integrated into the patient support apparatus. For example, the at least one patient vital sign that may be sensed by the at least one vital sign sensor may include heart rate or respiration rate. Alternatively or additionally, data from the patient support apparatus further may include patient weight. Further alternatively or additionally, data from the patient support apparatus may include patient weight and a position of the patient on the patient support apparatus. Still further alternatively or additionally, data from the patient support apparatus may include data indicative of an amount of motion by the patient while supported on the patient support apparatus.

0035In some embodiments, analyzing the data with the analytics engine may include analyzing the data in substantially real time and the method further may include updating the at least two first, second, and third scores in substantially real time. Data from the physiological monitor may include one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data. It is contemplated by this disclosure that the first score may be at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.

0036Optionally, the method further may include initiating with the analytics engine a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score increases from a previous value. Alternatively or additionally, the method further may include initiating with the analytics engine a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score reaches a threshold value.

0037If desired, the method further may include receiving at the analytics engine additional data that may relate to at least one wound of the patient and analyzing with the analytics engine the additional data in connection with determining at least one of the first, second, and third scores. For example, the additional data that may relate to the at least one wound may include an image of the at least one wound.

0038The patient support apparatus may include a patient bed or a stretcher. Optionally, the method further may include receiving at the analytics engine additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and analyzing with the analytics engine analyzes the additional data in connection with determining at least one of the first, second, and third scores.

0039In some embodiments of the method, the physiological monitor may include at least one of the following: a wireless patch sensor that may be attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer. Alternatively or additionally, the plurality of equipment of the method further may include a chair monitor to monitor patient movement while the patient is seated on a chair. Further alternatively or additionally, the plurality of equipment of the method further may include a toilet monitor to monitor patient movement while the patient is seated on a toilet.

0040According to a fifth aspect of the present disclosure, a method for assessing medical risks of a patient may include receiving at an analytics engine data from a plurality of equipment. The plurality of equipment may include at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The method further may include analyzing with the analytics engine the data from the plurality of equipment to determine each of the following: a first score that may relate to a risk of the patient developing sepsis, a second score that may relate to a risk of the patient falling, and a third score that may relate to a risk of the patient developing a pressure injury. The method also may include displaying on at least one display of a plurality of displays communicatively coupled to the analytics engine the first, second, and third scores.

0041In some embodiments of the method, the at least one display may include at least one of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In further embodiments of the method, the at least one display may include at least two of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In additional embodiments of the method, the at least one display may include at least three of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient. In still other embodiments of the method, the at least one display may include all four of the following: a status board display that may be located at a master nurse station, an in-room display that may be provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.

0042In some embodiments, the method of the fifth aspect set forth above in paragraph [0041] may be provided in combination with any one or more of the features set forth above in the various sentences of paragraphs [0031] through [0040].

0043According to a sixth aspect of the present disclosure, a method of assessing medical risks of a patient may include receiving at an analytics engine patient demographics data of the patient including at least one of age, race, and weight. The method of the sixth aspect may also include receiving at the analytics engine comorbidity data of the patient including data indicating that the patient has at least one of the following medical conditions: acquired immunodeficiency syndrome (AIDS), anemia, chronic congestive heart failure, asthma, cancer, chronic obstructive pulmonary disease (COPD), coronary artery disease, cystic fibrosis, dementia, emphysema, alcohol or drug abuse, stroke, pulmonary emboli, a history of sepsis, type 1 diabetes, morbid obesity, neuromuscular disease, prior intubation, scoliosis, smoker, delirium, asplenic, bone marrow transplant, cirrhosis, dialysis, diverticulosis, heart valve disorders, inflammatory bowel disease, joint replacement, leukopenia, malignancy, neoplasm, organ transplant, peripheral vascular disease, renal disease, pressure injury, recent abortion, recent childbirth, seizures, sickle cell anemia, or terminal illness. The method of the sixth aspect may further include receiving at the analytics engine physiological data that may be measured by a physiological monitor that may have at least one sensor coupled to, or in communication with, the patient. The physiological data may be dynamic and changing over time while the patient is being monitored by the physiological monitor. Still further, the method of the sixth aspect may include using the analytics engine to calculate a risk score of the patient in substantially real time based on the patient demographics data, the comorbidity data, and the physiological data.

0044In some embodiments, the method of the sixth aspect further may include receiving at the analytics engine laboratory data of the patient and using the laboratory data in connection with calculating the risk score. Optionally, the laboratory data may include data that may pertain to one or more of the following: albumin, arterial partial pressure of oxygen (arterial PaO2), arterial partial pressure of carbon dioxide (PCO2), arterial pH, acidosis, brain natriuretic peptide, blood urea nitrogen, cardiac ejection fraction, creatinine, hemoglobin, hematocrit, lactate, pulmonary function test, troponin, bilirubin, C-reactive protein, D-dimer, glucose, bicarbonate (HCO3), hyperlactatemia, international normalization ration (INR) for blood clotting, normal white blood count (WBC) with greater than 10% neutrophils, arterial partial pressure of carbon dioxide (PaCO2), fluid overload, Ph, platelets, procalcitonin, protein in urine, partial thromboplastin time (PTT) or white blood cell count.

0045Alternatively or additionally, the method of the sixth aspect further may include receiving at the analytics engine patient symptoms data of the patient and using the patient symptoms data in connection with calculating the risk score. Optionally, the patient symptoms data may include data that may pertain to one or more of the following: accessory muscle use, altered mental status, confusion, anxiety, chest pain, cough, cyanosis, diaphoresis, dyspnea, hemoptysis, fatigue, restlessness, sputum production, tachycardia, tachypnea, or lethargy.

0046Further alternatively or additionally, the method of the sixth aspect further may include receiving at the analytics engine clinical examination data and using the clinical examination data in connection with calculating the risk score. Optionally, the clinical examination data may include data pertaining to one or more of the following: abdominal respirations, abnormal lung sounds, accessory muscle use, capillary refill, chest pressure or pain, abnormal electrocardiograph (ECG), cough, cyanosis, decreased level of consciousness (LOC), agitation, encephalopathy, mottling, need for assistance with activities of daily living (ADLS), orthopnea, peripheral edema, sputum production, delirium, fluid overload, cardiac output, early state warm red skin and late state cool and pale with mottling, fever, headache, stiff neck, hypothermia, ileus, jaundice, meningitis, oliguria, peripheral cyanosis, petechial rash, positive fluid balance, seizures, stupor, or volume depletion.

0047Still further alternatively or additionally, the method of the sixth aspect further may include receiving at the analytics engine charted doctor's orders data and using the charted doctor's order data in connection with calculating the risk score. Optionally, the charted doctor's orders data may include data that may pertain to one or more of the following: delivery of breathing air other than with a cannula including with a Venturi, a rebreather, a non-rebreather, a continuous positive airway pressure (CPAP) machine, and a bi-level positive airway pressure (bi-PAP) machine; testing of arterial blood gases; testing of brain natriuretic peptide; breathing treatments; chest x-ray; Doppler echocardiography; high fluid rates or volumes (input and output (I&O)); pulmonary consultation; pulmonary function testing; ventilation-perfusion (VQ) scan; or thoracic computerized tomography (CT) scan.

0048In some embodiments, the method of the sixth aspect may further include receiving at the analytics engine admission data for the patient and using the admission data in connection with calculating the risk score. Optionally, the admission data may include data that may pertain to one or more of the following: abdominal aortic aneurysm surgery, acute myocardial ischemia, acute pancreatitis, aspiration, asthma, bronchiectasis, atelectasis, bronchitis, burns, cancer, cardiac or thoracic surgery, cardiac valve disorder or valvular insufficiency, chemo therapy, congestive heart failure, COPD exacerbation, deep vein thrombosis, drug overdose, dyspnea at rest, emergency surgery, hemoptysis, interstitial lung disease, lung abscess, neck surgery, neuro surgery, upper abdomen surgery, peripheral vascular surgery, pneumonia, pneumothorax, pulmonary emboli, pulmonary hypertension, pulmonary-renal syndrome, renal failure, sepsis, shock, sleep apnea, smoke inhalation injury, surgery, thoracentesis, trauma, lethargy, delirium, abscess, abdominal pain, abdominal tenderness, acute lung injury, appendicitis, bacteremia, cellulitis, cholangitis, cholecystitis, colitis, cystitis, dehydration, diverticulitis, encephalitis, encephalopathy, endocarditis, fever of unknown origin, gastroenteritis, gastrointestinal bleed, gastrointestinal tract infection, hypotension, infectious process, malaise, osteomyelitis, ostomy, pelvic pain, renal disease, pyelonephritis, respiratory infection, septic arthritis, soft tissue infection, surgical admission, wound, or acute respiratory distress syndrome.

0049Alternatively or additionally, the method of the sixth aspect further may include receiving at the analytics engine medications data for the patient and using the medications data in connection with calculating the risk score. Optionally, the medications data may include data that may pertain to one or more of the following: anticoagulants including heparin or levenox that may be delivered intravenously (IV) or subcutaneously (SC), bronchodilators, corticosteroids, diuretic use, high fluid rates or volumes or hypertonic fluids, opioids, sedatives, hypnotics, muscle relaxants, fluid overload, antibiotics, or immunosuppressants.

0050In some embodiments, the method of the sixth aspect may further include determining with the analytics engine that the patient may be at risk of developing respiratory distress if the patient is 70 years of age or older and has COPD. Alternatively or additionally, the method of the sixth aspect further may include determining with the analytics engine that the patient may be at risk of developing respiratory distress if the patient has COPD and has been prescribed opioids. Further alternatively or additionally, the method of the sixth aspect further may include determining with the analytics engine that the patient may be at risk of developing respiratory distress if the patient is 70 years of age or older and has been prescribed opioids. Still further alternatively or additionally, the method of the sixth aspect further may include determining with the analytics engine that the patient may be at risk of developing respiratory distress if the patient is 70 years of age or older, has asthma, and has a blood urea nitrogen (BUN) of greater than or equal to 30 milligrams (mg) per 100 milliliters (ml) of blood.

0051If desired, the method of the sixth aspect further may include determining with the analytics engine that the patient may be at risk of developing sepsis if the patient is 65 years of age or older and has cancer. Alternatively or additionally, the method of the sixth aspect further may include determining with the analytics engine that the patient may be at risk of developing sepsis if the patient has a history of developing sepsis. Further alternatively or additionally, the physiological data of the sixth method may include one or more of the following: heartrate, respiration rate, temperature, mean arterial pressure, systolic blood pressure, or pulse oximetry data including peripheral capillary oxygen saturation (SpO2).

0052According to a seventh aspect of the present disclosure, a method implemented on at least one computer may include receiving dynamic clinical variables and vital signs information of a patient, using the vital signs information to develop prior vital signs patterns and current vital signs patterns, and comparing the prior vital signs patterns with the current vital signs patterns. The method of the seventh aspect further may include receiving one or more of the following: static variables of the patient, subjective complaints of the patient, prior healthcare utilization patterns of the patient, or social determinants of health data of the patient. The method of the seventh aspect also may include using the dynamic clinical variables, the vital signs information, the results of the comparison of the prior vital signs patterns with the current vital signs patterns, and the one or more of the static variables, the subjective complaints, the healthcare utilization patterns, or the social determinants of health data in an algorithm to detect or predict that the patient has sepsis or is likely to develop sepsis.

0053In some embodiments of the method of the seventh aspect, the dynamic clinical variables may include point-of-care lab data. Optionally, the static variables may include comorbidities. Alternatively or additionally, the static variables may include whether the care setting of the patient is a pre-acute care setting, an acute care setting, or a post-acute care setting. If desired, the method of the seventh aspect further may include receiving historical data of the patient.

0054It is within the scope of the present disclosure that the method of the seventh aspect further may include outputting one or more recommended actions to one or more clinicians of the patient. For example, the one or more recommended actions may include sending the patient to an emergency department (ED). Alternatively or additionally, the one or more recommended actions may include increasing monitoring of the patient by the one or more clinicians. Further alternatively or additionally, the one or more recommended actions may include ordering a set of labs for the patient.

0055In some embodiments, the method of the seventh aspect further may include ranking clinicians of a healthcare facility. For example, ranking the clinicians of the healthcare facility may include ranking the clinicians by experience. Alternatively or additionally, ranking the clinicians of the healthcare facility may include ranking the clinicians by actions previously taken. Further alternatively or additionally, ranking the clinicians of the healthcare facility may include ranking the clinicians by prior patient outcomes. If desired, therefore, ranking the clinicians of the healthcare facility may include ranking the clinicians by experience, by actions previously taken, and by prior patient outcomes. Optionally, the actions that may have greatest impact on outcomes may be used by the at least one computer to inform newer or less experienced clinicians how an experienced clinician may attend to the patient.

0056In some embodiments of the system of the first aspect, a risk determination may be made or one or more of the first, second, or third risk scores may be calculated based on one or more of the data elements listed below in Table 11.

0057In some embodiments of the apparatus of the second aspect or the third aspect, a risk determination may be made or one or more of the first, second, or third risk scores may be calculated based on one or more of the data elements listed below in Table 11.

0058In some embodiments of the method of the fourth aspect or the fifth aspect, the method may further include making a risk determination or calculating one or more of the first, second, or third risk scores based on one or more of the data elements listed below in Table 11.

0059In some embodiments of the method of the sixth aspect, the method may further include calculating the risk score or making a risk determination based on one or more of the data elements listed below in Table 11.

0060In some embodiments of the method of the seventh aspect, the method may further include calculating a risk score or making a risk determination based on one or more of the data elements listed below in Table 11.

0061The invention will now be further described by way of example with reference to the accompanying drawings, in which: <ul id="ul0001" list-style="none" compact="compact"><li><figref idref="f0001">Fig. 1</figref> is a diagrammatic view of a system showing bed data, incontinence detection system data, vital signs data, and data from an international pressure ulcer prevalence (IPUP) survey being provided to an analytics engine and showing the analytics engine initiating real-time clinical communication to caregivers based on an analysis of the received data;</li><li><figref idref="f0002">Fig. 2</figref> is a diagrammatic view of a system, similar to <figref idref="f0001">Fig. 1</figref>, showing in a top row, from left to right, a patient supported on a patient bed, an analytics engine (labeled as "DSN platform" in <figref idref="f0002">Fig. 2</figref>) receiving data from the patient bed, the analytics engine communicating risk assessment messages back to the patient bed and to a vital signs monitor, and showing in a second row, from right to left, the patient bed monitoring patient position, and a caregiver taking a picture of a pressure injury of the patient;</li><li><figref idref="f0003">Fig. 3</figref> is a diagrammatic view of a system, similar to <figref idref="f0001">Figs. 1</figref> and <figref idref="f0002">2</figref>, showing a router located in a center of the view receiving data from a plurality of data source equipment situated to the left of the router and communicating to a plurality of data receiving equipment to the right of the router, the data source equipment including a patient bed, a graphical room station of a nurse call system, a vital signs monitor, a patient lift, a locating system, and an incontinence detection system, and the data receiving equipment including a status board, an in-room display, an analytics engine, an electronic medical records (EMR) or health information systems (HIS) server, and a set of mobile devices;</li><li><figref idref="f0004 f0005 f0006 f0007">Figs. 4A-4C</figref> form a flow chart showing an example of a patient's journey through an emergency department (ED), an intensive care unit (ICU) and a medical/surgical (MED/SURG) unit, and then home or to a long term care (LTC) facility and showing locations within the patient flow at which the analytics engine operates to determine the patient's risk of having or developing sepsis;</li><li><figref idref="f0008">Figs. 5A</figref> and <figref idref="f0009">5B</figref> form a flow chart showing an example of a patient's admission and stay at a healthcare facility including use of equipment in the patient's room to move the patient to a chair or into a bathroom, and showing locations within the patient flow at which the analytics engine operates to make a risk assessment for the patient;</li><li><figref idref="f0010">Fig. 6</figref> is a diagrammatic view of an alternative system, similar to <figref idref="f0003">Fig. 3</figref>, showing hospital on-premises equipment at the left side of the page including in-room devices, a device gateway, and a status board; cloud devices at a center of the page including an enterprise gateway (HL7), a clinical data repository, a risk engine, and an analytics artificial intelligence (AI) platform; and additional on-premises equipment at the right side of the page including a mobile device and 3^rd party solutions including EMR, ADT, and Labs servers;</li><li><figref idref="f0011">Fig. 7</figref> is a screen shot example of a Patient screen of a mobile application of the mobile devices of <figref idref="f0003">Figs. 3</figref> and <figref idref="f0010">6</figref>, showing the Patient screen including a list of patient names assigned to a caregiver that carries the mobile device, a room number to the left of each patient name, and risk scores including, when applicable, a system inflammatory response syndrome (SIRS) value and a modified early warning score (MEWS) value, beneath each of the patient names;</li><li><figref idref="f0011">Fig. 8</figref> is a screen shot example of a Risk Details screen that, beneath the patient's name, includes a MEWS window having additional information pertaining to the MEWS value, a Sepsis-Related Organ Failure Assessment (SOFA) window having additional information pertaining to a SOFA score, and a MORSE window having additional information pertaining to a MORSE Fall Scale (MFS) value, and that also includes a pair of Risk Contributors windows including a respiratory distress window listing factors contributing to a risk that the patient will experience respiratory distress and a sepsis window listing factors contributing to the patient's risk of developing sepsis;</li><li><figref idref="f0012">Fig. 9</figref> is a screen shot example of an alternative Risk Details screen that, beneath the patient's name, includes MEWS, SIRS, and SOFA windows having sub-scores information, where applicable, that contribute to the overall score, and that also includes the pair of Risk Contributors windows similar to those of <figref idref="f0011">Fig. 8</figref>; and</li><li><figref idref="f0012">Fig. 10</figref> is a screen shot example of a MEWS Details screen that provides greater details relating to the MEWS value including showing which vital signs or other information corresponds with each of the sub-score values that contribute to the overall MEWS value, the MEWS Details screen appearing on the caregiver's mobile device in response to selection of the MEWS window on the Risk Details screen of <figref idref="f0011">Figs. 8</figref> or <figref idref="f0012">9</figref>.</li></ul>

0062An apparatus or system 10 includes sources 12 of patient data that communicate with an analytics engine 20 in substantially real time for real-time clinical data aggregation as shown diagrammatically in <figref idref="f0001">Fig. 1</figref>. In the illustrative example of <figref idref="f0001">Fig. 1</figref>, the sources 12 of patient data include a patient bed 14, an incontinence detection system 16, a vital signs monitor 18, and an international pressure ulcer prevalence (IPUP) survey 22. Bed data from patient bed 14 includes, for example, data indicating whether bed siderails are up or down, data indicating whether caster brakes are set, data indicating an angle at which a head section of a mattress support deck is elevated, data indicating whether or not an upper frame of the patient bed 14 is at its lowest height relative to a base frame of the bed 14, and other bed data as is known to those skilled in the art. See <patcit id="pcit0001" dnum="US20120316892A1"><text>U.S. Patent Application Publication No. 2012/0316892 A1</text></patcit>, particularly with regard to Table 1, for additional examples of bed data.

0063Some embodiments of patient bed 14 have a weigh scale system that senses patient weight and that, in some embodiments, also monitors a position of a patient while supported on bed 14. See, for example, <patcit id="pcit0002" dnum="US7253366B"><text>U.S. Patent No. 7,253,366</text></patcit>. Some embodiments of patient bed 14 also include integrated vital signs sensors to sense the patient's heart rate or respiration rate. See, for example, <patcit id="pcit0003" dnum="US20180184984A1"><text>U.S. Patent Application Publication No. 2018/0184984 A1</text></patcit>. Thus, patient weight data, patient position data, and vital signs data sensed by one or more on-bed sensors is also among the data that bed 14 transmits to analytics engine 20 in some embodiments.

0064In some embodiments, the incontinence detection system 16 is the WATCHCARE™ incontinence detection system available from Hill-Rom Company, Inc. Additional details of suitable incontinence detection systems 16 can be found in <patcit id="pcit0004" dnum="US20170065464A1"><text>U.S. Patent Application Publication Nos. 2017/0065464 A1</text></patcit>; <patcit id="pcit0005" dnum="US20170246063A1"><text>2017/0246063 A1</text></patcit>; <patcit id="pcit0006" dnum="US20180021184A1"><text>2018/0021184 A1</text></patcit>; <patcit id="pcit0007" dnum="US20180325744A1"><text>2018/0325744 A1</text></patcit> and <patcit id="pcit0008" dnum="US20190060137A1"><text>2019/0060137 A1</text></patcit>. The incontinence detection system 16 communicates to analytics engine 20 data indicating whether an incontinence detection pad of system 16 that is placed underneath the patient is wet or dry.

0065In some embodiments, the incontinence detection pad of system 16 has a passive RFID tag that is activated by energy transmitted from one or more antennae that are situated beneath a mattress of patient bed 14 and on top of a mattress support deck of patient bed 14. Backscattered data from the passive RFID tag is read by one or more of these same antennae. A reader is provided to control which antenna of a plurality of antennae is the transmit antenna at any given instance, with the remaining antennae being receive antennae. The backscattered data received by the reader via the receive antennae is communicated to the analytics engine 20 via the reader, such as via a wireless transmission from the reader to a wireless access point of an Ethernet of the healthcare facility, or via the circuitry of bed 14 in those embodiments in which the reader is communicatively coupled to the bed circuitry such as via a wired connection.

0066Vital signs monitors 18 include, for example, electrocardiographs (ECG's or EKG's), electroencephalographs (EEG's), heart rate monitors, respiration rate monitors, temperature monitors, pulse oximeters, blood pressure monitors, and the like. Monitors 18 are standalone devices in some embodiments that are separate from bed 14. In some embodiments, at least one of the vital sign monitors 18 is the CONNEX® Spot Monitor available from Welch Allyn, Inc. of Skaneateles Falls, New York. As noted above, bed 14 includes its own integrated vital signs sensors in some embodiments. Thus, vital signs data provided to analytics engine 20 from vital signs monitors 18 or from bed 14 includes any one or more of the following: heart rate data, respiration rate data, temperature data, pulse oximetry data, blood pressure data, and the like.

0067The IPUP survey 22 includes information such as the following: 1) unit in which the patient is located, 2) patient age, 3) sex of the patient, 4) whether the patient is incontinent, 5) whether the patient has incontinence associated dermatitis, 6) whether an incontinence detection pad of system 16 is being used, 7) length of the patient's stay since admission to the healthcare facility, 8) the type of surface (e.g., mattress) on the patient's bed 14, 9) number of layers of linen (including diapers and briefs) between the patient and the support surface, 10) the type of linen used, 11) the patient's mobility status (e.g., completely immobile, makes small weight shifts but unable to turn to side, turns to side on own but requires help to stand, or independent), 12) observed position (e.g., on back, on side, prone, chair, or standing), 13) whether a patient lift has been used during the patient's stay, 14) whether the patient's heels are elevated when in bed, 15) patient's height (or length for infants), 16) patient's weight, 17) neonatal weight (in grams), 18) time spent in the emergency room (ER), 19) time spent in the operating room (OR), 20) whether the patient's skin was assessed within 24 hours of admission, 21) whether a pressure injury assessment was documented within 24 hours of admission, 22) the risk methodology used at admission, 23) the risk score(s) determined during admission, 24) the most recent or current risk methodology used, 25) the most recent or current risk score(s), 26) documentation of last risk assessment (e.g., time since last pressure ulcer/injury risk assessment prior to the current survey and whether the last risk assessment was documented), 27) whether the patient was determined to be at risk for pressure injuries, 28) whether pressure injury prevention protocols have been in effect for the last 24 hours for an at risk patient, 29) whether a skin assessment was documented within the past 24 hours, 30) whether a pressure redistribution surface was used within the past 24 hours, 31) whether patient repositioning as prescribed has occurred within the past 24 hours, 32) whether the patient has received nutritional support within the past 24 hours, 33) moisture management has been used for the patient in the past 24 hours (e.g., used of a low airloss feature or microclimate management feature of a surface), 34) whether patient restraints are in use, 35) the type of restraint being used, 36) the category of restraint being used, 37) the justification for use of the restraint, 38) whether Continuous Veno-Venous Hemofiltration (CVVH)/ Continuous Venovenous Hemodiafiltration (CVHD)/Femoral Lines are being used with the patient, 39) whether the patient has diabetes, 40) whether Extracorporeal Membrane Oxygenation (ECMO) is being used with the patient, 41) whether the patient has sepsis, 42) whether the patient has vascular disease, 43) whether vasopressors are being used for the patient or whether the patient has low mean arterial pressure (MAP), 44) whether the patient is ventilated, 45) whether the patient has a pressure injury, 46) pressure injury detail (e.g., location of wound such as right or left heel, sacrum, scapula, etc.; the stage of each wound; whether each wound was present at admission; whether each wound was present on arrival at the unit; and wound documentation), 47) whether any pressure injury is device related, 48) the type of device (if answer to 47 was "yes"), and 49) number of days from admission until the pressure injury was documented (if pressure injury was facility-acquired). The data from the IPUP survey is among the data communicated to the analytics engine 20. It should be appreciated that the IPUP survey data is input by a caregiver using a PC or tablet computer or some other computer device.

0068According to the present disclosure, the analytics engine 20 processes the data received from sources 12 and performs risk assessments for the associated patent. As discussed in further detail below, the risk assessments include determining the risk of the patient developing sepsis, the risk of the patient developing a pressure injury (e.g., a pressure sore or decubitus ulcer), and the risk that the patient may fall. These are referred to herein as a sepsis risk assessment, a pressure injury risk assessment, and a falls risk assessment. This disclosure contemplates that the analytics engine 20 is able to make other risk assessments for the patient based on the data received from sources 12. Such risk assessments are dependent upon the type of sources 12 providing the data and the identification of a relatively close correlation between the data from the multiple sources 12 and a particular patient risk.

0069Still referring to <figref idref="f0001">Fig. 1</figref>, the risk assessments are provided to caregivers or clinicians who may adjust or override the risk assessments based on clinical insights 24. The terms "caregiver" and "clinician" are used interchangeably herein. The adjustments to or overriding of the risk assessments based on the clinical insights 24 are implemented using a computer (not shown) such as a personal computer at a work station, a master nurse computer at a master nurse station, a mobile device such as a smart phone or tablet computer carried by a caregiver, and so forth. In some embodiments, each of the risk assessments results in a numerical score within a range of values between, and including, an upper limit and a lower limit. Thus, a caregiver is able to change the risk assessment scores output from the analytics engine 20 if, based on the caregiver's information about the patient and the caregiver's experience, such adjustment is warranted or otherwise desirable.

0070Based on the risk assessments made by analytics engine 20 and the adjustments made by caregivers due to clinical insights 24, if any, the risk assessments are used to determine clinical services and actions 26 as indicated diagrammatically in <figref idref="f0001">Fig. 1</figref>. The ultimate goal of the risk assessments made by the analytics engine 20 and the implemented clinical services and actions 26 is to improve patient outcomes as indicated by the breakthrough outcomes block 28 of <figref idref="f0001">Fig. 1</figref>. For example, if the patient has sepsis or a high risk assessment for sepsis, clinicians may implement one or more of the following services and actions 26 (aka sepsis protocols): providing high-flow oxygen to the patient, drawing blood for laboratory testing such as testing the levels of lactates and hemoglobin, providing intravenous (IV) antibiotics, providing IV fluids, and performing an hourly urine output measurement.

0071If the patient has a pressure injury or a high risk assessment for a pressure injury, clinicians may implement one or more of the following services and actions 26 (aka pressure injury protocols): a patient support surface therapy such as continuous lateral rotation therapy (CLRT) or alternating pressure therapy, applying a vacuum wound bandage to any pressure ulcer or wound of the patient, capturing an image of the wound(s) for a separate wound assessment, and monitoring the patient movement to assure the patient is repositioning themselves in bed 14 on a suitably frequent basis.

0072If the patient is a falls risk or has a high risk assessment for falling clinicians may implement one or more of the following services and actions 26 (aka falls protocols): enabling a falls risk protocol on bed 14 which results in the bed circuitry and/or a remote computer (e.g., a bed status computer or nurse call computer) monitoring patient position on the bed 14, monitoring siderail position to confirm that designated siderails are in their raised positions, monitoring caster brake status to confirm that the casters are braked, and monitoring a position of an upper frame of the bed 14 to confirm that it is in a low position relative to a base frame of the bed 14; providing an incontinence detection pad of incontinence detection system 16 between the patient and a mattress of bed 14; providing a walker adjacent to the bed; and providing adequate food and/or water near the patient.

0073Referring now to <figref idref="f0002">Fig. 2</figref>, a diagrammatic view shows various activities occurring around the patient bed 14 and also discloses aspects of a digital safety net (DSN) platform 30 based on the activities, the DSN platform including the analytics engine 20. The DSN platform also includes a Power over Ethernet (PoE) switch, router or gateway 32 (these terms are used interchangeably herein) that receives data from a multitude of sources 12, including bed 14, and routes risk assessment information to a plurality of output devices 34 which include graphical displays 36 and an indicator 38 (aka a dome light) of a nurse call system which provides visual information regarding the risk assessments performed by the analytics engine 20.

0074Beneath the upper left image of <figref idref="f0002">Fig. 2</figref>, the bullet points indicate that there is an admitted patient in bed 14 and that an initial assessment of the patient has been conducted. In connection with initial assessment, the patient's medical history is taken, the patient's initial vital signs and weight are captured, a baseline pressure injury risk is assessed, and a photo of a suspected pressure injury is taken with a camera 40, illustratively a WOUNDVUE™ camera 40 available from LBT Innovations Ltd. of Adelaide, Australia, and uploaded to the analytics engine 20 for a wound assessment. An arrow 42 situated between the upper left image and the upper center image of <figref idref="f0002">Fig. 2</figref> indicates that the data associated with the bullet points beneath the upper right image are communicated to the analytics engine of the DSN platform 30 of the upper center image.

0075Beneath the upper center image of <figref idref="f0002">Fig. 2</figref>, the bullet points indicate that the analytics engine 20 of the DSN platform 30 has engaged a sepsis protocol in connection with assessing the patient's risk of developing sepsis; the patient's sepsis risk has been stratified or normalized into a score range of 1 to 5; the patient's condition is being monitored including monitoring the patient's temperature, the patient's motion, and a surface status of a patient support surface (aka a mattress) of bed 14. According to this disclosure, DSN platform 30 also engages a falls protocol in connection with assessing the patient's falls risk and engages a pressure injury protocol in connection with assessing the patient's pressure injury risk. The falls risk and pressure injury risk are also stratified or normalized by the analytics engine 20 into a score range of 1 to 5 in the illustrative example. In other embodiments, the risk ranges for each of the sepsis, falls, and pressure injury risks is 0 to 5. Thus, each of the sepsis, falls, and pressure injury risks has the same maximum value (e.g., 5 in the illustrative examples) and the same minimum value (0 or 1 in the illustrative examples). In other embodiments, different risk ranges are used such as those having upper limits greater than 5 including 10, 20, 25, 30, etc.

0076Also beneath the upper center image of <figref idref="f0002">Fig. 2</figref> are bullet points indicating that the risk levels or scores determined by the analytics engine 20 of the DSN platform 30 are displayed on the output devices 34 across the DSN platform 30 (i.e., at multiple locations throughout the healthcare facility) and that a rounding protocol is adjusted based on one or more of the determined risk scores for the patient's sepsis, falls, and pressure injury risks. With regard to graphical displays 36, the actual values of the scores are displayed in some embodiments, whereas with regard to the dome light 38, a portion of the dome light is illuminated in a particular manner based on the risk scores. For example, if any of the risk scores are 4 or 5, then a red light may be illuminated on the dome light 38 but if each of the risk scores is only 2 or 3, then a yellow or amber light may be illuminated on the dome light 38. If the risk scores are all at a lower level (e.g., 0 or 1 as the case may be), then the portion of the dome light relating to patient risk remains unlit. This lighting scheme for dome light 38 is given as one illustrative example and other lighting schemes are within the scope of the present disclosure, including having a portion or section of dome light 38 allocated to each risk score such that there are three risk light regions of dome light 38 corresponding to the sepsis, falls, and pressure injury risks, with each risk light region being illuminated red, yellow/amber, or unlit for different risk level scores of the associated risk. Other zones on the dome light indicate, for example, whether a caregiver is in the room, whether a patient in the room has placed a nurse call, or whether an equipment alarm in the room is active, including for semi-private rooms, which of two patients has placed the nurse call or which patient is associated with the equipment that is alarming. Dome lights that have portions that illuminate in colors other than red and yellow/amber, such as white, green, blue, purple, etc., are within the scope of the present disclosure.

0077With regard to adjusting a rounding protocol, the rounding interval or time between caregiver rounds (i.e., the time between when an assigned caregiver is required to check on the patient) is shortened in some embodiments if one or more of the risk scores is high (e.g., level 4 or 5) or if a risk score increases from one level to the next (e.g., increasing from level 2 to level 3). It is contemplated by this disclosure that the higher a risk score is, the shorter the rounding interval will be. The correlation between rounding interval times and risk score levels, including summing two or three of the risk scores together for determining a rounding interval, is at the discretion of the system programmer or administrator. An arrow 44 situated between the upper center image and the upper right image of <figref idref="f0002">Fig. 2</figref> indicates that after the activities associated with the bullet points beneath the upper center image are performed by the DSN platform 30, the bed 14 and vital signs equipment 18 (and other equipment as disclosed herein) continue to provide data to the analytics engine 20 for dynamic, real-time risk assessment.

0078In some embodiments, adjustment of the rounding interval occurs dynamically, automatically, and substantially in real time as the risk scores increase and decrease. Thus, a rounding interval is decreased automatically from four hours to two hours if a risk score increases from, for example, a level 3 to level 4, and the rounding interval is increased from two hours to four hours, for example, if a risk score decreases from a level 4 to a level 3, just to give one arbitrary example to illustrate the concept. The rounding intervals are tracked and changed by an EMR computer or server or a nurse call computer or server in some embodiments. The rounding interval adjustments are made without human input or involvement at the computer or server that controls the rounding intervals in some embodiments. In other embodiments, a caregiver or clinician or other administrator at the rounding computer provides inputs to approve the rounding interval change. In either case, a rounding interval change notification is transmitted to the mobile device or devices of the affected caregiver(s) in some embodiments.

0079The phrase "substantially in real time" as used herein means the amount of time that data measurements or values which contribute to the risk scores are received and are processed for re-calculation of the risk scores. Some equipment 12 may provide readings only once every minute or once everty second and other equipment may provide readings 100 time per second, just to give some arbitrary examples. The present disclosure contemplates that the analytics engine 20 re-calculates risk scores each time a new data point is received and such is considered to be "substantially in real time" according to the present disclosure. The present disclosure also contemplates that the analytics engine 20 re-calculates risk scores only if a received measurement or value changes from a previous measurement or value. Thus, if a constant value is transmitted over and over again, the analytics engine does not re-calculate the risk score until one of the contributing measurements or values changes and this is also considered to be "substantially in real time" according to the present disclosure.

0080Beneath the upper right image of <figref idref="f0002">Fig. 2</figref>, the bullet points indicate that the dynamic patient risk assessment by the analytics engine 20 includes monitoring, on an ongoing basis, whether patient support surface status is consistent with reduced pressure injury risk or whether the patient support surface status has changed in such a manner as to create an increased pressure injury risk. For example, if a bladder of the mattress of bed 14 has a leak and a sufficient amount of air is lost, the bladder pressure may decrease enough to permit a patient to bottom out through the mattress so as to be supported on the underlying mattress support deck rather than being supported by the bladder. Such a situation increases the risk that the patient may develop a pressure injury. According to this disclosure, the dynamic risk assessment by the analytics engine 20 also includes monitoring whether the patient's vital signs sensed by monitors 18 or by the on-bed vital sign sensors, are consistent and within desirable limits or whether the vital signs are changing in a manner indicative of declining health of the patient. If the latter scenario is detected, the patient's sepsis risk score is increased. Further according to this disclosure, the dynamic risk assessment by the analytics engine 20 also includes determining whether the patient is sleeping or not in the room, in which case the patient's falls risk score is decreased, or whether the patient is moving, agitated, or in pain, in which case the patient's falls risk score is increased. As the patient's risks scores increase or decrease, the clinical protocols for the patient are adjusted in a commensurate manner to match the changing risk level.

0081An arrow 46 situated between the upper right image and the lower right image of <figref idref="f0002">Fig. 2</figref> indicates that after a period of time, other conditions of the patient on bed 14 may be detected. As indicated by the bullet points beneath the lower right image of <figref idref="f0002">Fig. 2</figref>, if a patient change is detected by bed 14, such as lack of patient motion or patient motion below a threshold, for a prolonged period of time, and/or if a problematic surface change is detected, then a pressure injury algorithm executed by the analytics engine 20 determines that there is an increased risk of a pressure injury and the patient's pressure injury score is increased. Furthermore, in response to the increased pressure injury score, the analytics engine 20 initiates one or more alerts to one or more caregivers of the increased pressure injury risk and, in some embodiments, automatically activates a pressure injury prevention protocol such as reducing the rounding time automatically and/or implementing a surface therapy protocol such as sending reminder messages to a caregiver to turn the patient, to activate a turn assist function of bed 14 at regular intervals (e.g., every hour or every two hours), to activate an alternating pressure therapy of the mattress of bed 14, or to activate a CLRT therapy of the mattress of bed 14.

0082If the analytics engine 20 receives data from bed 14 or vital signs monitors 18 resulting in an increased falls risk score or sepsis risk score, then the DSN platform 30 responds in a similar manner to alert caregivers of the increased score. For example, an increased patient heart rate coupled with increased patient movement may indicate that the patient is preparing to exit the bed 14 and the falls risk score may be increased accordingly. As another example, if the patient's heart rate or respiration increases but there is a lack of patient motion or patient movement below a threshold, thereby indicating a lethargic patient, then this may indicate an increased sepsis risk and the sepsis risk score may be increased accordingly.

0083In each of these cases of increasing risk score, the analytics engine 20 initiates an alert to one or more caregivers assigned to the patient in some embodiments. Such alerts may be sent to a mobile device (e.g., pager, personal digital assistant (PDA), smart phone, or tablet computer) carried by the respective one or more caregivers. Such alerts may also be displayed on graphical displays 36 and dome lights 38 of system 10. As was the case for the increasing pressure injury score, a falls risk protocol or a sepsis protocol may be initiated automatically by the analytics engine 20 in response to an increasing falls risk score or increasing sepsis risk score, respectively.

0084According to this disclosure, analytics engine 20 also provides risk score data or messages to sources 12, such as beds 14 and monitors 18 that are equipped with communications circuitry configured for bidirectional communication with analytics engine 20. Thus, in some embodiments, a message received by one or more of sources 12 from analytics engine 20 results in a risk reduction protocol or function of the source 12 being activated automatically (e.g., an alternating pressure function of a mattress being turned on automatically or an infusion pump for delivery of IV antibiotics being turned on automatically or a bed exit/patient position monitoring function of a bed being turned on automatically). In some embodiments, graphical displays of the sources 12, such as beds 14 and monitors 18, receiving such messages from analytics engine 20 display a message indicating that one or more of the pressure injury, falls, and sepsis risk scores have increased and, in appropriate circumstances, that a risk reduction protocol or function of the source 12 has been turned on or activated automatically.

0085An arrow 48 situated between the lower right image and the lower left image of <figref idref="f0002">Fig. 2</figref> indicates that a caregiver has been dispatched to the patient room of the patient whose risk score has increased. Thus, as indicated by the bullet points beneath the lower left image of <figref idref="f0002">Fig. 2</figref>, in response to an increasing pressure injury score, falls risk score, or sepsis risk score, the analytics engine 20 initiates an alert or notification to one or more assigned caregivers to immediately go to the patient's room and engage the patient. When the caregiver reaches the patient room, some of the risk factors resulting in the increased risk score may be addressed at that time. For example, the caregiver may assist a patient in going to the bathroom in response to an increase falls risk score or the caregiver may turn on a mattress turn assist function or therapy function for a patient having an increased pressure injury risk score or the caregiver may initiate delivery of IV antibiotics for a patient having an increased sepsis risk score.

0086After the caregiver addresses the patients falls risk, pressure injury, and/or sepsis needs, the data provided to analytics engine 20, in some cases, will result in the respective risk score being decreased automatically. In some cases, however, the caregiver provides clinical insights 24 to the analytics engine 20 that result in a decreased risk score after the caregiver has addresses the patient's needs. In the case of an increased pressure injury score, the caregiver dispatched to the patient's room may be required, in some embodiments, to take a picture of any of the patient's pressure injuries using camera 40 for upload to analytics engine 20 so that the most recent pressure injury data is used in connection with determining the patient's pressure injury score.

0087Referring now to <figref idref="f0003">Fig. 3</figref>, additional sources 12 of system 10 that provide data to analytics engine 20 via router or PoE switch 32 are shown. The additional sources 12 of <figref idref="f0003">Fig. 3</figref> include a graphical room stations 50, patient lifts 52, and a locating system 54. Graphical room station 50 is included as part of a nurse call system such as the NAVICARE® Nurse Call system available from Hill-Rom Company, Inc. of Batesville, IN. Additional details of suitable nurse call systems in which room stations 50 are included can be found in <patcit id="pcit0009" dnum="US7746218B"><text>U.S. Pat. Nos. 7,746,218</text></patcit>; <patcit id="pcit0010" dnum="US7538659B"><text>7,538,659</text></patcit>; <patcit id="pcit0011" dnum="US7319386B"><text>7,319,386</text></patcit>; <patcit id="pcit0012" dnum="US7242308B"><text>7,242,308</text></patcit>; <patcit id="pcit0013" dnum="US6897780B"><text>6,897,780</text></patcit>; <patcit id="pcit0014" dnum="US6362725B"><text>6,362,725</text></patcit>; <patcit id="pcit0015" dnum="US6147592A"><text>6,147,592</text></patcit>; <patcit id="pcit0016" dnum="US5838223A"><text>5,838,223</text></patcit>; <patcit id="pcit0017" dnum="US5699038A"><text>5,699,038</text></patcit> and <patcit id="pcit0018" dnum="US5561412A"><text>5,561,412</text></patcit> and in <patcit id="pcit0019" dnum="US20090217080A1"><text>U.S. Patent Application Publication Nos. 2009/0217080 A1</text></patcit>; <patcit id="pcit0020" dnum="US20090214009A1"><text>2009/0214009 A1</text></patcit>; <patcit id="pcit0021" dnum="US20090212956A1"><text>2009/0212956 A1</text></patcit>; and <patcit id="pcit0022" dnum="US20090212925A1"><text>2009/0212925 A1</text></patcit>. Room stations 50 are among the sources 12 that caregivers use to provide clinical insights 24 into system 10 for analysis by analytics engine 20.

0088Patient lifts 52 provide data to analytics engine 20 via router 32 in response to being used to lift a patient out of bed 12 for transfer to a stretcher, chair, or wheelchair, for example. The fact that a patient lift 52 needs to be used to move a patient to or from bed 14 is indicative that the patient is a falls risk because the patient is not able to exit from bed 14 and walk on their own or to get back onto bed 14 on their own. Thus, the falls risk score is increased by the analytics engine 20 in response to the patient lift 52 being used to move the patient. Furthermore, use of the patient lift 52 to move a patient to or from bed 14 also may be indicative that the patient is at higher risk of developing a pressure injury than an ambulatory patient. For example, lifts 52 are oftentimes used to transfer paraplegic or quadriplegic patients and such patients, while in bed, have limited ability to shift their weight to reduce the chances of developing pressure injuries. Also, slings used with patient lifts sometimes produce high interface pressures on portions of the patient, such as the patient's hips or sacral region, which also may increase the risk of developing a pressure injury. Thus, in some embodiments, use of lift 52 not only results in an increase in the patient's falls risk score but also an increase in the patient's pressure injury score.

0089The illustrative image of patient lift 52 in <figref idref="f0003">Fig. 3</figref> is an overhead lift 52 that is attached to a framework installed in the patient room. Other types of patient lifts 52 include mobile patient lifts which are wheeled into a patient room for use. A set of wireless communication icons 56 are included in <figref idref="f0003">Fig. 3</figref> to indicate that some of sources 12 of network 10 communicate wirelessly with the gateway 32, such as via one or more wireless access points (not shown) for example. In particular, icons 56 of <figref idref="f0003">Fig. 3</figref> indicate that beds 14, monitors 18, patient lifts 52, components of locating system 56, and components of incontinence detection system 16 communicate wirelessly with gateway 32. The lines extending from sources 12 to gateway 32 in <figref idref="f0003">Fig. 3</figref> indicate that the sources may communicate via wired connections with gateway 32 in addition to, or in lieu of, the wireless communication.

0090In some embodiments, the sources 12 that are able to communicate wirelessly have dedicated circuitry for this purpose. Alternatively or additionally, locating tags of locating system 54 are attached to sources 12, such as beds 14, monitors 18, patient lifts 52, and components of incontinence detection system 16. Locating tags of system 54 are also attached to caregivers and/or patients in some embodiments. The locating tags include transmitters to transmit wireless signals to receivers or transceivers installed at various fixed locations throughout a healthcare facility. In some embodiments, the tags have receivers or transceivers that receive wireless signals from the fixed transceivers. For example, to conserver battery power, the locating tags may transmit information, including tag identification (ID) data, only in response to having received a wireless signal from one of the fixed transceivers. The fixed receivers or transceivers communicate a location ID (or a fixed receiver/transceiver ID that correlates to a location of a healthcare facility) to a locating server that is remote from the various fixed transceivers. Based on the tag ID and location ID received by the locating server, the locations of the various tagged equipment of sources 12, the tag wearing caregivers, and the tag wearing patients is determined by the locating server.

0091With the foregoing discussion in mind, if a mobile patient lift 52 is determined by the locating system 54 to be in the room of a patient, analytics engine increases the pressure injury risk score and/or the falls risk score for the patient in some embodiments. A similar increase in the sepsis risk score may be made by the analytics engine 20 if certain equipment is determined by locating system 54 to be in the patient room. For example, if a heart rate monitor, respiration rate monitor, and blood pressure monitor are all locating in the patient room for a threshold period of time, then the sepsis risk score is increased by the analytics engine 20 in some embodiments. If a bag or bottle of IV antibiotics in the patient room has a locating tag attached, then the sepsis risk score is increased by the analytics engine 20 in some embodiments.

0092If an incontinence detection pad of incontinence detection system 16 is determined to be in the patient room, either due to detection of a locating tag attached to the pad by locating system 54 or due to detection of the incontinence detection pad by the circuitry of bed 14 or due to a reader of incontinence detection system 16 providing data to analytics engine 20, possibly via the nurse call system in some embodiments, then the patient's falls risk score and/or the patient's pressure injury score is increased by the analytics engine in some embodiments. Use of an incontinence detection pad with the patient is indicative that the patient is not sufficiently ambulatory to get out of bed 14 and go to the bathroom on their own, and therefore, the patient is a falls risk patient. Furthermore, use of an incontinence detection pad with the patient is indicative that the patient may be confined to their bed 14 which increases the risk of developing a pressure injury. In some embodiments, in response to incontinence detection system 16 detecting that the patient has soiled the incontinence detection pad and that the pad has remained beneath the patient for a threshold amount of time thereafter before being replaced with an unsoiled pad, then the pressure injury risk score is increased by the analytics engine because prolonged exposure to moisture or wetness increases the chance that the patient will develop a pressure injury.

0093In some embodiments, locating system 54 operates as a high-accuracy locating system 54 which is able to determine the location of each locating tag in communication with at least three fixed transceivers within one foot (30.48 cm) or less of the tag's actual location. One example of a high-accuracy locating system 54 contemplated by this disclosure is an ultra-wideband (UWB) locating system. UWB locating systems operate within the 3.1 gigahertz (GHz) to 10.6 GHz frequency range. Suitable fixed transceivers in this regard include WISER Mesh Antenna Nodes and suitable locating tags in this regard include Mini tracker tags, all of which are available from Wiser Systems, Inc. of Raleigh, North Carolina and marketed as the WISER LOCATOR™ system. UWB locating systems available from other manufacturers may be used just as well. In some embodiments, the high-accuracy locating system 54 uses 2-way ranging, clock synchronization, and time difference of arrival (TDoA) techniques to determine the locations of the locating tags. See, for example, International Publication No. <patcit id="pcit0023" dnum="WO2017083353A1"><text>WO 2017/083353 A1</text></patcit> for a detailed discussion of the use of these techniques in a UWB locating system.

0094In those embodiments in which locating system 54 is a high-accuracy locating system 54, a more granular set of rules for determining whether to increment or decrement a particular risk score may be implemented by analytics engine 20. For example, rather than increasing the falls risk score and/or pressure injury score in response to detection of a patient lift 52 in the room or detection of an incontinence detection pad in the room, the particular risk score is only incremented if the relative position between the lift 52 or incontinence detection pad and the patient bed 14 meets certain criteria. For example, the falls risk and/or pressure injury risk score is not incremented until a motorized lift housing and/or sling bar of the overhead lift 52 are determined to be located over a footprint of the hospital bed 14. This prevents the risk score(s) from being increased or incremented if the overhead lift 52 is not in use with the particular patient but is simply stored off to the side of the bed 14 or in a corner of the room. In a similar way, the falls risk and/or pressure injury risk score is not incremented until a mobile lift 52 is determined to be within a threshold distance, such as 1 or 2 feet of the bed 14 or patient just to give a couple arbitrary examples. Further similarly, the falls risk and/or pressure injury risk score is not incremented until the incontinence detection pad is determined to be within a footprint of the hospital bed 14.

0095Still referring to <figref idref="f0003">Fig. 3</figref>, the graphical displays 36 of output devices 34 include status boards 58, graphical audio stations 50, and mobile devices 60 of caregivers. The illustrative mobile devices 60 of <figref idref="f0003">Fig. 3</figref> are smart phones, but as indicated above, mobile devices 60 also include pagers, PDA's, tablet computers, and the like. Status boards 58 are oftentimes located at master nurse stations in healthcare facilities but these can be located elsewhere if desired, such as in staff breakrooms, hallways, and so forth. In some embodiments, the status boards 58 are included as part of the nurse call system. In this regard, see, for example, <patcit id="pcit0024" dnum="US8779924B"><text>U.S. Patent No. 8,779,924</text></patcit>. This disclosure contemplates that the status board has additional fields for displaying the falls risk, pressure injury risk, and sepsis risk scores for each of the listed patients on the status board.

0096As is apparent in <figref idref="f0003">Fig. 3</figref>, graphical room stations 50 serve as both sources 12 for providing data to the analytics engine 20 and as output devices 34 for displaying data from the analytics engine 20. Thus, graphical room stations 50 also have display screens with fields for displaying the falls risk, pressure injury risk, and sepsis risk scores for the patients located in the rooms having the room stations 50. In some embodiments, stations 50 are operable to obtain and display the risk scores of patients located in other rooms. Thus, a caregiver using the room station 50 in one room may be communicating with another caregiver, such as a nurse at a master nurse station, about a patient located in another room and can pull up information, including the risk scores, pertaining to the other patient being discussed.

0097Mobile devices 60 also have screens with fields to display the risk scores of patients. In some embodiments, a mobile software application is provided on the mobile devices 60 of caregivers and operates to limit the caregiver's ability access to information, such as only being able to see the risk scores for their assigned patients and not those of patients assigned other caregivers. Furthermore, it is contemplated by this disclosure that a pop-up window may appear on the caregiver's mobile device each time a risk score changes for any of the caregiver's assigned patients. Examples of screens that appear on mobile devices 60 in some embodiments are discussed below in connection with <figref idref="f0011 f0012">Figs. 7-10</figref>.

0098An electronic medical records (EMR) or health information systems (HIS) server 62 is also communicatively coupled to the analytics engine 20 via PoE switch 32 as shown in the illustrative example of <figref idref="f0003">Fig. 3</figref>. Server 62 is coupled to one or more EMR or HIS computers (not shown) that have display screens for showing the risk scores of the various patients of the healthcare facility. In some embodiments, server 62 is also a source 12 of data for analytics engine 20 to use in connection with determining the risk scores of the various patients. Analytics engine 20 is also communicatively coupled to an Internet of Things (loT) network or platform 64 via gateway 32 as shown in <figref idref="f0003">Fig. 3</figref>. Platform 64 receives information from multiple healthcare facilities and operates to analyze the incoming information to identify best practices for risk reduction protocols that, in turn, may be shared with other healthcare facilities that may subscribe to receive such best practice information. The best practice information may include relevant thresholds to use in risk assessment algorithms, steps to implement in a standard of care to keep patient risks to a minimum, and corrective actions to take in response to elevated patient risk scores, for example. Platform 64 also may implement analytics for predicting patient outcomes and communicate the predictions to subscribing healthcare facilities, for example.

0099As indicated in <figref idref="f0003">Fig. 3</figref>, analytics engine 20 communicates bidirectionally with some or all of sources 12, output devices 34, server 62, and platform 64. Analytics engine 20 comprises one or more servers or other computers that implement analytics software that is configured in accordance with the various algorithms and rules discussed above. It should be appreciated that <figref idref="f0001 f0002 f0003">Figs. 1-3</figref> are diagrammatic in nature and that other network infrastructure communicatively interconnects each of the devices of system 10 discussed above in each healthcare facility in which system or apparatus 10 is implemented. Another diagrammatic example of network infrastructure is discussed below in connection with <figref idref="f0010">Fig. 6</figref>.

0100Referring now to <figref idref="f0004 f0005 f0006 f0007">Figs. 4A-4C</figref>, a flow chart 70 shows an example of a patient's journey beginning at an emergency department (ED) indicated by block 72 or Surgical unit indicated by block 74, then moving on to an intensive care unit (ICU) or a medical/surgical (MED/SURG) unit indicated by block 76, and then home or to a long term care (LTC) facility or a skilled nursing facility (SNF) as indicated by block 78. Flow chart 70 shows locations within the patient flow at which the analytics engine 20 of DSN platform 30 operates to determine the patient's risk of having or developing sepsis. Wherever in flow chart 70 the DSN platform 30 is invoked for patient risk assessment of sepsis, a DSN platform block 80 is shown.

0101Referring now to <figref idref="f0004">Fig. 4A</figref>, a patient arrives in a hospital at the ED 72 as indicated at block 82 and is triaged and screened for sepsis as indicated at block 84. This initial screening is for the purpose of early detection of sepsis as indicated by Early Detection cloud 86 above ED 72. The information from the screening at block 84 is provided to DSN platform 30 as indicated by the associated block 80 and then a determination is made as to whether it is suspected that the patient has sepsis as indicated at block 88. The determination at block 88 is made by analytics engine 20 based on information communicated from DSN 30 as indicated by Communication cloud 90 above block 88.

0102If it is determined at block 88 that sepsis is suspected, then the patient gets Lactic Acid Culture (LAC) and Complete Blood Count (CBC) tests ordered as indicated at block 92. Lactic acid (aka lactate) in the blood greater than 2 millimoles per liter (mmol/L) is one of the indicators that the patient has sepsis. According to some sepsis determination protocols, this level of lactate in the blood is considered in combination with other sepsis risk factors including one or more of the following: i) systolic blood pressure being less than 90 millimeters of Mercury (mmHg) or a mean arterial blood pressure being less than 65 mmHg; ii) heart rate being greater than 130 beats per minute, iii) respiratory rate being greater than 25 breaths per minute, iv) oxygen saturation (e.g., SpO2) being less than 91%, v) the patient being unresponsive or responds only to voice or pain, and/or vi) the presence of a purpuric rash. According to other sepsis determination protocols, sepsis is determined to be likely if the following criteria are met: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute. Thus, different healthcare facility have different sepsis determination protocols and all such protocols are within the scope of the present disclosure.

0103After the blood test of block 92, a determination is made as to whether or not the patient has sepsis as indicated at block 94. If the patient has sepsis, as determined at block 94, then a 3 hour (Hr) bundle is kicked-off as indicated at block 96. A 3 Hr bundle includes, for example, administration of broad spectrum antibiotics and administering 30 milliliters per kilogram (mL/kg) of Crystalloid for Hypotension or Lactate greater than or equal to 4 mmol/L. The 3 Hr bundle also may include measuring Lactate level and obtaining blood cultures at some healthcare facilities, but in <figref idref="f0004">Fig. 4A</figref>, these were done at block 92 prior to kicking off the 3 Hr bundle at block 96. Above block 96 are a Correct Billing Code cloud 97 and a Bundle Compliance Cloud 98 which, in some embodiments, may invoke monitoring and feedback to caregivers by the DSN platform 30 or the HIS server 62.

0104A box 100 at the top of <figref idref="f0004">Fig. 4A</figref> includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in <figref idref="f0004">Fig. 4A</figref>. In particular, box 100 lists multi-parameter vitals devices, physical assessment devices, beds, ECG carts, and clinical workflow (nurse call) systems. These systems and equipment are sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. A box 102 at the bottom of <figref idref="f0004">Fig. 4A</figref> includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in <figref idref="f0004">Fig. 4A</figref>. In particular, box 102 lists advanced analytics to augment clinical decision making and early detection of conditions (e.g., analytics engine 20), smart sensing beds or stretchers (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies), and mobile communication platform to optimize workflow (e.g., caregiver mobile devices 60).

0105If at block 88 of <figref idref="f0004">Fig. 4A</figref> sepsis is not suspected, or if at block 94 of <figref idref="f0004">Fig. 4A</figref> it is determined that the patient does not have sepsis, then the patient is admitted to the healthcare facility and is sent to a Med/Surg unit as indicated at block 76 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.). The information regarding a negative sepsis suspicion or determination at blocks 88, 94 may be communicated to the analytics engine 20 of DSN platform 30 in connection with the patient being sent to the Med/Surg unit in some embodiments. Thus, two out of the three flow paths exiting from the right hand side of <figref idref="f0004">Fig. 4A</figref>, lead to the patient being admitted and sent to the Med/Surg unit as indicated at block 76 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.). As shown in <figref idref="f0005 f0006">Fig. 4B</figref>, instead of arriving at the emergency department, it is contemplated that a patient arrives at the Surgical unit 74 of the hospital for surgery as indicated at block 104 within surgical unit 74. Thereafter, the patient has surgery as indicated at block 106. During or after surgery, the patient's vitals (i.e., vital signs) are measured and the patient is screened for sepsis while in the Surgical unit 74 as indicated at block 108 of <figref idref="f0005 f0006">Fig. 4B</figref>. In this regard, Early detection cloud 86 is also shown in <figref idref="f0005 f0006">Fig. 4B</figref> above the Sugical unit 74.

0106After surgery, the patient's vitals information and sepsis screening information from block 108 is provided to the analytics engine 20 of the DSN platform 80 and then the patient is admitted to the healthcare facility and is sent to the Med/Surg unit as indicated at block 76 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.). After the patient is admitted to the Med/Surg unit at block 76, Q4 vitals and Best Practice Alerts (BPA) for sepsis are implemented as indicated at block 110 and the associated data is provided to the analytics engine 20 of the DSN platform as indicated by block 80 adjacent to block 110. Q4 vitals are vitals that are taken 4 hours apart, such as 8 am, noon, 4 pm, 8pm, midnight, 4 am, etc. Early Detection cloud 86 is shown above block 110 in <figref idref="f0005 f0006">Fig. 4B</figref> as is a Frequency of Data cloud 112. Thus, cloud 112 above block 110, indicates that caregivers may change the frequency of taking the patient's vital signs to Q1, Q2, or Q8 (i.e., one, two or eight hours apart, respectively, instead of four hours apart) based on clinical insights 24.

0107Based on the data obtained in connection with block 110, a determination is made as to whether it is suspected that the patient has sepsis as indicated at block 114. If it is determined at block 114 that sepsis is not suspected, the work flow 70 returns back to block 110 and proceeds from block 110. If it is determined at block 114 that sepsis is suspected, then the patient gets LAC and CBC tests ordered as indicated at block 116. The LAC and CBC tests were discussed above in connection block 92 of <figref idref="f0004">Fig. 4A</figref> and the same discussion is applicable to block 116 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.). The results of the LAC and CBC are communicated to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 that is situated above block 116 in <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.).

0108Based on the results of the LAC and CBS tests at block 116, a determination is made as to whether the patient has sepsis as indicated at block 118. If at block 118 it is determined that the patient does not have sepsis, the workflow 70 returns back to block 110 and proceeds from block 110. If the patient has sepsis, as determined at block 118, then a 3 Hr bundle is kicked-off as indicated at block 120. The 3 Hr bundle was discussed above in connection with block 96 of <figref idref="f0004">Fig. 4A</figref> and the same description is applicable to block 120 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.). Above block 120 are Correct Billing Code cloud 97 and Bundle Compliance cloud 98 which, in some embodiments, may invoke monitoring and feedback to caregivers by the DSN platform 30, as indicated by block 80 to the right of block 120, or by the HIS server 62. After the 3 Hr bundle is kicked-off at block 120 of <figref idref="f0005 f0006">Fig. 4B</figref>, the patient is evaluated as indicated at block 122 of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.).

0109A box 124 at the top of <figref idref="f0005 f0006">Fig. 4B</figref> includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in <figref idref="f0005 f0006">Figs. 4B and 4B</figref> (Cont.). In particular, box 124 lists multi-parameter vitals devices, physical assessment devices, beds, clinical workflow (nurse call) systems, real time locating solutions (RTLS's), patient monitoring solutions, clinical consulting services, ECG carts, and patient mobility solutions. These systems (or solutions) and equipment of block 124 are sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. A box 126 at the bottom of <figref idref="f0005 f0006">Fig. 4B</figref> (Cont.) includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in <figref idref="f0005 f0006">Figs. 4B and 4B</figref> (Cont.). In particular, box 126 lists advanced analytics to augment clinical decision making and early detection of patient deterioration (e.g., analytics engine 20), wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), smart sensing beds (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies that output vital signs, including cardiac output), and mobile communication platforms (e.g., caregiver mobile devices 60).

0110After the 3 Hr bundle of block 96 of <figref idref="f0004">Fig. 4A</figref> is kicked off, the patient is evaluated as indicated at block 128 of <figref idref="f0005 f0006">Fig. 4B</figref> and data regarding the 3 Hr bundle is provided to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 in <figref idref="f0005 f0006">Fig. 4B</figref> which is situated to the left of block 128. The data obtained during the evaluation of the patient at block 128 is provided to the analytics engine 20 of the DSN platform as indicated by the block 80 to the right of block 128. In the illustrative example, a 6 Hr bundle is kicked off as indicated at block 130 after the data from the patient evaluation of block 128 has been analyzed by the analytics engine 20 of the DSN platform. The 6 Hr bundle, in some embodiments, includes applying vasopressors to maintain MAP greater than or equal to 65 mmHg, measuring central venous pressure (CVP), measuring central venous oxygen saturation (S_CVO2), and re-measuring lactate if initial lactate level was elevated. The 6 Hr bundle may vary from healthcare facility to healthcare facility. After the 6 Hr bundle of block 130, the patient is evaluated once more as indicated at block 132 and the data from the evaluation, including information regarding the steps of the 6 Hr bundle of block 130, is provided to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 to the right of block 132 in <figref idref="f0005 f0006">Fig. 4B</figref>.

0111If the patient evaluation at block 122 or at block 132, as the case may be, indicates that the patient no longer has sepsis, as is the case in the illustrative example of flow chart 70, then the patient is discharged to return home or to an LTC facility or to an SNF as indicated at block 78 of <figref idref="f0007">Fig. 4C</figref>. A Home Monitoring Readmission cloud 134 is situated above block 78 to indicate that continued monitoring of the patient's condition while at home is contemplated. In this regard, a box 136 at the top of <figref idref="f0007">Fig. 4C</figref> includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in <figref idref="f0007">Fig. 4C</figref>. In particular, box 136 lists home health monitoring (BP and weighing scales), ambulatory cardiac monitoring (including vitals monitoring equipment 18 such as an ambulatory blood pressure monitor (ABPM), a Holter monitor, and/or a TAGecg device), and an airway clearance device. These at-home devices and equipment of block 136 are also sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. Thus, such at-home sources 12 communicate with analytics engine 20 via the Internet in some embodiments.

0112A box 138 at the bottom of <figref idref="f0007">Fig. 4C</figref> includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in <figref idref="f0007">Fig. 4C</figref>. In particular, box 138 lists advanced analytics for early detection of patient conditions at home (e.g., analytics engine 20), remote patient monitoring of multiple parameters and related communication platforms, wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), smart sensing beds (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), and integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies that output vital signs).

0113Referring now to <figref idref="f0008">Figs. 5A</figref> and <figref idref="f0009">5B</figref>, a flow chart 140 is provided showing an example of a patient's admission and stay at a healthcare facility including use of equipment in the patient's room to move the patient and showing locations within the patient flow at which the analytics engine 20 operates to make a risk assessment for the patient. At block 142 of <figref idref="f0008">Fig. 5A</figref> of flow chart 140, a patient is transported to a patient room on a stretcher. Thereafter, the patient is transferred from the stretcher to the patient bed 14 in the room as indicated at block 144. At this point, the patient is admitted to the healthcare facility as indicated at block 146. In some embodiments, the patient is admitted prior to being transported to the patient room.

0114Once in the room, a nurse assesses the patient as indicated at block 148 of <figref idref="f0008">Fig. 5A</figref>. As shown in block 148, if a real time locating system (RTLS) determines that a caregiver is located in the patient room, then information on a display board, displays of mobile devices 60, displays 50 of the nurse call system, and status board 58 are updated to indicate the caregiver's presence in the room. Block 148 also indicates that the nurse assesses the bed condition (e.g., siderails in proper position, caster brakes are set, etc.), assesses the patient, conducts an assessment of monitors 18, checks patient temperature, documents patient anxiety level in connection with a heart rate assessment, activates a Patient Safety Application (PSA) (e.g., enables or arms a bed exit/patient position monitoring (PPM) system), and arms bed rails (e.g., indicates which siderails should be in the raised position in connection with the bed exit/PPM system).

0115As indicated at block 150 to the right of block 148, a feed from an admission/discharge/transfer (ADT) system is received by the nurse call system of the healthcare facility and, if the ADT feed indicates the patient is a falls risk, the nurse call system sends a message to the bed 14 associated with the patient to arm systems on bed 14 (e.g., arm the bed exit/PPM system and monitor bed siderail position, caster brake status, etc.) as indicated at block 152. In the illustrative example of <figref idref="f0008">Fig. 5A</figref>, bed pressure sensors are used to monitor patient movement as indicated at block 154 to the right of block 152. Alternatively or additionally, load cells of a weigh scale system of the bed 14 monitors patient movement.

0116As indicated at block 156 of <figref idref="f0008">Fig. 5A</figref> beneath block 154, some or all of the information obtained in the nurse assessment of block 148 is displayed on one or more display devices such as output devices 34 discussed above. Furthermore, as indicated in block 158 down and to the left of block 156, bed 14 sends patient safety status information for displays such as a display at a foot end of the bed, a display board (e.g., status board 58), one or more patient monitoring devices 18, and mobile devices 60 (the "Clarion application" listed in block 158 is software used by mobile devices 60 for caregiver-to-caregiver communication and for communication of alerts (aka alarms) and device data). In some embodiments, the "Clarion application" is the LINQ™ mobile application available from Hill-Rom Company, Inc.

0117The data associated with blocks 148, 150, 152, 154, 156, 158 is also captured for predictive analysis by analytics engine 20 of the DSN platform as indicated by block 160 to the left of block 158. In this regard, the analytics engine 20 receives patient movement data as monitored by load cells of bed 14 as indicated at block 162 to the left of block 160, and then communicates messages indicative of patient probability of bed exit and notifies one or more clinicians of the probability as indicated at block 164. As indicated at block 166 below block 164 in <figref idref="f0008">Fig. 5A</figref>, if a clinician enters the patient room, the PSA disables any alarms associated with features monitored by the PSA.

0118In the illustrative example of flow chart 140 of <figref idref="f0008">Fig. 5A</figref>, the clinician uses a patient lift to move the patient from the bed 14 to a wheelchair as indicated at block 168. Thereafter, as indicated at block 170, the clinician transports the patient to a toilet, such as a toilet in a bathroom included as part of the patient room, for example. Block 170 also indicates that a toilet seat identifies the patient as being present (e.g., sitting on the toilet seat) which results in a change of status on one or more of the displays of output devices 34 to toilet status for the patient and also indicates on the displays that the caregiver is in the room.

0119After the patient is finished using the bathroom, the clinician transports the patient to a chair in the room using the wheelchair as indicated at block 172 of <figref idref="f0009">Fig. 5B</figref>. Block 172 also indicates that the chair identifies the patient as being present (e.g., sitting on the chair) which results in a change of status on one or more of the displays of output devices 34 to Patient-in-Chair status for the patient and one or more of these displays also continue to indicate that the caregiver is in the room. Block 172 further indicates that the chair senses patient movement. Thus, this disclosure contemplate that the chair has load cells, pressure sensors, force sensitive resistors (FSR's), or the like, along with associated circuitry, to sense patient position in the chair and to communicate the patient position in the chair to the analytics engine 20. As indicated in block 174 to the left of block 172, in the illustrative example of flow chart 140, the clinician hands the patient a nurse call communication device (e.g., a pillow speaker unit) that the patient can use to place a nurse call if assistance is needed after the caregiver leaves the patient room while the patient is sitting in the chair.

0120While the patient is sitting in the chair, the analytics engine 20 of the DSN platform 30 captures data from the chair for predicative analysis of chair exit as indicated at block 176 to the left of block 174 in <figref idref="f0009">Fig. 5B</figref>. In the given example, patient movement is monitored by chair pad pressure cells as indicated at block 178 to the left of block 176. As indicated by block 180 below blocks 176, 178 in the illustrative flow chart 140, the clinician leaves the room, the caregiver's status of no longer being present in the room is updated on the displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 but the patient's status as Patient-in-Chair remains on these displays.

0121As indicated in block 182 which is situated to the right of block 180 and beneath block 174 in <figref idref="f0009">Fig. 5B</figref>, system 10 indicates patient probability of chair exit by the patient and notifies one or more clinicians of the probability. Thereafter, a nurse enters the room as indicated at block 184. In response to the caregiver entering the room, the PSA receives information from the locating system that the caregiver is in the room, silences alarms on the bed 14, and sends a message resulting in one or more of displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 being updated to indicate that the caregiver is in the room.

0122In the illustrative example of flow chart 140, after the caregiver enters the room at block 184, the caregiver transports the patient back to bed 14 as indicated at block 186. Thereafter, the bed siderails are raised as indicated at block 188 and the caregiver leaves the room. As also indicated in block 188, the PSA receives information from the locating system that the caregiver has left the room and sends a message resulting in one or more of displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 being updated to indicate that the caregiver is out of the room and that the patient is in bed. Thereafter, data is captured from bed 14 relating to patient movement and the predictive analysis of bed exit at analytics engine 20 of the DSN platform 30 begins again as indicated at block 190 of <figref idref="f0009">Fig. 5B</figref>.

0123Based on the foregoing, it is apparent that data is generated by a number of devices 14, 16, 18 and other sources 12 as described above and sent to the analytics engine 20 of DSN platform 30. The algorithms of analytics engine establish a risk profile (e.g., risk scores) for each patient based on protocols established by a given healthcare facility. Some or all of the devices 14, 16, 18 and other sources 12 are updated with the risk profile information. In some embodiments, the sources 12 have displays that provide guided steps to caregivers that can be taken by the caregivers at the point of care to reduce or mitigate the risk profiles. The risk profiles for each patient are updated in substantially real time by the analytics engine as the incoming data changes. In some embodiments, the analytics engine 20 also sends data to other systems, such as loT platform 64, for further analysis.

0124Referring now to <figref idref="f0010">Fig. 6</figref>, a diagrammatic view of another system 10, similar to <figref idref="f0003">Fig. 3</figref>, is provided and shows hospital on-premises equipment at the left side of the page including in-room devices 12, device gateway 32, and a status board 58. The illustrative in-room devices 12 of <figref idref="f0010">Fig. 6</figref> include hospital bed 14, incontinence detection system 16, vital signs monitor 18, and room station 50. However, devices 12 of system 10 of <figref idref="f0010">Fig. 6</figref> can include any other type of device 12 discussed herein. System 10 of <figref idref="f0010">Fig. 6</figref> further includes cloud devices 200 at a center of the page including an enterprise gateway (HL7) 202, a clinical data repository 204, a risk engine 206, and analytics platform 20 that implements artificial intelligence (AI) to process data in some embodiments. Additional on-premises equipment of system 10 of <figref idref="f0010">Fig. 6</figref> is shown at the right side of the page includes one or more mobile devices 60 and 3^rd party solutions 208 including EMR server 62, an ADT server 210, and a Labs server 212.

0125As indicated in <figref idref="f0010">Fig. 6</figref>, messages and/or data transmitted to 3^rd party solutions 208 from devices 12 via gateway 32 and from clinical data repository 204, risk engine 206, and analytics platform 20 pass through enterprise gateway (HL7) 202. Thus, gateway 202 converts the various messages and data into the health level 7 (HL7) format for subsequent delivery to the 3^rd party devices 208 such as EMR, ADT, and Labs servers 62, 210, 212. In the embodiment of system 10 in <figref idref="f0010">Fig. 6</figref>, risk engine 206 manages the risk levels of the pressure injury risk score, falls risk score, and sepsis risk score based on the incoming data from devices 12 and the analytics platform (aka analytics engine) 20 analyzes the incoming data from devices 12 to determine correlations to the various patient risk scores.

0126According to the present disclosure, a multitude of devices 12 provide a multitude of types of data (e.g., patient data, vital signs data, physiological data, device data, etc.) to the analytics engine 20 which processes the data and determines one or more risk scores based on the data. The risk scores are adjusted substantially in real time as new data is received by the analytics engine 20. In the discussion above, risk scores relating to pressure injuries, falls, and sepsis were given as risk score examples. However, the present disclosure contemplates that other risk scores pertaining to other patient risks can be established at the discretion of a designer or programmer of system 10. In this regard, the following table is a list of the types of data (referred to as "risk factors" that may contribute to risk scores according to the present disclosure, including contributing to the risk scores relating to pressure injuries, falls, and sepsis: <tables id="tabl0001" num="0001"><table frame="all"><title><b>Table 1</b></title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="74mm" /><colspec colnum="2" colname="col2" colwidth="11mm" /><colspec colnum="3" colname="col3" colwidth="13mm" /><colspec colnum="4" colname="col4" colwidth="38mm" /><colspec colnum="5" colname="col5" colwidth="32mm" /><thead><row><entry valign="top"><b>Risk factor</b></entry><entry valign="top"><b>rfid</b></entry><entry valign="top"><b>rfid_type</b></entry><entry valign="top"><b>Description</b></entry><entry valign="top"><b>Type</b></entry></row></thead><tbody><row><entry>Abdominal Aortic Aneurysm Surgery</entry><entry>1</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Abdominal Respirations</entry><entry>2</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Abnormal Lung Sounds</entry><entry>3</entry><entry>0</entry><entry>Diminished, wheezes, Crackles</entry><entry>Clinical exam</entry></row><row><entry>Accessory Muscle Use</entry><entry>4</entry><entry>1</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Accessory Muscle Use</entry><entry>4</entry><entry>2</entry><entry>intracostals and Sub-clavicular retractions</entry><entry>Clinical exam</entry></row><row><entry>Acute Myocardial Ischemia</entry><entry>5</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Acute Pancreatitis</entry><entry>6</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Age</entry><entry>7</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Autoimmune disease, acquired autoimmune disease, acquired immune deficiency syndrome (AIDS), Immune Suppression or HIV</entry><entry>8</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Albumin</entry><entry>9</entry><entry>0</entry><entry /><entry>Labs</entry></row><row><entry>Altered mental status or Confusion</entry><entry>10</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Anemia</entry><entry>11</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Anticoagulants (IV or SC) ex. heparin, lovenox</entry><entry>12</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Anxiety</entry><entry>13</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Any delivery other than cannula (venturi, rebreather, Non-Rebreather, CPAP, BiPAP)</entry><entry>14</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Any New Complaint in last 24 hrs</entry><entry>15</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Arterial Blood Gases</entry><entry>16</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Arterial PaO2</entry><entry>17</entry><entry>0</entry><entry>(Decreased)</entry><entry>Labs</entry></row><row><entry>Arterial PCO2</entry><entry>18</entry><entry>0</entry><entry>(abnormal)</entry><entry>Labs</entry></row><row><entry>Arterial Ph (Acidosis)</entry><entry>19</entry><entry>0</entry><entry /><entry>Labs</entry></row><row><entry>Aspiration</entry><entry>20</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Asthma</entry><entry>21</entry><entry>1</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Asthma</entry><entry>21</entry><entry>2</entry><entry /><entry>Comorbidities</entry></row><row><entry>Blood Transfusion</entry><entry>22</entry><entry>0</entry><entry /><entry>Procedures</entry></row><row><entry>Brain Natriuretic Peptide</entry><entry>23</entry><entry>0</entry><entry>(lab order)</entry><entry>Charted MD orders</entry></row><row><entry>Brain Natriuretic Peptide</entry><entry>24</entry><entry>0</entry><entry>(Elevated)</entry><entry>Labs</entry></row><row><entry>Breathing treatments</entry><entry>25</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Bronchodilators</entry><entry>26</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Bronchiectasis or atelectasis</entry><entry>27</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Bronchitis</entry><entry>28</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Blood Urea Nitrogen</entry><entry>29</entry><entry>0</entry><entry>BUN</entry><entry>Labs</entry></row><row><entry>Burns</entry><entry>30</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cancer</entry><entry>31</entry><entry>1</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cancer</entry><entry>31</entry><entry>2</entry><entry /><entry>Comorbidities</entry></row><row><entry>Capillary refill time</entry><entry>32</entry><entry>0</entry><entry>>3 seconds</entry><entry>Clinical exam</entry></row><row><entry>Cardiac Ejection Fraction</entry><entry>33</entry><entry>0</entry><entry>(decreased)</entry><entry>Labs</entry></row><row><entry>Cardiac or Thoracic Surgery</entry><entry>34</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cardiac Valve Disorder or Valvular Insufficiency</entry><entry>35</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Chemotherapy (aka Chemo)</entry><entry>36</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Chest pain</entry><entry>37</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Chest pressure or pain or Abnormal ECG</entry><entry>38</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Chest x-ray</entry><entry>39</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Chronic Congestive Heart Failure or Congestive Heart Disease</entry><entry>40</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Chronic Obstructive Pulmonary Disease</entry><entry>41</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Congestive Heart Failure</entry><entry>42</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>COPD Exacerbation</entry><entry>43</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Corticosteriods</entry><entry>44</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Cost of Prior care</entry><entry>45</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Cough</entry><entry>46</entry><entry>1</entry><entry /><entry>Clinical exam</entry></row><row><entry>Cough</entry><entry>46</entry><entry>2</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Creatinine</entry><entry>47</entry><entry>0</entry><entry>(Increased)</entry><entry>Labs</entry></row><row><entry>Cyanosis</entry><entry>48</entry><entry>1</entry><entry /><entry>Clinical exam</entry></row><row><entry>Cyanosis</entry><entry>48</entry><entry>2</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Cystic Fibrosis</entry><entry>49</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Decreased level of consciousness (LOC)(from AVPU of modified early warning score (MEWS) or Glasgow Coma Scale (GCS) or Facility specific or agitation or encephalopathy)</entry><entry>50</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Deep Vein Thrombosis</entry><entry>51</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Dementia</entry><entry>52</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Diaphoresis (sweating)</entry><entry>53</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Diuretic Use</entry><entry>54</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Doppler Echocardiography (imaging)</entry><entry>55</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Drug Overdose</entry><entry>56</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Dyspnea</entry><entry>57</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Dyspnea at rest</entry><entry>58</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Emergency Surgery</entry><entry>59</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Emphysema</entry><entry>60</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Alcohol (EtOH) Abuse or Drug Abuse including intravenous (IV) drug abuse</entry><entry>61</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Hemoglobin</entry><entry>62</entry><entry>0</entry><entry>Low</entry><entry>Labs</entry></row><row><entry>Hematocrit</entry><entry>63</entry><entry>0</entry><entry>Low</entry><entry>Labs</entry></row><row><entry>Hemoptysis</entry><entry>64</entry><entry>1</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Hemoptysis</entry><entry>64</entry><entry>2</entry><entry /><entry>Patient symptoms</entry></row><row><entry>High Emergency Department Use</entry><entry>65</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>High Fluid Rates or Volumes (I&O)</entry><entry>66</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>High Fluid Rates or Volumes or Hypertonic Fluids</entry><entry>67</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Hx Coronary Artery Disease (CAD)</entry><entry>68</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Hx Cerebral Vascular Accident (CVA) (Stroke)</entry><entry>69</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Hx Pulmonary Emboli</entry><entry>70</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Hx Sepsis</entry><entry>71</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Insulin-Dependent Diabetes Mellitus (IDDM) (aka type 1 diabetes)</entry><entry>72</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Interstitial Lung Disease</entry><entry>73</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Lactate (elevated)</entry><entry>74</entry><entry>0</entry><entry /><entry>Labs</entry></row><row><entry>Long Term Care (LTC) Resident or Nursing Home Resident</entry><entry>75</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Lung abscess</entry><entry>76</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Male</entry><entry>77</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Morbid Obesity</entry><entry>78</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Mottling of skin</entry><entry>79</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Neck Surgery</entry><entry>80</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Neuro surgery, upper abd. or Peripheral Vascular Surgery</entry><entry>81</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Neuromuscular Disease</entry><entry>82</entry><entry>0</entry><entry>ALS, MS, Stroke, Spinal Cord Injury, Guillain-Barre, myasthenia Gravis</entry><entry>Comorbidities</entry></row><row><entry>New need or greater need for assist with ADLS</entry><entry>83</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Non-White</entry><entry>84</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Opioids</entry><entry>85</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Orthopnea</entry><entry>86</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Peripheral edema</entry><entry>87</entry><entry>0</entry><entry>Ankles and legs</entry><entry>Clinical exam</entry></row><row><entry>Pneumonia</entry><entry>88</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Pneumothorax</entry><entry>89</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Polypharmacy</entry><entry>90</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Prior Functional Status</entry><entry>91</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Prior Intubation</entry><entry>92</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Fatigue (acute or profound)</entry><entry>93</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Pulmonary Consult</entry><entry>94</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Pulmonary Emboli</entry><entry>95</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Pulmonary Function Test</entry><entry>96</entry><entry>0</entry><entry>(One or more Abnormals)</entry><entry>Labs</entry></row><row><entry>Pulmonary Hypertension</entry><entry>97</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Pulmonary-Renal Syndrome</entry><entry>98</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Pulmonary Function Testing</entry><entry>99</entry><entry>0</entry><entry /><entry>Charted MD orders</entry></row><row><entry>Recent hospitalization</entry><entry>100</entry><entry>0</entry><entry>hospitalization within 90 days</entry><entry>Demographics</entry></row><row><entry>Renal Failure</entry><entry>101</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Respiratory rate</entry><entry>102</entry><entry>0</entry><entry /><entry>Vitals</entry></row><row><entry>Restlessness</entry><entry>103</entry><entry>0</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Scoliosis</entry><entry>104</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Sedatives or hypnotics or muscle relaxants</entry><entry>105</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Sepsis</entry><entry>106</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Shock</entry><entry>107</entry><entry>0</entry><entry>cardiogenic, Septic, etc</entry><entry>Associated admission DX</entry></row><row><entry>Sleep Apnea</entry><entry>108</entry><entry>1</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Sleep Apnea</entry><entry>108</entry><entry>2</entry><entry /><entry>Comorbidities</entry></row><row><entry>Smoke Inhalation Injury</entry><entry>109</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Smoker</entry><entry>110</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Sp02</entry><entry>111</entry><entry>0</entry><entry>On Room Air or decreasing</entry><entry>Vitals</entry></row><row><entry>Sputum production</entry><entry>112</entry><entry>1</entry><entry /><entry>Clinical exam</entry></row><row><entry>Sputum production</entry><entry>112</entry><entry>2</entry><entry /><entry>Patient symptoms</entry></row><row><entry>Supplemental 02 or anything other than nasal cannula</entry><entry>113</entry><entry>0</entry><entry /><entry>Vitals</entry></row><row><entry>Surgery including elective surgery</entry><entry>114</entry><entry>1</entry><entry>Any recent surgery</entry><entry>Associated admission DX</entry></row><row><entry>Surgery including elective surgery</entry><entry>114</entry><entry>2</entry><entry>Any surgery during admission</entry><entry>Procedures</entry></row><row><entry>Tachycardia</entry><entry>115</entry><entry>1</entry><entry>Heartrate (HR) > 90 beats per minute</entry><entry>Vitals</entry></row><row><entry>Tachycardia</entry><entry>115</entry><entry>2</entry><entry>Heartrate (HR) > 90 beats per minute</entry><entry>Patient symptoms</entry></row><row><entry>Tachypnea</entry><entry>116</entry><entry>0</entry><entry>Respiration rate (RR) > 20 or 22 breaths per minute</entry><entry>Patient symptoms</entry></row><row><entry>Thoracentesis</entry><entry>117</entry><entry>0</entry><entry /><entry>Procedures</entry></row><row><entry>Transfer from Outside ED</entry><entry>118</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Transfer from Higher level of Care</entry><entry>119</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Trauma</entry><entry>120</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Troponin</entry><entry>121</entry><entry>0</entry><entry>(elevated)</entry><entry>Labs</entry></row><row><entry>VQ Scan or Thoracic CT Scan</entry><entry>122</entry><entry>0</entry><entry>(imaging)</entry><entry>Charted MD orders</entry></row><row><entry>Weight loss</entry><entry>123</entry><entry>0</entry><entry>>10% (six months)</entry><entry>Demographics</entry></row><row><entry>Chronic infectious disease</entry><entry>124</entry><entry>0</entry><entry /><entry>Other</entry></row><row><entry>Lethargy</entry><entry>125</entry><entry /><entry /><entry>Patient symptoms or Associated admission DX</entry></row><row><entry>Delirium</entry><entry>126</entry><entry>0</entry><entry /><entry>Associated admission DX or Clinical exam or Comorbidities</entry></row><row><entry>Fluid overload</entry><entry>127</entry><entry>0</entry><entry /><entry>Clinical exam or Medications or Labs</entry></row><row><entry>Abscess</entry><entry>128</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Abdominal pain</entry><entry>129</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Abdominal tenderness</entry><entry>130</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Acute Lung Injury</entry><entry>131</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Transfer from ICU</entry><entry>132</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Recent, Prior, or Acute Antibiotics</entry><entry>133</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Appendicitis</entry><entry>134</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Asplenic</entry><entry>135</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Bacteremia</entry><entry>136</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Bilirubin</entry><entry>137</entry><entry>0</entry><entry>>/= 1.2 mg/dL (or 20 mmol), ALT and AST also elevated</entry><entry>Labs</entry></row><row><entry>Bone marrow transplant</entry><entry>138</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>C-reactive protein</entry><entry>139</entry><entry>0</entry><entry>>2 sd over normal</entry><entry>Labs</entry></row><row><entry>Cardiac Output</entry><entry>140</entry><entry>0</entry><entry>Increased (early) decreased later as CO drops from volume depletion</entry><entry>Clinical Exam</entry></row><row><entry>Cellulitis</entry><entry>141</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cholangitis</entry><entry>142</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cholecystitis</entry><entry>143</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cirrhosis</entry><entry>144</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Colitis</entry><entry>145</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Cystitis</entry><entry>146</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>D-dimer</entry><entry>147</entry><entry>0</entry><entry /><entry>Labs</entry></row><row><entry>Decrease in daily functions</entry><entry>148</entry><entry>0</entry><entry /><entry>Demographics</entry></row><row><entry>Dehydration</entry><entry>149</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Dialysis</entry><entry>150</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Diverticulitis</entry><entry>151</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Diverticulosis</entry><entry>152</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Early state warm and red skin, late state cool and pale w/ mottling</entry><entry>153</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Encephalitis</entry><entry>154</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Encephalopathy</entry><entry>155</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Endocarditis</entry><entry>156</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Fever</entry><entry>157</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Fever of unknown origin</entry><entry>158</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Gastroenteritis</entry><entry>159</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Gastrointestinal bleed</entry><entry>160</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Gastrointestinal tract infection</entry><entry>161</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Glucose</entry><entry>162</entry><entry>0</entry><entry>Increased (early in diabetic or elevated in non-diabetic) >140 mg/dL</entry><entry>Labs</entry></row><row><entry>Bicarbonate (HCO3)</entry><entry>163</entry><entry>0</entry><entry>Low (early)</entry><entry>Labs</entry></row><row><entry>Headache, Stiff neck</entry><entry>164</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Heart valve disorders</entry><entry>165</entry><entry>0</entry><entry>(including artificial valves)</entry><entry>Comorbidities</entry></row><row><entry>Hyperlactatemia</entry><entry>166</entry><entry>0</entry><entry>>1 mmol/L</entry><entry>Labs</entry></row><row><entry>Hypothermia</entry><entry>167</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Hypotension</entry><entry>168</entry><entry>0</entry><entry>Symptom based admission</entry><entry>Associated admission DX</entry></row><row><entry>Ileus</entry><entry>169</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Immunosuppressants</entry><entry>170</entry><entry>0</entry><entry /><entry>Medications</entry></row><row><entry>Infectious process</entry><entry>171</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Inflammatory bowel disease</entry><entry>172</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>International normalized ratio (INR) for blood clotting</entry><entry>173</entry><entry>0</entry><entry>>1.5</entry><entry>Labs</entry></row><row><entry>Jaundice</entry><entry>174</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Joint Replacement</entry><entry>175</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Leukopenia</entry><entry>176</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Malaise</entry><entry>177</entry><entry>0</entry><entry>Symptom based admission</entry><entry>Associated admission DX</entry></row><row><entry>Malignancy</entry><entry>178</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Mean arterial pressure</entry><entry>179</entry><entry>0</entry><entry><70</entry><entry>Vitals</entry></row><row><entry>Meningitis</entry><entry>180</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Neoplasm</entry><entry>181</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Normal white blood count (WBC) with >10% neutrophils (bands)</entry><entry>182</entry><entry>0</entry><entry /><entry>Labs</entry></row><row><entry>Oliguria (decreased or low urine output)</entry><entry>183</entry><entry>0</entry><entry>(<0.5 ml/kg/hr) × 2 hrs or (500 ml/day)</entry><entry>Clinical exam</entry></row><row><entry>Organ transplant</entry><entry>184</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Osteomyelitis</entry><entry>185</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Ostomy</entry><entry>186</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>PaCO2</entry><entry>187</entry><entry>0</entry><entry><32</entry><entry>Labs</entry></row><row><entry>PaO2</entry><entry>188</entry><entry>0</entry><entry><400</entry><entry>Labs</entry></row><row><entry>PaO2/FiO2</entry><entry>189</entry><entry>0</entry><entry><300</entry><entry>Vitals</entry></row><row><entry>Pelvic pain</entry><entry>190</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Peripheral vascular disease</entry><entry>191</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Peripheral cyanosis</entry><entry>192</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Petechial rash</entry><entry>193</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Ph</entry><entry>194</entry><entry>0</entry><entry>Increase early d/t resp alkalosis then decrease later d/t metabolic acidosis</entry><entry>Labs</entry></row><row><entry>Platelets</entry><entry>195</entry><entry>0</entry><entry><150</entry><entry>Labs</entry></row><row><entry>Positive fluid balance</entry><entry>196</entry><entry>0</entry><entry>>20 ml/kf ocwe 24 hours</entry><entry>Clinical exam</entry></row><row><entry>Pre-existing or current renal disease</entry><entry>197</entry><entry>0</entry><entry /><entry>Associated admission DX or Comorbidities</entry></row><row><entry>Pressure injury</entry><entry>198</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Procalcitonin</entry><entry>199</entry><entry>0</entry><entry>Elevated >2 sd over normal</entry><entry>Labs</entry></row><row><entry>Protein in urine</entry><entry>200</entry><entry>0</entry><entry>Azotemia</entry><entry>Labs</entry></row><row><entry>Partial thromboplastin time (PTT)</entry><entry>201</entry><entry>0</entry><entry>>60 s</entry><entry>Labs</entry></row><row><entry>Pyelonephritis</entry><entry>202</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Recent abortion</entry><entry>203</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Recent childbirth</entry><entry>204</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Recent surgery (including dental)</entry><entry>205</entry><entry>0</entry><entry /><entry>Demographic</entry></row><row><entry>Respiratory infection</entry><entry>206</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Seizures</entry><entry>207</entry><entry>0</entry><entry /><entry>Clinical exam or comorbidities</entry></row><row><entry>Septic arthritis</entry><entry>208</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Sickle cell anemia</entry><entry>209</entry><entry>0</entry><entry /><entry>Comorbidities</entry></row><row><entry>Soft tissue infection</entry><entry>210</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Stupor</entry><entry>211</entry><entry>0</entry><entry /><entry>Clinical exam</entry></row><row><entry>Surgical admission</entry><entry>212</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Syncope (fainting)</entry><entry>213</entry><entry>0</entry><entry /><entry>Other</entry></row><row><entry>Systolic blood pressure (SBP)</entry><entry>214</entry><entry>0</entry><entry>< 100 or change from baseline SBP drop 40 pt from baseline</entry><entry>Vitals</entry></row><row><entry>Temperature</entry><entry>215</entry><entry>0</entry><entry>>38° Celsius (C) or <36° C</entry><entry>Vitals</entry></row><row><entry>Terminal illness</entry><entry>216</entry><entry>0</entry><entry>Any</entry><entry>Comorbidities</entry></row><row><entry>Volume depletion</entry><entry>217</entry><entry>0</entry><entry>Nausea, vomiting, diarrhea</entry><entry>Clinical exam</entry></row><row><entry>White blood cell count</entry><entry>218</entry><entry>0</entry><entry><4000 or >12000</entry><entry>Labs</entry></row><row><entry>Wound</entry><entry>219</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row><row><entry>Acute respiratory distress syndrome</entry><entry>220</entry><entry>0</entry><entry /><entry>Associated admission DX</entry></row></tbody></tgroup></table></tables>

0127It should be noted that some risk factors in Table 1 appear twice but are designated in a separate column as either risk factor identification (rfid) type (rfid_type) 1 or rfid_type 2, with the others having rfid_type 0. The two different types of risk factors mean, for example, that there are multiple sources from which the risk factor may be obtained or, in some instances, that the risk factor is based on gender (e.g., male or female). One or more of the risk factors in Table 1 are selectable in a spread sheet to set up a risk rule that is implemented by the analytics engine 20 in system 10. An example of such risk rules that may be established include determining with the analytics engine 20 that the patient may be at risk of developing respiratory distress if any of the following conditions are met: (1) the patient is 70 years of age or older and has COPD; (2) the patient has COPD and has been prescribed opioids; (3) the patient is 70 years of age or older and has been prescribed opioids; (4) the patient is 70 years of age or older, has asthma, and has a blood urea nitrogen (BUN) of greater than or equal to 30 milligrams (mg) per 100 milliliters (ml) of blood; or (5) any four of the patient conditions listed in Table 1 are present. Further examples of such risk rules that may be established include determining with the analytics engine 20 that the patient may be at risk of developing sepsis if any of the following conditions are met: (1) the patient is 65 years of age or older and has cancer; or (2) the patient has a history of developing sepsis.

0128It is within the scope of the present disclosure for risk rules to be established based on any number of the risk factors set forth in Table 1 and, with regard to those risk factors that pertain to dynamically measureable parameters such as patient physiological parameters (e.g., those indicated at Vitals in the Type column of Table 1), the risk rules can be based on the particular measureable parameter being above or below a threshold criteria. Thus, the present disclosure contemplates that assessing medical risks of a patient includes receiving at the analytics engine 20 patient demographics data of the patient including, for example, at least one of age, race, and weight as shown in Table 1. The analytics engine 20 also receives comorbidity data of the patient in some embodiments including data indicating that the patient has at least one of the following medical conditions or characteristics: acquired immunodeficiency syndrome (AIDS), anemia, chronic congestive heart failure, asthma, cancer, chronic obstructive pulmonary disease (COPD), coronary artery disease, cystic fibrosis, dementia, emphysema, alcohol or drug abuse, stroke, pulmonary emboli, a history of sepsis, type 1 diabetes, morbid obesity, neuromuscular disease, prior intubation, scoliosis, smoker, delirium, asplenic, bone marrow transplant, cirrhosis, dialysis, diverticulosis, heart valve disorders, inflammatory bowel disease, joint replacement, leukopenia, malignancy, neoplasm, organ transplant, peripheral vascular disease, renal disease, pressure injury, recent abortion, recent childbirth, seizures, sickle cell anemia, or terminal illness.

0129In some embodiments, the analytics engine 20 also receives physiological data that may be measured by a physiological monitor that may have at least one sensor coupled to, or in communication with, the patient. The physiological data includes data that is dynamic and changing over time while the patient is being monitored by the physiological monitor. For example, the physiological data includes one or more of the following: heartrate, respiration rate, temperature, mean arterial pressure, systolic blood pressure, or pulse oximetry data including peripheral capillary oxygen saturation (SpO2). In some embodiments, the analytics engine 20 calculates a risk score or performs a risk assessment of the patient in substantially real time based on one or more of the patient demographics data, the comorbidity data, and the physiological data.

0130The analytics engine 20 also receives laboratory data of the patient in some embodiments and uses the laboratory data in connection with calculating the risk score. As shown in Table 1, examples of the laboratory data includes data that pertains to one or more of the following: albumin, arterial partial pressure of oxygen (arterial PaO2), arterial partial pressure of carbon dioxide (PCO2), arterial pH, acidosis, brain natriuretic peptide, blood urea nitrogen, cardiac ejection fraction, creatinine, hemoglobin, hematocrit, lactate, pulmonary function test, troponin, bilirubin, C-reactive protein, D-dimer, glucose, bicarbonate (HCO3), hyperlactatemia, international normalization ration (INR) for blood clotting, normal white blood count (WBC) with greater than 10% neutrophils, arterial partial pressure of carbon dioxide (PaCO2), fluid overload, Ph, platelets, procalcitonin, protein in urine, partial thromboplastin time (PTT) or white blood cell count. Alternatively or additionally, the analytics engine 20 receives patient symptoms data of the patient and uses the patient symptoms data in connection with calculating the risk score. As shown in Table 1, examples of the patient symptoms data includes data that pertains to one or more of the following: accessory muscle use, altered mental status, confusion, anxiety, chest pain, cough, cyanosis, diaphoresis, dyspnea, hemoptysis, fatigue, restlessness, sputum production, tachycardia, tachypnea, or lethargy.

0131Further alternatively or additionally, the analytics engine 20 receives clinical examination data and uses the clinical examination data in connection with calculating the risk score. As shown in Table 1, examples of the clinical examination data includes data pertaining to one or more of the following: abdominal respirations, abnormal lung sounds, accessory muscle use, capillary refill, chest pressure or pain, abnormal electrocardiograph (ECG or EKG), cough, cyanosis, decreased level of consciousness (LOC), agitation, encephalopathy, mottling, need for assistance with activities of daily living (ADLS), orthopnea, peripheral edema, sputum production, delirium, fluid overload, cardiac output, early state warm red skin and late state cool and pale with mottling, fever, headache, stiff neck, hypothermia, ileus, jaundice, meningitis, oliguria, peripheral cyanosis, petechial rash, positive fluid balance, seizures, stupor, or volume depletion.

0132Still further alternatively or additionally, the analytics engine 20 receives charted doctor's orders data and uses the charted doctor's order data in connection with calculating the risk score. As shown in Table 1, examples of the charted doctor's orders data includes data that pertains to one or more of the following: delivery of breathing air other than with a cannula including with a Venturi, a rebreather, a non-rebreather, a continuous positive airway pressure (CPAP) machine, and a bi-level positive airway pressure (bi-PAP) machine; testing of arterial blood gases; testing of brain natriuretic peptide; breathing treatments; chest x-ray; Doppler echocardiography; high fluid rates or volumes (input and output (I&amp;O)); pulmonary consultation; pulmonary function testing; ventilation-perfusion (VQ) scan; or thoracic computerized tomography (CT) scan.

0133In some embodiments, the analytics engine 20 also receives admission data for the patient and uses the admission data in connection with calculating the risk score. As shown in Table 1, examples of the admission data includes data that pertains to one or more of the following: abdominal aortic aneurysm surgery, acute myocardial ischemia, acute pancreatitis, aspiration, asthma, bronchiectasis, atelectasis, bronchitis, burns, cancer, cardiac or thoracic surgery, cardiac valve disorder or valvular insufficiency, chemo therapy, congestive heart failure, COPD exacerbation, deep vein thrombosis, drug overdose, dyspnea at rest, emergency surgery, hemoptysis, interstitial lung disease, lung abscess, neck surgery, neuro surgery, upper abdomen surgery, peripheral vascular surgery, pneumonia, pneumothorax, pulmonary emboli, pulmonary hypertension, pulmonary-renal syndrome, renal failure, sepsis, shock, sleep apnea, smoke inhalation injury, surgery, thoracentesis, trauma, lethargy, delirium, abscess, abdominal pain, abdominal tenderness, acute lung injury, appendicitis, bacteremia, cellulitis, cholangitis, cholecystitis, colitis, cystitis, dehydration, diverticulitis, encephalitis, encephalopathy, endocarditis, fever of unknown origin, gastroenteritis, gastrointestinal bleed, gastrointestinal tract infection, hypotension, infectious process, malaise, osteomyelitis, ostomy, pelvic pain, renal disease, pyelonephritis, respiratory infection, septic arthritis, soft tissue infection, surgical admission, wound, or acute respiratory distress syndrome.

0134Alternatively or additionally, the analytics engine 20 receives medications data for the patient and uses the medications data in connection with calculating the risk score. As shown in Table 1, examples of the medications data includes data that pertains to one or more of the following: anticoagulants including heparin or levenox that may be delivered intravenously (IV) or subcutaneously (SC), bronchodilators, corticosteroids, diuretic use, high fluid rates or volumes or hypertonic fluids, opioids, sedatives, hypnotics, muscle relaxants, fluid overload, antibiotics, or immunosuppressants.

0135Based on the forgoing, it should be appreciated that the present disclosure contemplates a method implemented on at least one computer such one or more of analytics engine 20 and other servers such as servers 62, 210, 212, 206. In the discussion that follows, it will be assumed that analytics engine 20 implements the various algorithms and functions. According to the method, the analytics engine 20 receives dynamic clinical variables and vital signs information of a patient. The analytics engine 20 uses the vital signs information to develop prior vital signs patterns and current vital signs patterns and then compares the prior vital signs patterns with the current vital signs patterns. The analytics engine 20 also receives one or more of the following: static variables of the patient, subjective complaints of the patient, prior healthcare utilization patterns of the patient, or social determinants of health data of the patient. The analytics engine 20 uses the dynamic clinical variables, the vital signs information, the results of the comparison of the prior vital signs patterns with the current vital signs patterns, and the one or more of the static variables, the subjective complaints, the healthcare utilization patterns, or the social determinants of health data in an algorithm to detect or predict that the patient has sepsis or is likely to develop sepsis.

0136In some embodiments, the dynamic clinical variables received by the analytics engine 20 includes point-of-care lab data. Optionally, the static variables received by the analytics engine 20 includes comorbidities. Alternatively or additionally, the static variables received by the analytics engine 20 includes whether the care setting of the patient is a pre-acute care setting, an acute care setting, or a post-acute care setting. If desired, the analytics engine 20 also receives historical data of the patient.

0137It is within the scope of the present disclosure for the analytics engine 20 to output one or more recommended actions to one or more clinicians of each of the patients being monitored. Examples of the one or more recommended actions include, for example, sending the patient to an emergency department (ED), increasing monitoring of the patient by the one or more clinicians, or ordering a set of labs for the patient.

0138In some embodiments, the analytics engine 20 ranks the clinicians of a healthcare facility. For example, the analytics engine 20 ranks the clinicians of the healthcare facility by one or of experience, actions previously taken, and prior patient outcomes. Optionally, the actions that have greatest impact on outcomes may be used by the analytics engine 20 to inform newer or less experienced clinicians how an experienced clinician may attend to the patient.

0139It is contemplated by the present disclosure that artificial intelligence (AI) and machine learning is used by the analytics engine 20 to analyze risk factor data of the type listed in Table 1 and to determine correlations between one or more of the risk factors and particular risks such as pressure injuries, falls, and sepsis, as well as other risks for patients. Risk factors that are highly correlated to particular risks are then used to established risk rules based on two or more of the highly-correlative risk factors.

0140As discussed above in connection with <figref idref="f0003">Figs. 3</figref> and <figref idref="f0010">6</figref>, mobile devices 60 of caregivers are among the output devices 34 on which risk scores and risk data are displayed. <figref idref="f0011 f0012">Figs. 7-10</figref> show screen shot examples of the type of information displayed on mobile devices 60 of caregivers. The examples of <figref idref="f0011 f0012">Figs. 7-10</figref>, in some embodiments, are contemplated as being provided by additional software functionality of the LINQ™ mobile application available from Hill-Rom Company, Inc. Additional details of the LINQ™ mobile application can be found in <patcit id="pcit0025" dnum="US14397118A"><text>U.S. Application No. 16/143,971, filed September 27, 2018</text></patcit>, titled "Caregiver and Staff Information System," published as <patcit id="pcit0026" dnum="USXXXXXXXXXXXA1"><text>U.S. Patent Application Publication No. XXXX/XXXXXXX A1</text></patcit>.

0141Referring now to <figref idref="f0011">Fig. 7</figref>, an example of a Patient screen 220 of a mobile application displayed on a touch screen display of mobile devices 60 of <figref idref="f0003">Figs. 3</figref> and <figref idref="f0010">6</figref> includes a My Patients button or icon 222 and a My Unit 224 button or icon near the top of screen 220. In the illustrative example, the My Patients icon 222 has been selected and, as a result, screen 220 includes a list 226 of the patients assigned to the caregiver of the mobile device 60 on which screen 220 is shown. Each of the caregiver's assigned patient's is shown in a separate row of the list 224 and includes the patient's name and the room in the healthcare facility to which the patient has been assigned. Beneath each of the patient's room number and name, one or more risk scores and associated information is shown, when applicable. If the My Unit button 224 is selected, then similar information is shown on the display screen of the mobile device 60 for all patients in the unit of the healthcare facility to which the caregiver is assigned, including patients assigned to other caregivers of the unit.

0142In the illustrative example of screen 220 in <figref idref="f0011">Fig. 7</figref>, beneath the text "2160 HILL, LARRY" in the first line of list 226, a first risk score box 228 shows a systemic inflammatory response syndrome (SIRS) score having a value of 4 and a second risk score box 230 shows a modified early warning score (MEWS) scored having a value of 5. Also in the illustrative example, an up arrow icon 232 is shown to the left of each of boxes 228, 230 in the first row of list 226 to indicate that the SIRS and MEWS scores have both increased as compared to their prior readings. In the illustrative example, "@ 9:20" appears to the right of the text "MEWS" in the first row of list to indicate the time that the MEWS score was most recently updated. In rows two through four of the illustrative example of list 226, only box 230 is shown with the MEWS score for the respective patient. The fifth row of list 226 has the text "2159 NO PATIENT" to indicate that room 2159 does not currently have any patient assigned to it, but if there was a patient assigned to room 2159, then that patient would be among the patients assigned to the caregiver of the mobile device 60 on which screen 220 is shown. Screen 220 also has a menu 234 of icons or buttons (these terms are used interchangeable herein) which is beneath list 226 and which includes a Home icon 236, a Contacts icon 238, a Messages icon 240, a Patients icon 242 and a Phone icon 244. Additional details of the screens and functions associated with icons 236, 238, 240, 242, 244 can be found in <patcit id="pcit0027" dnum="US14397118A"><text>U.S. Application No. 16/143,971, filed September 27, 2018</text></patcit>, published as <patcit id="pcit0028" dnum="USXXXXXXXXXXXA1"><text>U.S. Patent Application Publication No. XXXX/XXXXXXX A1</text></patcit>.

0143Referring now to <figref idref="f0011">Fig. 8</figref>, an example is shown of a Risk Details screen 250 that appears on the touchscreen display of the caregiver's mobile device 60 in response to selection of one of the right arrow icons 252 of screen 220 at the right side of each row of list 226. In the illustrative example of <figref idref="f0011">Fig. 8</figref>, screen 250 shows risk details for patient Larry Hill as indicated at the top of screen 250. A left arrow icon 254 is provided to the left of the text "PATIENTS 2160 HILL, L." at the top of screen 250 and is selectable to return the caregiver back to screen 220. In the illustrative example of screen 250, phone icon 244 no longer appears in menu 234 but rather appears at the top right of screen 250. The other icons 236, 238, 240, 242 remain in menu 234 at the bottom of screen 250.

0144Still near the top of screen 250, the patient's medical record number (MRN) is shown in field 256 and the patient's age is shown in field 258. In the illustrative example, the patient's MRN is 176290 and the patient is 76 years old. Beneath field 256 of screen 250, three status icons are shown. In particular, a falls risk icon 260, a pulmonary risk icon 262, and a pressure injury icon 264 is shown. If the patient is determined to be at risk of falling, then icon 260 is highlighted. If the patient is determined to be at risk for respiratory distress, then icon 262 is highlighted. If the patient is determined to be at risk of developing a pressure injury, then icon 264 is highlighted. Icons 260, 262, 264 are grayed out or are absent if the corresponding patient is determined not to have the associated risk.

0145With continued reference to <figref idref="f0011">Fig. 8</figref>, a MEWS window 266 is shown beneath icons 260, 262, 264 and has additional information pertaining to the MEWS score appearing in box 230. Box 230 and up arrow icon 232 appear at the left side of window 266. To the right of box 230 and icon 232 in window 266, various vital signs information that relate to or contribute to the MEWS score are shown. In the illustrative example of screen 250, the patient, Larry Hill, has a temperature of 100.6° Fahrenheit (F), an SPO2 of 92%, a non-invasive blood pressure (NIBP) of 200/96 mmHg, a heart rate (HR) of 118 beats per minute (BPM), and a respiration rate (RR) of 26 breaths per minute (BPM). Up arrow icons 267 appear in window 266 to the right of any of the vital signs that have increased since the prior reading.

0146According to this disclosure, the data needed to calculate the MEWS is obtained from sensors included as part of medical devices 12 such as patient beds 14 and vital signs monitors 18, and/or is received as manual user inputs based on clinical insights 24 of caregivers, and/or obtained from the person's EMR of EMR server 62. The MEWS is a known score calculated based on the following table: <tables id="tabl0002" num="0002"><table frame="all"><title><b>Table 2</b></title><tgroup cols="8"><colspec colnum="1" colname="col1" colwidth="38mm" /><colspec colnum="2" colname="col2" colwidth="11mm" /><colspec colnum="3" colname="col3" colwidth="14mm" /><colspec colnum="4" colname="col4" colwidth="16mm" /><colspec colnum="5" colname="col5" colwidth="19mm" /><colspec colnum="6" colname="col6" colwidth="17mm" /><colspec colnum="7" colname="col7" colwidth="17mm" /><colspec colnum="8" colname="col8" colwidth="13mm" /><thead><row><entry align="center" valign="top"><b>Score</b></entry><entry align="center" valign="top"><b>3</b></entry><entry align="center" valign="top"><b>2</b></entry><entry align="center" valign="top"><b>1</b></entry><entry align="center" valign="top"><b>0</b></entry><entry align="center" valign="top"><b>1</b></entry><entry align="center" valign="top"><b>2</b></entry><entry align="center" valign="top"><b>3</b></entry></row></thead><tbody><row><entry>Systolic BP</entry><entry><70</entry><entry>71-80</entry><entry>81-100</entry><entry>101-199</entry><entry>-</entry><entry>>200</entry><entry>-</entry></row><row><entry>Heart rate (BPM)</entry><entry>-</entry><entry><40</entry><entry>41-50</entry><entry>51-100</entry><entry>101-110</entry><entry>111-129</entry><entry>>130</entry></row><row><entry>Respiratory rate (RPM)</entry><entry>-</entry><entry><9</entry><entry>-</entry><entry>9-14</entry><entry>15-20</entry><entry>21-29</entry><entry>>30</entry></row><row><entry>Temperature (°C)</entry><entry>-</entry><entry><35</entry><entry>-</entry><entry>35.0-38.4</entry><entry>-</entry><entry>>38.5</entry><entry>-</entry></row><row><entry>AVPU</entry><entry>-</entry><entry>-</entry><entry>-</entry><entry>A</entry><entry>V</entry><entry>P</entry><entry>U</entry></row></tbody></tgroup></table></tables>

0147In Table 2, the various integers in the column headings are added together based on the various readings for the person of the data corresponding to the rows of the table. A score of 5 or greater indicates a likelihood of death. With regard to the systolic blood pressure, heart rate, respiratory rate, and temperature portions of the MEWS, those pieces of information are obtained using sensors of patient beds 14 and/or using the other manners of obtaining a person's physiological data as discussed above. The AVPU portion of the MEWS indicates whether a person is alert (A), responsive to voice (V), responsive to pain (P), or unresponsive (U). A caregiver selects the appropriate AVPU letter for each patient and enters it into a computer such as room station 50, their mobile device 60, or another computer of system 10 such as a nurse call computer, an EMR computer, an ADT computer, or the like.

0148Still referring to screen 250 of <figref idref="f0011">Fig. 8</figref>, a Sepsis-Related Organ Failure Assessment (SOFA) window 268 is shown beneath window 266 and has information pertaining to a SOFA score. At the left side of window 268 a risk score box 270 shows the SOFA score value, 2 in the illustrative example, and an up arrow icon 272 indicates that the SOFA score has increased as compared to the previous score. To the right of box 270 and icon 272 in window 268, the patient's physiological parameters that contribute or relate to the SOFA score are shown. In the illustrative example, the patient has platelets of 145 per microliter (µL), an output/input of 800 milliliters per day, and a cardiovascular (CV) of 58 mean arterial pressure (MAP).

0149A MORSE window 274 having information pertaining to a MORSE Fall Scale (MFS) score or value is shown on screen 250 of <figref idref="f0011">Fig. 8</figref> beneath window 268. At the left side of window 274 a risk score box 276 shows the MORSE or MFS score value, 3 in the illustrative example. There is no up arrow icon or down arrow icon shown next to box 276 thereby indicating that the MORSE score has not changed since the previous reading. To the right of box 276 are risk factors that contribute or relate to the MORSE score. In the illustrative example, the patient's mobility risk factors include the patient being vision impaired and having a hip replacement and the patient's medications risk factors include that the patient is prescribed a sedative. In each of windows 266, 268, 274, the time at which the score in the respective risk score box 230, 270, 276 was most recently updated is indicated beneath the respective box 230, 270, 276.

0150As shown in <figref idref="f0011">Fig. 8</figref>, screen 250 includes a pair of Risk Contributors windows including a respiratory distress window 278 listing factors contributing or relating to a risk that the patient will experience respiratory distress and a sepsis window 280 listing factors contributing or relating to the patient's risk of developing sepsis. In the illustrative example, the risk factors in respiratory distress window 278 include the patient having chronic obstructive pulmonary disease (COPD), the patient being over 65 years of age, and the patient being a smoker, and the risk factors in the sepsis window 280 include the patient having a urinary tract infection (UTI) and the patient being over 65 years of age. The example of <figref idref="f0011">Fig. 8</figref> demonstrates that patient risk factors can be used in connection with multiple risk scores or risk contributors to the risk scores or risk determinations.

0151With regard to windows 266, 268, 274, some or all of these are color coded in some embodiments to indicate the severity level of the particular risk score or the particular risk factors relating to the risk scores or determinations. For example, the area around box 230 of window 266 and the border of window 266 is color coded red if the risk value in box 230 is 5 or greater to indicate that the patient is at a high amount of risk. Similarly, the area around boxes 270, 276 of windows 268, 274, respectively, is color coded yellow if the risk values in boxes 270, 276 indicate a medium amount of risk, as is the case in the illustrative example. The arrows 232, 267, 272 are also color coded in some embodiments, typically with a darker shade of red or yellow, as the case may be. If the risk score for any particular risk factor indicates a low level of risk, then the associated window on screen 250 is color coded green or some other color such as blue or black. Risk contributors windows 278, 280 are similarly color coded (e.g., red, yellow, green) in some embodiments, depending upon the number or severity of risk factors that are present for the particular patient. The individual numerical data or risk factors in windows 266, 268, 274 are also color coded in some embodiments.

0152Referring now to <figref idref="f0012">Fig. 9</figref>, an example is shown of an alternative Risk Details screen 250' that appears on the touchscreen display of the caregiver's mobile device 60 in response to selection of one of the right arrow icons 252 of screen 220 at the right side of each row of list 226 of <figref idref="f0011">Fig. 7</figref>. Portions of screen 250' that are substantially the same as like portions of screen 250 are indicated with like references and the description above of these portions of screen 250 is equally applicable to screen 250'. In the illustrative example of <figref idref="f0012">Fig. 9</figref>, screen 250' shows risk details for patient Larry Hill as indicated at the top of screen 250' Beneath the MRN data 256 and age data 258 of screen 250' is a MEWS window 282. At the right side of window 282, the MEWS score box 230 and up arrow icon 232 is shown.

0153Window 282 includes a temperature score box 284, a respiration rate (RR) score box 286, a level of consciousness (LOC) score box 288, a first custom score box 290, and a second custom score box 292 as shown in <figref idref="f0012">Fig. 9</figref>. In the illustrative example, boxes 284, 286 each have a score of 2 and box 288 has the letter P from the AVPU score shown above in Table 2. Illustrative MEWS box 230 has a score of 5 in the illustrative example of screen 250' in <figref idref="f0012">Fig. 9</figref>, but really, the score should be shown as 6 assuming that the P in box 288 corresponds to a score of 2 as shown in Table 2. In the illustrative example of screen 250' up arrow icons 294 are shown beneath boxes 284, 288 to indicate that the temperature portion and the LOC portion, respectively, of the MEWS have each increased since the previous values used to calculate the previous MEWS. A dash icon 296 is shown in window 282 beneath box 286 to indicate that the patient's RR portion of the MEWS has not changed since the previous MEWS calculation.

0154The custom score boxes 290, 292 of window 282 indicate that a revised MEWS or amended MEWS is within the scope of the present disclosure. Thus, designers or programmers of system 10 for any given healthcare facility are able to pick other risk factors, such as those shown above in Table 1, that contribute to such a revised or amended MEWS. Just to give one example, age could be the risk factor chosen as corresponding to one of the boxes 290, 292. The score values based on age ranges are also at the discretion of the system designer or programmer. Thus, integers between 0 and 3 could be assigned to different age ranges just to give one arbitrary example (e.g., 20 year of age or younger = 0; 21-40 years of age = 1; 41-60 years of age =2; 61 years of age or older = 3). Optionally, negative numbers for certain age ranges could be used. For example, 20 years of age or younger could be assigned an age score of -1 which would result in the illustrative score of 5 for such an amended MEWS score assuming the patient associated with window 282 is 20 years of age or younger (i.e., boxes 284, 286, 288 would add up to 6 and then with the -1 age score, the overall amended MEWS would be 5). Again, this is just an arbitrary example and it should be appreciated that there are practically limitless possibilities of risk factors from Table 1 and numerical score scenarios that could be chosen in connection with custom boxes 290, 292 of window 282 to create a revised or amended MEWS.

0155Still referring to screen 250' of <figref idref="f0012">Fig. 9</figref>, a systemic inflammatory response syndrome (SIRS) window 298 is shown beneath window 282. A SIRS score box 300 is shown at the right side of window 298 and a check mark 302 appears in box 300 to indicate that the patient is positive for SIRS. If the patient is negative for SIRS, then box 300 is blank. In the left side of window 298, the risk factors and associated data that have contributed or that relate to the positive SIRS determination for the patient are shown. In the illustrative example of screen 250', window 298 includes heart rate (HR) data of 118 beats per minute and a white blood count (WBC) less than 4,000. In some embodiments, the determination as whether or not the patient is positive for SIRS is based on the following table: <tables id="tabl0003" num="0003"><table frame="all"><title><b>Table 3</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="37mm" /><colspec colnum="2" colname="col2" colwidth="98mm" /><thead><row><entry namest="col1" nameend="col2" align="center" valign="top">Systemic inflammatory response syndrome (SIRS)</entry></row><row><entry align="center" valign="top"><b>Finding</b></entry><entry align="center" valign="top"><b>Value</b></entry></row></thead><tbody><row><entry align="center">Temperature</entry><entry align="center"><36 °C (98.6 °F) or >38 °C (100.4 °F)</entry></row><row><entry align="center">Heart rate</entry><entry align="center">>90/min</entry></row><row><entry align="center">Respiratory rate</entry><entry align="center">>20/min or PaCO2<32 mmHg (4.3 kPa)</entry></row><row><entry align="center">WBC</entry><entry align="center"><4×10⁹/L (<4000/MM³), >12×10⁹/L (>12,000/mm³), or 10% bands</entry></row></tbody></tgroup></table></tables>

0156In typical embodiments, if any two or more conditions indicated in the rows of table 3 is met, then the patient is considered to be positive for SIRS. In other embodiments, at the discretion of the system designer or programmer, two, three, or all four of the conditions indicate in table 3 need to be met before a patient is considered to be positive for SIRS. The present disclosure also contemplates that additional patient risk factors, such as those listed above in table 1, are used in connection with assessing patients for SIRS. It should be appreciated that there are practically limitless possibilities of risk factors from Table 1 and numerical score scenarios that could be chosen in connection with adding additional rows to table 3 or replacing one or more of the current rows of table 3 to create the criteria for the revised or amended SIRS assessment.

0157Some other factors that are commonly used in connection with a SIRS determination include suspected or present source of infection (SIRS + source of infection), severe sepsis criteria (organ dysfunction, hypotension, or hypoperfusion) indicated by lactic acidosis or SBP &lt; 90 or SBP drop ≥ 40 mmHg of normal, and evidence of ≥ 2 organs failing (multiple organ dysfunction syndrome criteria), just to name a few. In any event the SIRS value is sometimes displayed on mobile devices 60 as a numerical score indicating the number of SIRS risk factors that are met, and sometimes is displayed as a check mark that indicates that patient is considered to be positive for SIRS.

0158With continued reference to screen 250' of <figref idref="f0012">Fig. 9</figref>, a Sepsis-Related Organ Failure Assessment (SOFA) window 304 is shown beneath window 298. At the right side of window 304, the SOFA score box 270 and up arrow icon 272 is shown. These are basically the same as shown in window 268 of <figref idref="f0011">Fig. 8</figref> and so the same reference numbers are used. However, unlike window 268 of screen 250 which shows numerical data for the risk factors that contribute to the SOFA score, window 304 of screen 250' has risk score boxes for each of the contributing risk factors. In the illustrative example, a platelets risk score box 306 and a cardiovascular risk score box 308 is shown in window 304 and each box 306, 308 has a score of 1 which, when added together, results in the overall SOFA risk score of 2 shown in box 270 of window 304.

0159In some embodiments of system 10, a quick SOFA (qSOFA) score is also determined and shown on the mobile devices 60 of caregivers. The qSOFA score may be shown in lieu of or in addition to the SOFA score. The following table 4 is used in connection with calculating the qSOFA score in some embodiments: <tables id="tabl0004" num="0004"><table frame="all"><title><b>Table 4</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="61mm" /><colspec colnum="2" colname="col2" colwidth="26mm" /><thead><row><entry align="center" valign="top"><b>Assessment</b></entry><entry align="center" valign="top"><b>qSOFA score</b></entry></row></thead><tbody><row><entry align="center">Low blood pressure (SBP ≤ 100 mmHg)</entry><entry align="center">1</entry></row><row><entry align="center">High respiratory rate (≥ 22 breaths/min)</entry><entry align="center">1</entry></row><row><entry align="center">Altered mentation (GCS ≤ 14)</entry><entry align="center">1</entry></row></tbody></tgroup></table></tables>

0160In some embodiments, one or more of the following tables are used in connection with calculating the SOFA score: <tables id="tabl0005" num="0005"><table frame="all"><title><b>Table 5 - Respiratory system</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="52mm" /><colspec colnum="2" colname="col2" colwidth="25mm" /><thead><row><entry align="center" valign="top"><b>PaO₂/FiO₂ (mmHg)</b></entry><entry align="center" valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>≥ 400</entry><entry>0</entry></row><row><entry>< 400</entry><entry>+1</entry></row><row><entry>< 300</entry><entry>+2</entry></row><row><entry>< 200 <b>and</b> mechanically ventilated</entry><entry>+3</entry></row><row><entry>< 100 <b>and</b> mechanically ventilated</entry><entry>+4</entry></row></tbody></tgroup></table></tables><tables id="tabl0006" num="0006"><table frame="all"><title><b>Table 6 - Nervous system</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="36mm" /><colspec colnum="2" colname="col2" colwidth="23mm" /><thead><row><entry valign="top"><b>Glasgow coma scale</b></entry><entry valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>15</entry><entry>0</entry></row><row><entry>13-14</entry><entry>+1</entry></row><row><entry>10-12</entry><entry>+2</entry></row><row><entry>6-9</entry><entry>+3</entry></row><row><entry>< 6</entry><entry>+4</entry></row></tbody></tgroup></table></tables><tables id="tabl0007" num="0007"><table frame="all"><title><b>Table 7 - Cardiovascular system</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="137mm" /><colspec colnum="2" colname="col2" colwidth="24mm" /><thead><row><entry valign="top"><b>Mean arterial pressure OR administration of vasopressors required</b></entry><entry align="center" valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>MAP ≥ 70 mmHg</entry><entry>0</entry></row><row><entry>MAP < 70 mmHg</entry><entry>+1</entry></row><row><entry>dopamine ≤ 5 µg/kg/min or dobutamine (any dose)</entry><entry>+2</entry></row><row><entry>dopamine > 5 µg/kg/min OR epinephrine ≤ 0.1 µg/kg/min OR norepinephrine ≤ 0.1 µg/kg/min</entry><entry>+3</entry></row><row><entry>dopamine > 15 µg/kg/min OR epinephrine > 0.1 µg/kg/min OR norepinephrine > 0.1 µg/kg/min</entry><entry>+4</entry></row></tbody></tgroup></table></tables><tables id="tabl0008" num="0008"><table frame="all"><title><b>Table 8 - Liver</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="44mm" /><colspec colnum="2" colname="col2" colwidth="24mm" /><thead><row><entry valign="top"><b>Bilirubin (mg/db) [µmol/L]</b></entry><entry valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>< 1.2 [< 20]</entry><entry>0</entry></row><row><entry>1.2-1.9 [20-32]</entry><entry>+1</entry></row><row><entry>2.0-5.9 [33-101]</entry><entry>+2</entry></row><row><entry>6.0-11.9 [102-204]</entry><entry>+3</entry></row><row><entry>> 12.0 [>204]</entry><entry>+4</entry></row></tbody></tgroup></table></tables><tables id="tabl0009" num="0009"><table frame="all"><title><b>Table 9 - Coagulation</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="30mm" /><colspec colnum="2" colname="col2" colwidth="24mm" /><thead><row><entry valign="top"><b>Platelets^x10³/µl</b></entry><entry valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>≥ 150</entry><entry>0</entry></row><row><entry>< 150</entry><entry>+1</entry></row><row><entry>< 100</entry><entry>+2</entry></row><row><entry>< 50</entry><entry>+3</entry></row><row><entry>< 20</entry><entry>+4</entry></row></tbody></tgroup></table></tables><tables id="tabl0010" num="0010"><table frame="all"><title><b>Table 10 - Kidneys</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="69mm" /><colspec colnum="2" colname="col2" colwidth="25mm" /><thead><row><entry valign="top"><b>Creatinine (mg/dl) [µmol/L] (or urine output)</b></entry><entry valign="top"><b>SOFA score</b></entry></row></thead><tbody><row><entry>< 1.2 [< 110]</entry><entry>0</entry></row><row><entry>1.2-1.9 [110-170]</entry><entry>+1</entry></row><row><entry>2.0-3.4 [171-299]</entry><entry>+2</entry></row><row><entry>3.5-4.9 [300-440] (or < 500 ml/d)</entry><entry>+3</entry></row><row><entry>> 5.0 [> 440] (or < 200 ml/d)</entry><entry>+4</entry></row></tbody></tgroup></table></tables>

0161To calculate the overall qSOFA score, the score values in the right hand column of table 4 or, with regard to the SOFA score, the right hand column of whichever of tables 5-10 are being used in connection with the SOFA score, are added together. In the illustrative example of window 304, an up arrow icon 310 is shown beneath box 306 to indicate that the patient's platelets have increased since the previous platelets reading and a dash icon 312 is shown beneath box 308 to indicate that the patient's cardiovascular reading has not changed since the prior cardiovascular reading.

0162Screen 250' of <figref idref="f0012">Fig. 9</figref> also has respiratory distress window 278 and sepsis window 280 which are basically the same as windows 278, 280 of screen 250 of <figref idref="f0011">Fig. 8</figref> and so the same reference numbers are used. However, in addition to text indicating that the patient has COPD, is older than 65 years of age, and is a smoker, window 278 of <figref idref="f0012">Fig. 9</figref> also indicates that the patient has a respiration rate less than 15 breaths per minute. Also, in addition to text indicating that the patient has a UTI and is older than 65 years of age, window 280 of <figref idref="f0012">Fig. 9</figref> also indicates that the patient has a WBC less than 4,000. Similar to the color coding discussed above in connection with windows 266, 268, 274, 278, 280 of screen 250 of <figref idref="f0011">Fig. 8</figref> and the information therein, windows 278, 280, 282, 298, 304 of screen 250' of <figref idref="f0012">Fig. 9</figref> can be similarly color coded in some embodiments.

0163Referring now to <figref idref="f0012">Fig. 10</figref>, an example is shown of a MEWS Details screen 320 that provides greater details relating to the MEWS of screens 250, 250' of <figref idref="f0011">Figs. 8</figref> and <figref idref="f0012">9</figref>. Thus, if the caregiver touches, taps, or swipes MEWS window 230 of screen 250 or MEWS window 282 of screen 250', then screen 320 appears on the touchscreen display of the caregiver's mobile device 60. Portions of screen 320 that are substantially the same as like portions of screens 220, 250, 250' of <figref idref="f0011 f0012">Figs. 7-9</figref>, respectively, are indicated with like reference numbers and the description above is equally applicable to screen 320 with regard to the like portions.

0164Screen 320 has an expanded MEWS data window 322 beneath the MRN data 256 and age data 258. In the illustrative example, the SIRS and SOFA windows 298, 304 of screen 250' of <figref idref="f0012">Fig. 9</figref> are minimized into smaller windows 298', 304', respectively, beneath expanded MEWS data window 322. Windows 298', 304' omit the risk factor data shown, for example, in windows 298, 304. However, windows 298', 304' still show boxes 272, 300 with the respective SOFA score and SIRS check mark icon 302. The up arrow icon 272 is also still shown in window 304'. The expanded MEWS data window 322 includes the boxes 230, 284, 286, 288 that were shown in window 282, but the positions of these boxes has been rearranged and several other boxes, along with numerical data, are also shown in window 322. Up arrow icons 232, 294 are also shown in window 322 to the right of boxes 230, 284, respectively. In the illustrative example of screen 320, an up arrow icon 324 is shown to the right of box 286 and a dash icon 326 is shown to the right of box 288 in window 322.

0165Window 322 also includes a noninvasive blood pressure (NIBP) - systolic risk score box 328, an SPO2 risk score box 330, an NIBP - diastolic risk score box 332, and a pulse rate risk box 334. In the illustrative example, each of boxes 328, 330, 332 has an "X" to indicate that the numerical values of the associated patient physiological parameters do not contribute to the overall MEWS for the patient. In other embodiments, "0" appears in the respective boxes when the associated risk factor does not contribute to the MEWS of the patient. In the illustrative example, a risk score value of 2 appears in box 334. Dash icons 326 are shown to the right of each of boxes 328, 339, 332, 334 to indicate that the respective readings have not changed since the prior readings. The values in boxes 284, 286, 288, 328, 330, 332, 334 of window 322 are sub-scores that, when added together, provide the overall MEWS score for the patient. As noted above, risk factors from table 1 can be used to create a revised or amended MEWS (aka a customized MEWS) and in such instances, the selected risk factors from table 1 have associated risk score boxes and risk data in window 322. Similarly, relevant risk score boxes and data are also shown if windows 268, 264 of screen 250 of <figref idref="f0011">Fig. 8</figref> or if windows 298, 304 of screen 250' of <figref idref="f0012">Fig. 9</figref> are selected on the caregiver's mobile device 60 rather than window 266 of screen 250 or window 282 of screen 250'.

0166According to the present disclosure, an EMR plug-in in the form of a software module is provided in system 10 in some embodiments. The EMR plug-in is used by hospital administrators and caregivers to view a patient's deterioration (e.g., development of sepsis, respiratory distress, pressure injury, etc.) and falls risks giving users dynamic risk monitoring allowing earlier and more consistent identification of patient risk. The plug-in provides viewing of the risk scoring with additional context beyond conventional early warning scores (EWS's) and builds caregiver trust by providing criteria and reasoning behind the risk scoring. The EMR plug-in also indicates if there are missing parameters in a patient's deterioration risk score(s) on an ongoing basis so caregivers are informed of which risk parameters still need to be assessed and entered.

0167In some embodiments, the EMR plug-in is accessed via navigation in an EMR computer that is in communication with EMR server 62. The EMR computer launches a webpage provided by the EMR plug-in. The EMR plug-in is configured to assist in reducing/eliminating delays and communication shortcomings between care personnel/teams during an escalation event or handoff. A Situation, Background, Assessment, Recommendation (SBAR) feature is provided in the EMR plug-in and ensures that a patient's deterioration risk is promptly communicated to the appropriate caregivers upon a hand-off or escalation event to facilitate an efficient transfer of knowledge of the patient's deterioration risk.

0168With regard to calculating a falls risk score according to the present disclosure, additional details can be found in <patcit id="pcit0029" dnum="US62818828A"><text>U.S. Provisional Patent Application No. 62/818,828</text></patcit>, which was filed March 15, 2019, and which is titled "Patient Fall Likelihood," and in <patcit id="pcit0030" dnum="US62818836A"><text>U.S. Provisional Patent Application No. 62/818,836</text></patcit>, which was also filed on March 15, 2019, which is titled "Patient Fall Likelihood and Severity,". According to these two provisional patent applications, a falls risk score (or just, fall score) is determined based on the following formula: <maths id="math0001"><math display="block"><mrow><mi>fall score</mi><mo>=</mo><mi>immediate risk model score</mi><mo>+</mo><mi>attribute risk model score</mi></mrow></math><img file="EP3553786A1_D0001.tif" /></maths>

0169The immediate risk model score is based on the following formula: <maths id="math0002"><math display="block"><mrow><mi>immediate risk model score</mi><mo>=</mo><mi>data</mi><mn>1</mn><mo>×</mo><mi>weight</mi><mn>1</mn><mo>+</mo><mi>data</mi><mn>2</mn><mo>×</mo><mi>weight</mi><mn>2</mn><mo>+</mo><mn>...</mn><mi>dataN</mi><mo>×</mo><mi>weightN</mi></mrow></math><img file="EP3553786A1_D0002.tif" /></maths> where the data can include activity at a given period of time (e.g., toileting during sleeping hours), a medication change, acute motion detected for the patient, etc. Thus, the immediate risk model score is a numerical quantification of the likelihood of an immediate fall with each relevant piece of data weighted and added to create the score. For example, the acute movement of the patient can be weighted more highly than change in medication.

0170The attribute risk model score is based on the following formula: <maths id="math0003"><math display="block"><mrow><mi>attribute risk model score</mi><mo>=</mo><mi>data</mi><mn>1</mn><mo>×</mo><mi>weight</mi><mn>1</mn><mo>+</mo><mi>data</mi><mn>2</mn><mo>×</mo><mi>weight</mi><mn>2</mn><mo>+</mo><mn>...</mn><mi>dataN</mi><mo>×</mo><mi>weightN</mi></mrow></math><img file="EP3553786A1_D0003.tif" /></maths> where the data can include bibliographic / demographic information associated with the patient, such as history of falling, age, frequency or urgency of urination, type of medication taken, procedures under which the patient has gone, a gait analysis, etc. Thus, the attribute risk model score is a numerical quantification of the likelihood of a fall based on attributes of the patient collected over time with each relevant piece of data weighted and added to create the score. For example, the poor gait of the patient can be weighted more highly than motion of the patient in bed over time.

0171With regard to specific devices for detecting and monitoring sepsis according to the present disclosure, additional details can be found in <patcit id="pcit0031" dnum="US62825844A"><text>U.S. Provisional Patent Application No. 62/825,844</text></patcit> ("the '844 application), filed March 29, 2019, titled "Sepsis Detection and Monitoring,". The devices disclosed in the '844 application provide further examples of the type of medical devices 14 of system 10 that provide data to analytics engine 20. For example, the '844 application contemplates that an ECG or photophlethysmogram (PPG) or radar transmitter/receiver can detect heart rate variability of a patient and if the heart variability decreases, which is an indicator of the onset sepsis, the rate of acquiring vital signs data is increased. The '844 application references <patcit id="pcit0032" dnum="US62798124A"><text>U.S. Provisional Patent Application No. 62/798,124, filed January 29, 2019</text></patcit>, for its disclosure of monitoring devices that use radar signals.

0172Further according to the '844 application, a fundus imaging system including a camera is used to capture images of the fundus (e.g., the retina, optic nerve, macula, vitreous, choroid and posterior pole) of a patient during a full cardiac cycle. The images are analyzed to determine whether the patient has microvascular dysregulation which is another indicator of the onset or existence of sepsis in the patient. The fundus imaging system can also be configured to measure the patient's flicker response by exposing the patient's retina to a flashing light and then measuring the reactivity of the retinal blood vessels which is diminished in septic patients due to neurovascular decoupling. Still further, the fundus imaging system can be configured to measure local oxygenation of the retina in connection with determining whether the patient has sepsis. The fundus imaging system can also be configured to measure blood flow velocity changes to detect that the patient is septic because blood vessel walls become "sticky" and blood cells become rigid causing sluggish blood flow in septic patients. The fundus imaging system further may be configured to measure blood vessel diameters and lumen to wall thickness ratios which change in response to dysregulated vasomotor reactions in septic patients. Based on the foregoing, therefore, it should be appreciated that the present disclosure contemplates that analytics engine 20 processes and analyzes image data from a fundus imaging system to make sepsis determinations in some embodiments.

0173Still further according to the '844 application, screening a patient for sepsis involves the use of PPG measurements, bio-impedance measurements, skin perfusion measurements, or temperature measurements at the patient's skin. During early onset of sepsis, vasodilation occurs at the endothelial level and stimuli applied at the patient's skin to produce these measurements causes less of a differential in vasodilation of septic patients than in non-septic patients. The '844 application discloses a temperature induction device that applies a range of temperatures to the patient's skin using a Peltier heater and cooler that heats or cools, respectively, the patient's skin based on a direction of current (e.g., a polarity of voltage applied) through the Peltier heater and cooler. A PPG sensor measures the patient's microvascular response to the changing temperatures. The PPG sensor includes infrared (IR) red and green light emitting diodes (LED's) in some embodiments.

0174The '844 application also discloses an impedance sensor including electrodes attached to the patient's skin surface through which a low voltage (up to 10 Volts) sinusoidal signal is applied via the patient's skin. The impedance of the patient's skin between the electrodes is determined after heating and cooling the skin with the temperature induction device. The measured electrical impedance is then used to determine the microvascular response. In another aspect of the '844 application, a portion of a patient support apparatus, such as a hospital bed, is moved to raise a patient's extremity and to determine whether a septic patient is responding to fluid resuscitation treatment. In some embodiments, a head section or leg section of a hospital bed is raised to determine the patient's macrovascular response which is done by using vital signs measurements to determine a response to the fluid shift away from the raised extremity and toward the patient's heart.

0175In addition to the risk factors or data elements of Tables 1-10 above, the present disclosure contemplates that any one or more of the data elements in Table 11 below can be used to calculate risk scores or to make risk determinations, including calculating the patient falls score, pressure injury score, and sepsis score discussed herein (some of the data elements being risk factors including the same risk factors as listed in Table 1): <tables id="tabl0011" num="0011"><table frame="all"><title><b>Table 11</b></title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="18mm" /><colspec colnum="2" colname="col2" colwidth="148mm" /><thead><row><entry align="center" valign="top"><b>Number</b></entry><entry align="center" valign="top"><b>Data Element</b></entry></row></thead><tbody><row><entry align="center">1</entry><entry><b>BED DATA</b></entry></row><row><entry align="center">2</entry><entry>Connection State</entry></row><row><entry align="center">3</entry><entry>Connectivity Protocol</entry></row><row><entry align="center">4</entry><entry>LastKnownBedConnect</entry></row><row><entry align="center">5</entry><entry>BedPosition (height)</entry></row><row><entry align="center">6</entry><entry>HeadRailsPosition</entry></row><row><entry align="center">7</entry><entry>FootRailsPosition</entry></row><row><entry align="center">8</entry><entry>HeadAnglelnDegrees</entry></row><row><entry align="center">9</entry><entry>HeadAngleAlarmMode</entry></row><row><entry align="center">10</entry><entry>HeadAngleAlarmAudibleMode</entry></row><row><entry align="center">11</entry><entry>HeadAngleAlarmStatus</entry></row><row><entry align="center">12</entry><entry>NurseCalllndicatorState</entry></row><row><entry align="center">13</entry><entry>NurseAnswerlndicatorState</entry></row><row><entry align="center">14</entry><entry>NaviCareAlertsl ndicatorState</entry></row><row><entry align="center">15</entry><entry>BedCleanedlndicatorState</entry></row><row><entry align="center">16</entry><entry>BedOnlineWithServerIndicatorState</entry></row><row><entry align="center">17</entry><entry>HeadAngleMotorLockoutState</entry></row><row><entry align="center">18</entry><entry>KneeAngleMotorLockoutState</entry></row><row><entry align="center">19</entry><entry>BedHeightMotorLockoutState</entry></row><row><entry align="center">20</entry><entry>TiltAngleMotorLockoutState</entry></row><row><entry align="center">21</entry><entry>AllMotorsLockoutState</entry></row><row><entry align="center">22</entry><entry>BedModelName</entry></row><row><entry align="center">23</entry><entry>SidecomSerialNumber</entry></row><row><entry align="center">24</entry><entry>SidecomSoftwareRevision</entry></row><row><entry align="center">25</entry><entry>PatientEnvironmentLastCommand</entry></row><row><entry align="center">26</entry><entry>PatientHistoryLastCommand</entry></row><row><entry align="center">27</entry><entry>ACPowerStatus</entry></row><row><entry align="center">28</entry><entry>BatteryPowerStatus</entry></row><row><entry align="center">29</entry><entry>PatientPositioningAlarmMode</entry></row><row><entry align="center">30</entry><entry>PatientPositioningAlarmStatus</entry></row><row><entry align="center">31</entry><entry>PatientMovementMagnitude</entry></row><row><entry align="center">32</entry><entry>PatientMovementDirection</entry></row><row><entry align="center">33</entry><entry>SafeViewMode</entry></row><row><entry align="center">34</entry><entry>SafeViewlndicatorStatus</entry></row><row><entry align="center">35</entry><entry>ScaleLastCommand</entry></row><row><entry align="center">36</entry><entry>CapturePatientWeightlnKg</entry></row><row><entry align="center">37</entry><entry>CapturedPatientWeightlnLbs</entry></row><row><entry align="center">38</entry><entry>LivePatientWeightInKg</entry></row><row><entry align="center">39</entry><entry>LivePatientWeightlnLbs</entry></row><row><entry align="center">40</entry><entry>ServiceRequiredStatus</entry></row><row><entry align="center">41</entry><entry>SurfaceMode</entry></row><row><entry align="center">42</entry><entry>NurseCallSwitchState</entry></row><row><entry align="center">43</entry><entry>NaviCareAlertsSwitchState</entry></row><row><entry align="center">44</entry><entry>CPRSwitchState</entry></row><row><entry align="center">45</entry><entry>BedCleanedSwitchState</entry></row><row><entry align="center">46</entry><entry>RotationTherapyStatus</entry></row><row><entry align="center">47</entry><entry>PercussionTherapyStatus</entry></row><row><entry align="center">48</entry><entry>VibrationTherapyStatus</entry></row><row><entry align="center">49</entry><entry>BrakeSwitchState</entry></row><row><entry align="center">50</entry><entry>BedServiceCode</entry></row><row><entry align="center">51</entry><entry>FrameSerialNumber</entry></row><row><entry align="center">52</entry><entry>PatientDetected</entry></row><row><entry align="center">53</entry><entry>SafeViewLoLo</entry></row><row><entry align="center">54</entry><entry>SafeViewSideRail</entry></row><row><entry align="center">55</entry><entry>SafeViewPatientPosition</entry></row><row><entry align="center">56</entry><entry>HeadAngleLimitEnabled</entry></row><row><entry align="center">57</entry><entry>PatientPositionChairMode</entry></row><row><entry align="center">58</entry><entry>SafeViewlncontinence</entry></row><row><entry align="center">59</entry><entry>IncontinenceDetected</entry></row><row><entry align="center">60</entry><entry>Deterioration Detected</entry></row><row><entry align="center">61</entry><entry>MacAddress</entry></row><row><entry align="center">62</entry><entry>IPAddress</entry></row><row><entry align="center">63</entry><entry>SignalStrengthInDBm</entry></row><row><entry align="center">64</entry><entry>Load cell data</entry></row><row><entry align="center">65</entry><entry>Log files</entry></row><row><entry align="center">66</entry><entry><b>VITALS (EWS inputs)</b></entry></row><row><entry align="center">67</entry><entry>Respiratory rate</entry></row><row><entry align="center">68</entry><entry>Heart Rate</entry></row><row><entry align="center">69</entry><entry>Pulse Rate</entry></row><row><entry align="center">70</entry><entry>SpO2/SaO2</entry></row><row><entry align="center">71</entry><entry>SBP</entry></row><row><entry align="center">72</entry><entry>DBP</entry></row><row><entry align="center">73</entry><entry>MAP</entry></row><row><entry align="center">74</entry><entry>Temperature</entry></row><row><entry align="center">75</entry><entry>PaO2/FiO2</entry></row><row><entry align="center">76</entry><entry>EtCO2</entry></row><row><entry align="center">77</entry><entry>Vitals Trend</entry></row><row><entry align="center">78</entry><entry>Pain Score</entry></row><row><entry align="center">79</entry><entry>Urine Output</entry></row><row><entry align="center">80</entry><entry><b>LABS</b></entry></row><row><entry align="center">81</entry><entry>Abnormal Labs</entry></row><row><entry align="center">82</entry><entry>POC Blood Glucose</entry></row><row><entry align="center">83</entry><entry>New Lab Results Received</entry></row><row><entry align="center">84</entry><entry>Complete Blood Count (CBC) (panel)</entry></row><row><entry align="center">85</entry><entry>White Blood Cell Count</entry></row><row><entry align="center">86</entry><entry>Red Blood Cell Count</entry></row><row><entry align="center">87</entry><entry>Hemoglobin (Hgb)</entry></row><row><entry align="center">88</entry><entry>Hematocrit (Hct) or Packed Cell Volume (PCV)</entry></row><row><entry align="center">89</entry><entry>Mean Corpuscular Volume (MCV)</entry></row><row><entry align="center">90</entry><entry>Platelet Count (Plt)</entry></row><row><entry align="center">91</entry><entry>Mean Corpuscular Hemoglobin(MCH)</entry></row><row><entry align="center">92</entry><entry>Mean Corpuscular Hemoglobin Concentration (MCHC)</entry></row><row><entry align="center">93</entry><entry>Red Cell Distribution Width (RDW)</entry></row><row><entry align="center">94</entry><entry>Platelet Distribution Width (PDW)</entry></row><row><entry align="center">95</entry><entry>Mean Platelet Volume (MPV)</entry></row><row><entry align="center">96</entry><entry>Reticulocyte Count</entry></row><row><entry align="center">97</entry><entry>Basic Metabolic Panel (BMP)</entry></row><row><entry align="center">98</entry><entry>Glucose</entry></row><row><entry align="center">99</entry><entry>Calcium</entry></row><row><entry align="center">100</entry><entry>Sodium</entry></row><row><entry align="center">101</entry><entry>Potassium</entry></row><row><entry align="center">102</entry><entry>Carbon Dioxide (aka Bicarbonate)</entry></row><row><entry align="center">103</entry><entry>Chloride</entry></row><row><entry align="center">104</entry><entry>Blood Urea Nitrogen (BUN)</entry></row><row><entry align="center">105</entry><entry>Creatinine</entry></row><row><entry align="center">106</entry><entry>When Next Labs Due</entry></row><row><entry align="center">107</entry><entry>Normal Lab Results Ranges</entry></row><row><entry align="center">108</entry><entry>International Normalized Ratio (INR)</entry></row><row><entry align="center">109</entry><entry>Blood Gases</entry></row><row><entry align="center">110</entry><entry>Partial Thromboplastin Time (PTT)</entry></row><row><entry align="center">111</entry><entry>Activated Partial Thromboplastin Time (aPTT)</entry></row><row><entry align="center">112</entry><entry>Prothrombin Time (PT)</entry></row><row><entry align="center">113</entry><entry>Arterial Blood Gas (panel)</entry></row><row><entry align="center">114</entry><entry>pH</entry></row><row><entry align="center">115</entry><entry>PaO2</entry></row><row><entry align="center">116</entry><entry>PaCO2</entry></row><row><entry align="center">117</entry><entry>SaO2</entry></row><row><entry align="center">118</entry><entry>Oxygen Content</entry></row><row><entry align="center">119</entry><entry>Bicarbonate</entry></row><row><entry align="center">120</entry><entry>Base Excess (BE)</entry></row><row><entry align="center">121</entry><entry>Blood Glucose</entry></row><row><entry align="center">122</entry><entry>Urinalysis (panel)</entry></row><row><entry align="center">123</entry><entry>pH</entry></row><row><entry align="center">124</entry><entry>Concentration (aka Specific Gravity)</entry></row><row><entry align="center">125</entry><entry>Protein</entry></row><row><entry align="center">126</entry><entry>Glucose</entry></row><row><entry align="center">127</entry><entry>Ketones</entry></row><row><entry align="center">128</entry><entry>Bilirubin</entry></row><row><entry align="center">129</entry><entry>Evidence of Injection</entry></row><row><entry align="center">130</entry><entry>Evidence of Blood</entry></row><row><entry align="center">131</entry><entry>White Blood Cell Count</entry></row><row><entry align="center">132</entry><entry>Red Blood Cell Count</entry></row><row><entry align="center">133</entry><entry>Bacteria and/or yeasts</entry></row><row><entry align="center">134</entry><entry>Casts</entry></row><row><entry align="center">135</entry><entry>Crystals</entry></row><row><entry align="center">136</entry><entry>Lactate</entry></row><row><entry align="center">137</entry><entry>Platelets</entry></row><row><entry align="center">138</entry><entry>Creatinine</entry></row><row><entry align="center">139</entry><entry>Suspected or present Infection</entry></row><row><entry align="center">140</entry><entry>WBC Count</entry></row><row><entry align="center">141</entry><entry>Neutrophils/Bands</entry></row><row><entry align="center">142</entry><entry>Bilirubin</entry></row><row><entry align="center">143</entry><entry><b>INTERVENTIONS</b></entry></row><row><entry align="center">144</entry><entry>Supplemental O2</entry></row><row><entry align="center">145</entry><entry>Mechanical ventilation</entry></row><row><entry align="center">146</entry><entry>Quarter-hourly nebulizers</entry></row><row><entry align="center">147</entry><entry><b>PATIENT STATUS</b></entry></row><row><entry align="center">148</entry><entry>Allergies</entry></row><row><entry align="center">149</entry><entry>Do Not Resuscitate (DNR)</entry></row><row><entry align="center">150</entry><entry>NPO (Nothing by the mouth)</entry></row><row><entry align="center">151</entry><entry>Precautions (isolation, violent, elopement, psych)</entry></row><row><entry align="center">152</entry><entry>General (language, blind/deaf, amputee, pacemaker, DVT, cardiac abnormalities, etc)</entry></row><row><entry align="center">153</entry><entry>Dietary status</entry></row><row><entry align="center">154</entry><entry>Capillary Refill Time</entry></row><row><entry align="center">155</entry><entry>Color (pink/pale/gray/gray and mottled)</entry></row><row><entry align="center">156</entry><entry>Respiratory flow rate</entry></row><row><entry align="center">157</entry><entry>Intercostal retractions</entry></row><row><entry align="center">158</entry><entry>Hypotension/Pressor Use</entry></row><row><entry align="center">159</entry><entry>Ambulatory aid (none/bedrest/nurse assist/crutches/cane/walker/furniture</entry></row><row><entry align="center">160</entry><entry>Gait (normal/bedrest/immobile/weak/unsteady/impaired)</entry></row><row><entry align="center">161</entry><entry>Visual impairment affecting everyday function</entry></row><row><entry align="center">162</entry><entry>Vertigo/orthostatic hypotension/weakness</entry></row><row><entry align="center">163</entry><entry>Transfer from bed to chair (unable/needs major help/needs minor help/independent)</entry></row><row><entry align="center">164</entry><entry>Rising from a seated position (in single movement/pushes up in one attempt/successful after multiple attempts/requires assistance)</entry></row><row><entry align="center">165</entry><entry>Mobility (immobile/independent with wheelchair/walking aid or person assisting/independent)</entry></row><row><entry align="center">166</entry><entry>IV/Heparin lock</entry></row><row><entry align="center">167</entry><entry>Incontinence</entry></row><row><entry align="center">168</entry><entry>Urgency or frequency of urination</entry></row><row><entry align="center">169</entry><entry>Urinary catheter/ostomy</entry></row><row><entry align="center">170</entry><entry>Elimination with assistance</entry></row><row><entry align="center">171</entry><entry>Nocturia</entry></row><row><entry align="center">172</entry><entry>Sedated procedure</entry></row><row><entry align="center">173</entry><entry>Tethered patient care equipment (e.g. IV, chest tube, indwelling catheter, SCDs, etc)</entry></row><row><entry align="center">174</entry><entry>Response to Surgery/Sedation/Anesthesia (within 24 hours/within 48 hours/more than 48 hours or none)</entry></row><row><entry align="center">175</entry><entry>Persistent vomiting after surgery</entry></row><row><entry align="center">176</entry><entry>Consciousness (AVPU)</entry></row><row><entry align="center">177</entry><entry>Consciousness (GCS)</entry></row><row><entry align="center">178</entry><entry>Mental status (oriented to own ability/forgets limitations/fully alert/agitation or anxiety/intermittently confused, confusion or disorientation)</entry></row><row><entry align="center">179</entry><entry>Cognition (altered awareness of physical environment/impulsive/forgets limitations)</entry></row><row><entry align="center">180</entry><entry>Behavior (playing or appropriate/sleeping/irritable/lethargic or confused or reduced pain response)</entry></row><row><entry align="center">181</entry><entry><b>DEMOGRAPHICS</b></entry></row><row><entry align="center">182</entry><entry>Current chronological age (observable entity)</entry></row><row><entry align="center">183</entry><entry>Age (qualifier value)</entry></row><row><entry align="center">184</entry><entry>Aging (finding)</entry></row><row><entry align="center">185</entry><entry>Premature aging (finding)</entry></row><row><entry align="center">186</entry><entry>Old-age (finding)</entry></row><row><entry align="center">187</entry><entry>Senile debility (finding)</entry></row><row><entry align="center">188</entry><entry>Senility (finding)</entry></row><row><entry align="center">189</entry><entry>Extreme old age (over 100 years) (finding)</entry></row><row><entry align="center">190</entry><entry>Senile exhaustion (finding)</entry></row><row><entry align="center">191</entry><entry>Senile asthenia (finding)</entry></row><row><entry align="center">192</entry><entry>Old age (qualifier value)</entry></row><row><entry align="center">193</entry><entry>Entire life (qualifier value)</entry></row><row><entry align="center">194</entry><entry>Old-age (finding)</entry></row><row><entry align="center">195</entry><entry>Senile debility (finding)</entry></row><row><entry align="center">196</entry><entry>Senility (finding)</entry></row><row><entry align="center">197</entry><entry>Extreme old age (over 100 years) (finding)</entry></row><row><entry align="center">198</entry><entry>Senile exhaustion (finding)</entry></row><row><entry align="center">199</entry><entry>Senile asthenia (finding)</entry></row><row><entry align="center">200</entry><entry>Gender (observable entity)</entry></row><row><entry align="center">201</entry><entry><b>MEDICATIONS</b></entry></row><row><entry align="center">202</entry><entry>Current Medications</entry></row><row><entry align="center">203</entry><entry>Aminoglycoside (substance)</entry></row><row><entry align="center">204</entry><entry>Analgesic (substance)</entry></row><row><entry align="center">205</entry><entry>Medicinal product acting as analgesic agent (product)</entry></row><row><entry align="center">206</entry><entry>Substance with opioid receptor agonist mechanism of action (substance)</entry></row><row><entry align="center">207</entry><entry>Antiarrhythmic agent (substance)</entry></row><row><entry align="center">208</entry><entry>Medicinal product acting as antiarrhythmic agent (product)</entry></row><row><entry align="center">209</entry><entry>Quaternary ammonium compound with anticholinergic mechanism of action (substance)</entry></row><row><entry align="center">210</entry><entry>Vasodilator (substance)</entry></row><row><entry align="center">211</entry><entry>Hypotensive agent (substance)</entry></row><row><entry align="center">212</entry><entry>Hypotensive agent (product)</entry></row><row><entry align="center">213</entry><entry>Anti-psychotic agent (substance)</entry></row><row><entry align="center">214</entry><entry>Medicinal product acting as antipsychotic agent (product)</entry></row><row><entry align="center">215</entry><entry>Diuretic (substance)</entry></row><row><entry align="center">216</entry><entry>Medicinal product acting as diuretic (product)</entry></row><row><entry align="center">217</entry><entry>Loop diuretic (substance)</entry></row><row><entry align="center">218</entry><entry>Loop diuretic overdose (disorder)</entry></row><row><entry align="center">219</entry><entry>Psychoactive substance (substance)</entry></row><row><entry align="center">220</entry><entry>Antidepressant (substance)</entry></row><row><entry align="center">221</entry><entry>Medicinal product acting as antidepressant agent (product)</entry></row><row><entry align="center">222</entry><entry>Anti-psychotic agent (substance)</entry></row><row><entry align="center">223</entry><entry>Medicinal product acting as antipsychotic agent (product)</entry></row><row><entry align="center">224</entry><entry>Benzodiazepine (substance)</entry></row><row><entry align="center">225</entry><entry>Psychoactive substance (substance)</entry></row><row><entry align="center">226</entry><entry>Nicotine cyclodextrin complex (substance)</entry></row><row><entry align="center">227</entry><entry>Cannabinoid (substance)</entry></row><row><entry align="center">228</entry><entry>Psychotropic agent (substance)</entry></row><row><entry align="center">229</entry><entry>Nicotine polacrilex (substance)</entry></row><row><entry align="center">230</entry><entry>Nicotine (substance)</entry></row><row><entry align="center">231</entry><entry>Trichloroethylene (substance)</entry></row><row><entry align="center">232</entry><entry>Central depressant (substance)</entry></row><row><entry align="center">233</entry><entry>Nicotine resin complex (substance)</entry></row><row><entry align="center">234</entry><entry>Medication Dosage</entry></row><row><entry align="center">235</entry><entry>When Meds are Due</entry></row><row><entry align="center">236</entry><entry>When Meds Last Received</entry></row><row><entry align="center">237</entry><entry>Medication Route</entry></row><row><entry align="center">238</entry><entry>Medication Form (liquid, pill, etc)</entry></row><row><entry align="center">239</entry><entry>PRN (as needed medications)</entry></row><row><entry align="center">240</entry><entry>Drug Class Type (beta blockers, barbiturates, etc)</entry></row><row><entry align="center">241</entry><entry><b>DIAGNOSES/COMORBIDITIES</b></entry></row><row><entry align="center">242</entry><entry>Anemia (disorder)</entry></row><row><entry align="center">243</entry><entry>Anemia due to metabolic disorder (disorder)</entry></row><row><entry align="center">244</entry><entry>Central nervous system calcification, deafness, tubular acidosis, anemia syndrome (disorder)</entry></row><row><entry align="center">245</entry><entry>Fetal anemia (disorder)</entry></row><row><entry align="center">246</entry><entry>Anemia caused by substance (disorder)</entry></row><row><entry align="center">247</entry><entry>Anemia associated with acquired immunodeficiency syndrome (disorder)</entry></row><row><entry align="center">248</entry><entry>Anemia due to blood loss (disorder)</entry></row><row><entry align="center">249</entry><entry>Refractory anemia with excess blasts (disorder)</entry></row><row><entry align="center">250</entry><entry>Sports anemia (disorder)</entry></row><row><entry align="center">251</entry><entry>Perinatal anemia (disorder)</entry></row><row><entry align="center">252</entry><entry>Anemia due to intrinsic red cell abnormality (disorder)</entry></row><row><entry align="center">253</entry><entry>Normocytic anemia (disorder)</entry></row><row><entry align="center">254</entry><entry>Deficiency anemias (disorder)</entry></row><row><entry align="center">255</entry><entry>Neonatal anemia (disorder)</entry></row><row><entry align="center">256</entry><entry>Microcytic anemia (disorder)</entry></row><row><entry align="center">257</entry><entry>Anemia of renal disease (disorder)</entry></row><row><entry align="center">258</entry><entry>Anemia of chronic disorder (disorder)</entry></row><row><entry align="center">259</entry><entry>Dilutional anemia (disorder)</entry></row><row><entry align="center">260</entry><entry>Chronic anemia (disorder)</entry></row><row><entry align="center">261</entry><entry>Anemia in neoplastic disease (disorder)</entry></row><row><entry align="center">262</entry><entry>Anemia due to disorders of nucleotide metabolism (disorder)</entry></row><row><entry align="center">263</entry><entry>On examination - profoundly anemic (disorder)</entry></row><row><entry align="center">264</entry><entry>On examination - clinically anemic (disorder)</entry></row><row><entry align="center">265</entry><entry>On examination - equivocally anemic (disorder)</entry></row><row><entry align="center">266</entry><entry>Regenerative anemia (disorder)</entry></row><row><entry align="center">267</entry><entry>Anemia caused by physical agent (disorder)</entry></row><row><entry align="center">268</entry><entry>Refractory anemia with excess blasts in transformation (disorder)</entry></row><row><entry align="center">269</entry><entry>Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts (disorder)</entry></row><row><entry align="center">270</entry><entry>Anemia related to disturbed deoxyribonucleic acid synthesis (disorder)</entry></row><row><entry align="center">271</entry><entry>Aregenerative anemia (disorder)</entry></row><row><entry align="center">272</entry><entry>Non megaloblastic anemia due to alcoholism (disorder)</entry></row><row><entry align="center">273</entry><entry>Macrocytic anemia (disorder)</entry></row><row><entry align="center">274</entry><entry>Anemia due to unknown mechanism (disorder)</entry></row><row><entry align="center">275</entry><entry>Nutritional anemia (disorder)</entry></row><row><entry align="center">276</entry><entry>Congenital anemia (disorder)</entry></row><row><entry align="center">277</entry><entry>Hemolytic anemia (disorder)</entry></row><row><entry align="center">278</entry><entry>Anemia due to decreased red cell production (disorder)</entry></row><row><entry align="center">279</entry><entry>Normocytic normochromic anemia (disorder)</entry></row><row><entry align="center">280</entry><entry>Anemia in mother complicating pregnancy, childbirth AND/OR puerperium (disorder)</entry></row><row><entry align="center">281</entry><entry>Anemia due to multiple mechanisms (disorder)</entry></row><row><entry align="center">282</entry><entry>Normocytic hypochromic anemia (disorder)</entry></row><row><entry align="center">283</entry><entry>Sideroblastic anemia (disorder)</entry></row><row><entry align="center">284</entry><entry>Anemia due to disturbance of proliferation AND/OR differentiation of erythroid precursor cells (disorder)</entry></row><row><entry align="center">285</entry><entry>Anemia of endocrine disorder (disorder)</entry></row><row><entry align="center">286</entry><entry>Acquired Heinz body anemia (disorder)</entry></row><row><entry align="center">287</entry><entry>Anemia due to disturbance of hemoglobin synthesis (disorder)</entry></row><row><entry align="center">288</entry><entry>Relative anemia (disorder)</entry></row><row><entry align="center">289</entry><entry>Myelophthisic anemia (disorder)</entry></row><row><entry align="center">290</entry><entry>Cardiac arrhythmia (disorder)</entry></row><row><entry align="center">291</entry><entry>Cardiac arrhythmia in mother complicating childbirth (disorder)</entry></row><row><entry align="center">292</entry><entry>Arrhythmia during surgery (disorder)</entry></row><row><entry align="center">293</entry><entry>Arrhythmia due to and following acute myocardial infarction (disorder)</entry></row><row><entry align="center">294</entry><entry>Heart-hand syndrome type 2 (disorder)</entry></row><row><entry align="center">295</entry><entry>Cardiac channelopathy (disorder)</entry></row><row><entry align="center">296</entry><entry>Cardiac arrhythmia associated with genetic disorder (disorder)</entry></row><row><entry align="center">297</entry><entry>Arrhythmia due to vegetation of infective endocarditis (disorder)</entry></row><row><entry align="center">298</entry><entry>Bundle branch reentrant ventricular tachycardia (disorder)</entry></row><row><entry align="center">299</entry><entry>Bradyarrhythmia (disorder)</entry></row><row><entry align="center">300</entry><entry>Cardiac arrest (disorder)</entry></row><row><entry align="center">301</entry><entry>Neonatal dysrhythmia (disorder)</entry></row><row><entry align="center">302</entry><entry>Fetal dysrhythmia (disorder)</entry></row><row><entry align="center">303</entry><entry>Atrial escape complex (disorder)</entry></row><row><entry align="center">304</entry><entry>Ventricular escape complex (disorder)</entry></row><row><entry align="center">305</entry><entry>Aberrantly conducted complex (disorder)</entry></row><row><entry align="center">306</entry><entry>Aberrant premature complexes (disorder)</entry></row><row><entry align="center">307</entry><entry>Pacemaker twiddler's syndrome (disorder)</entry></row><row><entry align="center">308</entry><entry>Supraventricular arrhythmia (disorder)</entry></row><row><entry align="center">309</entry><entry>Nodal rhythm disorder (disorder)</entry></row><row><entry align="center">310</entry><entry>Atrioventricular dissociation (disorder)</entry></row><row><entry align="center">311</entry><entry>Tic-tac rhythm (disorder)</entry></row><row><entry align="center">312</entry><entry>Conduction disorder of the heart (disorder)</entry></row><row><entry align="center">313</entry><entry>Ventricular arrhythmia (disorder)</entry></row><row><entry align="center">314</entry><entry>Fibrillation (disorder)</entry></row><row><entry align="center">315</entry><entry>Ectopic beats (disorder)</entry></row><row><entry align="center">316</entry><entry>Premature beats (disorder)</entry></row><row><entry align="center">317</entry><entry>Ectopic rhythm (disorder)</entry></row><row><entry align="center">318</entry><entry>Holt-Oram syndrome (disorder)</entry></row><row><entry align="center">319</entry><entry>Anomalous atrioventricular excitation (disorder)</entry></row><row><entry align="center">320</entry><entry>Accelerated atrioventricular conduction (disorder)</entry></row><row><entry align="center">321</entry><entry>Tachyarrhythmia (disorder)</entry></row><row><entry align="center">322</entry><entry>Withdrawal arrhythmia (disorder)</entry></row><row><entry align="center">323</entry><entry>Carotid sinus syncope (disorder)</entry></row><row><entry align="center">324</entry><entry>Chronic obstructive lung disease (disorder)</entry></row><row><entry align="center">325</entry><entry>Asthma-chronic obstructive pulmonary disease overlap syndrome (disorder)</entry></row><row><entry align="center">326</entry><entry>Chronic obstructive lung disease co-occurrent with acute bronchitis (disorder)</entry></row><row><entry align="center">327</entry><entry>Severe chronic obstructive pulmonary disease (disorder)</entry></row><row><entry align="center">328</entry><entry>Moderate chronic obstructive pulmonary disease (disorder)</entry></row><row><entry align="center">329</entry><entry>Mild chronic obstructive pulmonary disease (disorder)</entry></row><row><entry align="center">330</entry><entry>Chronic obstructive pulmonary disease with acute lower respiratory infection (disorder)</entry></row><row><entry align="center">331</entry><entry>Acute exacerbation of chronic obstructive airways disease (disorder)</entry></row><row><entry align="center">332</entry><entry>End stage chronic obstructive airways disease (disorder)</entry></row><row><entry align="center">333</entry><entry>Pulmonary emphysema (disorder)</entry></row><row><entry align="center">334</entry><entry>Chronic obliterative bronchiolitis (disorder)</entry></row><row><entry align="center">335</entry><entry>Dehydration (disorder)</entry></row><row><entry align="center">336</entry><entry>Dehydration due to radiation (disorder)</entry></row><row><entry align="center">337</entry><entry>Mild dehydration (disorder)</entry></row><row><entry align="center">338</entry><entry>Moderate dehydration (disorder)</entry></row><row><entry align="center">339</entry><entry>Dehydration following exertion (disorder)</entry></row><row><entry align="center">340</entry><entry>Severe dehydration (disorder)</entry></row><row><entry align="center">341</entry><entry>Hypernatremic dehydration (disorder)</entry></row><row><entry align="center">342</entry><entry>Deprivation of water (disorder)</entry></row><row><entry align="center">343</entry><entry>Isonatremic dehydration (disorder)</entry></row><row><entry align="center">344</entry><entry>On examination - dehydrated (disorder)</entry></row><row><entry align="center">345</entry><entry>Neonatal dehydration (disorder)</entry></row><row><entry align="center">346</entry><entry>Pneumonia (disorder)</entry></row><row><entry align="center">347</entry><entry>Pneumonia caused by Bordetella parapertussis (disorder)</entry></row><row><entry align="center">348</entry><entry>Chronic pneumonia (disorder)</entry></row><row><entry align="center">349</entry><entry>Idiopathic eosinophilic pneumonia (disorder)</entry></row><row><entry align="center">350</entry><entry>Recurrent pneumonia (disorder)</entry></row><row><entry align="center">351</entry><entry>Cavitary pneumonia (disorder)</entry></row><row><entry align="center">352</entry><entry>Ventilator-acquired pneumonia (disorder)</entry></row><row><entry align="center">353</entry><entry>Aspiration pneumonia (disorder)</entry></row><row><entry align="center">354</entry><entry>Pneumonia associated with acquired immunodeficiency syndrome (disorder)</entry></row><row><entry align="center">355</entry><entry>Bilateral pneumonia (disorder)</entry></row><row><entry align="center">356</entry><entry>Bronchopneumonia (disorder)</entry></row><row><entry align="center">357</entry><entry>Community acquired pneumonia (disorder)</entry></row><row><entry align="center">358</entry><entry>Postobstructive pneumonia (disorder)</entry></row><row><entry align="center">359</entry><entry>Postoperative pneumonia (disorder)</entry></row><row><entry align="center">360</entry><entry>Infective pneumonia (disorder)</entry></row><row><entry align="center">361</entry><entry>Lobar pneumonia (disorder)</entry></row><row><entry align="center">362</entry><entry>Neonatal pneumonia (disorder)</entry></row><row><entry align="center">363</entry><entry>Hemorrhagic pneumonia (disorder)</entry></row><row><entry align="center">364</entry><entry>Abscess of lung with pneumonia (disorder)</entry></row><row><entry align="center">365</entry><entry>Pneumonia and influenza (disorder)</entry></row><row><entry align="center">366</entry><entry>Post measles pneumonia (disorder)</entry></row><row><entry align="center">367</entry><entry>Confluent pneumonia (disorder)</entry></row><row><entry align="center">368</entry><entry>Focal pneumonia (disorder)</entry></row><row><entry align="center">369</entry><entry>Non-infectious pneumonia (disorder)</entry></row><row><entry align="center">370</entry><entry>Hypostatic pneumonia (disorder)</entry></row><row><entry align="center">371</entry><entry>Congenital pneumonia (disorder)</entry></row><row><entry align="center">372</entry><entry>Granulomatous pneumonia (disorder)</entry></row><row><entry align="center">373</entry><entry>Organized pneumonia (disorder)</entry></row><row><entry align="center">374</entry><entry>Interstitial pneumonia (disorder)</entry></row><row><entry align="center">375</entry><entry>Unresolved pneumonia (disorder)</entry></row><row><entry align="center">376</entry><entry>Catarrhal pneumonia (disorder)</entry></row><row><entry align="center">377</entry><entry>Gangrenous pneumonia (disorder)</entry></row><row><entry align="center">378</entry><entry>Sepsis (disorder)</entry></row><row><entry align="center">379</entry><entry>Sepsis due to incomplete miscarriage (disorder)</entry></row><row><entry align="center">380</entry><entry>Sepsis due to ectopic pregnancy (disorder)</entry></row><row><entry align="center">381</entry><entry>Sepsis without acute organ dysfunction (disorder)</entry></row><row><entry align="center">382</entry><entry>Line sepsis associated with dialysis catheter (disorder)</entry></row><row><entry align="center">383</entry><entry>Sepsis caused by virus (disorder)</entry></row><row><entry align="center">384</entry><entry>Sepsis due to urinary tract infection (disorder)</entry></row><row><entry align="center">385</entry><entry>Perinatal sepsis (disorder)</entry></row><row><entry align="center">386</entry><entry>Sepsis due to oral infection (disorder)</entry></row><row><entry align="center">387</entry><entry>Sepsis with cutaneous manifestations (disorder)</entry></row><row><entry align="center">388</entry><entry>Sepsis caused by fungus (disorder)</entry></row><row><entry align="center">389</entry><entry>Sepsis associated with acquired immunodeficiency syndrome (disorder)</entry></row><row><entry align="center">390</entry><entry>Sepsis in asplenic subject (disorder)</entry></row><row><entry align="center">391</entry><entry>Postoperative sepsis (disorder)</entry></row><row><entry align="center">392</entry><entry>Induced termination of pregnancy complicated by sepsis (disorder)</entry></row><row><entry align="center">393</entry><entry>Sepsis caused by herpes simplex (disorder)</entry></row><row><entry align="center">394</entry><entry>Neutropenic sepsis (disorder)</entry></row><row><entry align="center">395</entry><entry>Transient respiratory distress with sepsis (disorder)</entry></row><row><entry align="center">396</entry><entry>Umbilical sepsis (disorder)</entry></row><row><entry align="center">397</entry><entry>Sepsis of the newborn (disorder)</entry></row><row><entry align="center">398</entry><entry>Miscarriage with sepsis (disorder)</entry></row><row><entry align="center">399</entry><entry>Sepsis following infusion, injection, transfusion AND/OR vaccination (disorder)</entry></row><row><entry align="center">400</entry><entry>Sepsis following molar AND/OR ectopic pregnancy (disorder)</entry></row><row><entry align="center">401</entry><entry>Pyemia (disorder)</entry></row><row><entry align="center">402</entry><entry>Tracheostomy sepsis (disorder)</entry></row><row><entry align="center">403</entry><entry>Failed attempted abortion with sepsis (disorder)</entry></row><row><entry align="center">404</entry><entry>Acute tubulointerstitial nephritis associated with systemic infection (disorder)</entry></row><row><entry align="center">405</entry><entry>Bacterial sepsis (disorder)</entry></row><row><entry align="center">406</entry><entry>Brazilian purpuric fever (disorder)</entry></row><row><entry align="center">407</entry><entry>Gas gangrene septicemia (disorder)</entry></row><row><entry align="center">408</entry><entry>Puerperal sepsis (disorder)</entry></row><row><entry align="center">409</entry><entry>Intrauterine sepsis of fetus (disorder)</entry></row><row><entry align="center">410</entry><entry>Diabetes mellitus (disorder)</entry></row><row><entry align="center">411</entry><entry>Atypical diabetes mellitus (disorder)</entry></row><row><entry align="center">412</entry><entry>Diabetes mellitus due to pancreatic injury (disorder)</entry></row><row><entry align="center">413</entry><entry>Erectile dysfunction co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">414</entry><entry>Acute complication co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">415</entry><entry>Metabolic acidosis co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">416</entry><entry>Lactic acidosis co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">417</entry><entry>Alaninuria, microcephaly, dwarfism, enamel hypoplasia, diabetes mellitus syndrome (disorder)</entry></row><row><entry align="center">418</entry><entry>Diabetic mastopathy (disorder)</entry></row><row><entry align="center">419</entry><entry>Pancreatic hypoplasia, diabetes mellitus, congenital heart disease syndrome (disorder)</entry></row><row><entry align="center">420</entry><entry>Gingival disease co-occurrent with diabetes mellitus (disorder)</entry></row><row><entry align="center">421</entry><entry>Diabetes mellitus in remission (disorder)</entry></row><row><entry align="center">422</entry><entry>Diabetes mellitus due to genetic defect in insulin action (disorder)</entry></row><row><entry align="center">423</entry><entry>Diabetes mellitus due to genetic defect in beta cell function (disorder)</entry></row><row><entry align="center">424</entry><entry>Disorder of nervous system co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">425</entry><entry>Peripheral vascular disorder co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">426</entry><entry>Disorder of soft tissue co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">427</entry><entry>Diabetes mellitus during pregnancy, childbirth and the puerperium (disorder)</entry></row><row><entry align="center">428</entry><entry>Disorder of kidney co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">429</entry><entry>Houssay's syndrome (disorder)</entry></row><row><entry align="center">430</entry><entry>Diabetes mellitus without complication (disorder)</entry></row><row><entry align="center">431</entry><entry>Diabetes mellitus type 1 (disorder)</entry></row><row><entry align="center">432</entry><entry>Diabetes mellitus type 2 (disorder)</entry></row><row><entry align="center">433</entry><entry>Disorder of eye co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">434</entry><entry>Secondary diabetes mellitus (disorder)</entry></row><row><entry align="center">435</entry><entry>Disorder of thyroid gland (disorder)</entry></row><row><entry align="center">436</entry><entry>Nodular thyroid disease (disorder)</entry></row><row><entry align="center">437</entry><entry>Thyrocerebrorenal syndrome (disorder)</entry></row><row><entry align="center">438</entry><entry>Hypoplasia of thyroid (disorder)</entry></row><row><entry align="center">439</entry><entry>Thyroid infection (disorder)</entry></row><row><entry align="center">440</entry><entry>Perinatal thyroid disorder (disorder)</entry></row><row><entry align="center">441</entry><entry>Thyroid dysfunction (disorder)</entry></row><row><entry align="center">442</entry><entry>Injury of thyroid gland (disorder)</entry></row><row><entry align="center">443</entry><entry>Iodine deficiency syndrome (disorder)</entry></row><row><entry align="center">444</entry><entry>Thyroid hormone binding abnormality (disorder)</entry></row><row><entry align="center">445</entry><entry>Sick-euthyroid syndrome (disorder)</entry></row><row><entry align="center">446</entry><entry>Thyroid atrophy (disorder)</entry></row><row><entry align="center">447</entry><entry>Disorder of thyrocalcitonin secretion (disorder)</entry></row><row><entry align="center">448</entry><entry>Neoplasm of thyroid gland (disorder)</entry></row><row><entry align="center">449</entry><entry>Complex thyroid endocrine disorder (disorder)</entry></row><row><entry align="center">450</entry><entry>Abscess of thyroid (disorder)</entry></row><row><entry align="center">451</entry><entry>Thyroiditis (disorder)</entry></row><row><entry align="center">452</entry><entry>Cyst of thyroid (disorder)</entry></row><row><entry align="center">453</entry><entry>Transient decreased production of thyroid hormone (disorder)</entry></row><row><entry align="center">454</entry><entry>Multiple endocrine neoplasia, type 3 (disorder)</entry></row><row><entry align="center">455</entry><entry>Thyroid disease in mother complicating pregnancy, childbirth AND/OR puerperium (disorder)</entry></row><row><entry align="center">456</entry><entry>Hypothyroidism (disorder)</entry></row><row><entry align="center">457</entry><entry>Inherited disorder of thyroid metabolism (disorder)</entry></row><row><entry align="center">458</entry><entry>Hyperthyroidism (disorder)</entry></row><row><entry align="center">459</entry><entry>Congenital anomaly of the thyroid gland (disorder)</entry></row><row><entry align="center">460</entry><entry>Ascher's syndrome (disorder)</entry></row><row><entry align="center">461</entry><entry>Hurthle cell metaplasia of thyroid gland (disorder)</entry></row><row><entry align="center">462</entry><entry>Infarction of thyroid (disorder)</entry></row><row><entry align="center">463</entry><entry>Goiter (disorder)</entry></row><row><entry align="center">464</entry><entry>Hemorrhage of thyroid (disorder)</entry></row><row><entry align="center">465</entry><entry>Hypersecretion of calcitonin (disorder)</entry></row><row><entry align="center">466</entry><entry>Hypoglycemia (disorder)</entry></row><row><entry align="center">467</entry><entry>Post gastrointestinal tract surgery hypoglycemia (disorder)</entry></row><row><entry align="center">468</entry><entry>Neonatal hypoglycemia (disorder)</entry></row><row><entry align="center">469</entry><entry>Diabetic hyperosmolar non-ketotic state (disorder)</entry></row><row><entry align="center">470</entry><entry>Hyperosmolar hyperglycemic coma due to diabetes mellitus without ketoacidosis (disorder)</entry></row><row><entry align="center">471</entry><entry>Hyperosmolar non-ketotic state in type 2 diabetes mellitus (disorder)</entry></row><row><entry align="center">472</entry><entry>Orthostatic hypotension (disorder)</entry></row><row><entry align="center">473</entry><entry>Postural hypotension following exercise (disorder)</entry></row><row><entry align="center">474</entry><entry>Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder)</entry></row><row><entry align="center">475</entry><entry>Postural orthostatic tachycardia syndrome (disorder)</entry></row><row><entry align="center">476</entry><entry>Sympathotonic orthostatic hypotension (disorder)</entry></row><row><entry align="center">477</entry><entry>Chronic orthostatic hypotension (disorder)</entry></row><row><entry align="center">478</entry><entry>Hypoadrenergic postural hypotension (disorder)</entry></row><row><entry align="center">479</entry><entry>Hyperadrenergic postural hypotension (disorder)</entry></row><row><entry align="center">480</entry><entry>Congestive heart failure due to valvular disease (disorder)</entry></row><row><entry align="center">481</entry><entry>Delirium (disorder)</entry></row><row><entry align="center">482</entry><entry>Delirium following surgical procedure (disorder)</entry></row><row><entry align="center">483</entry><entry>Delirium co-occurrent with dementia (disorder)</entry></row><row><entry align="center">484</entry><entry>Delirium due to multiple etiological factors (disorder)</entry></row><row><entry align="center">485</entry><entry>Delirium caused by substance or medication (disorder)</entry></row><row><entry align="center">486</entry><entry>Delirium in remission (disorder)</entry></row><row><entry align="center">487</entry><entry>Chronic confusional state (disorder)</entry></row><row><entry align="center">488</entry><entry>Psychosis associated with intensive care (disorder)</entry></row><row><entry align="center">489</entry><entry>Delirium of mixed origin (disorder)</entry></row><row><entry align="center">490</entry><entry>Toxic confusional state (disorder)</entry></row><row><entry align="center">491</entry><entry>Subacute delirium (disorder)</entry></row><row><entry align="center">492</entry><entry>Acute confusional state, of cerebrovascular origin (disorder)</entry></row><row><entry align="center">493</entry><entry>Acute confusional state, of metabolic origin (disorder)</entry></row><row><entry align="center">494</entry><entry>Acute confusional state, of endocrine origin (disorder)</entry></row><row><entry align="center">495</entry><entry>Acute confusional state, of infective origin (disorder)</entry></row><row><entry align="center">496</entry><entry>Acute confusional state, post-traumatic (disorder)</entry></row><row><entry align="center">497</entry><entry>Drug-induced delirium (disorder)</entry></row><row><entry align="center">498</entry><entry>Acute non-psychotic brain syndrome (disorder)</entry></row><row><entry align="center">499</entry><entry>Postseizure delirium (disorder)</entry></row><row><entry align="center">500</entry><entry>Multi-infarct dementia with delirium (disorder)</entry></row><row><entry align="center">501</entry><entry>Dementia (disorder)</entry></row><row><entry align="center">502</entry><entry>Primary degenerative dementia (disorder)</entry></row><row><entry align="center">503</entry><entry>Dementia with behavioral disturbance (disorder)</entry></row><row><entry align="center">504</entry><entry>Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments (disorder)</entry></row><row><entry align="center">505</entry><entry>Subcortical dementia (disorder)</entry></row><row><entry align="center">506</entry><entry>Dementia following injury caused by exposure to ionizing radiation (disorder)</entry></row><row><entry align="center">507</entry><entry>Dementia caused by heavy metal exposure (disorder)</entry></row><row><entry align="center">508</entry><entry>Delirium co-occurrent with dementia (disorder)</entry></row><row><entry align="center">509</entry><entry>Rapidly progressive dementia (disorder)</entry></row><row><entry align="center">510</entry><entry>Dementia caused by toxin (disorder)</entry></row><row><entry align="center">511</entry><entry>Parkinsonism co-occurrent with dementia of Guadeloupe (disorder)</entry></row><row><entry align="center">512</entry><entry>Dementia co-occurrent with human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">513</entry><entry>Dementia in remission (disorder)</entry></row><row><entry align="center">514</entry><entry>Dementia of frontal lobe type (disorder)</entry></row><row><entry align="center">515</entry><entry>Senile and presenile organic psychotic conditions (disorder)</entry></row><row><entry align="center">516</entry><entry>Patchy dementia (disorder)</entry></row><row><entry align="center">517</entry><entry>Semantic dementia (disorder)</entry></row><row><entry align="center">518</entry><entry>Dementia associated with another disease (disorder)</entry></row><row><entry align="center">519</entry><entry>Drug-induced dementia (disorder)</entry></row><row><entry align="center">520</entry><entry>Parkinson-dementia complex of Guam (disorder)</entry></row><row><entry align="center">521</entry><entry>General paresis - neurosyphilis (disorder)</entry></row><row><entry align="center">522</entry><entry>Alzheimer's disease (disorder)</entry></row><row><entry align="center">523</entry><entry>Senile dementia (disorder)</entry></row><row><entry align="center">524</entry><entry>Presenile dementia (disorder)</entry></row><row><entry align="center">525</entry><entry>Dialysis dementia (disorder)</entry></row><row><entry align="center">526</entry><entry>Cerebrovascular accident (disorder)</entry></row><row><entry align="center">527</entry><entry>Cerebellar stroke (disorder)</entry></row><row><entry align="center">528</entry><entry>Cerebrovascular accident due to stenosis of left carotid artery (disorder)</entry></row><row><entry align="center">529</entry><entry>Cerebrovascular accident due to stenosis of right carotid artery (disorder)</entry></row><row><entry align="center">530</entry><entry>Cerebrovascular accident due to occlusion of right cerebellar artery (disorder)</entry></row><row><entry align="center">531</entry><entry>Cerebrovascular accident due to occlusion of left cerebellar artery (disorder)</entry></row><row><entry align="center">532</entry><entry>Cerebrovascular accident due to occlusion of left carotid artery (disorder)</entry></row><row><entry align="center">533</entry><entry>Cerebrovascular accident due to occlusion of right pontine artery (disorder)</entry></row><row><entry align="center">534</entry><entry>Cerebrovascular accident due to occlusion of left pontine artery (disorder)</entry></row><row><entry align="center">535</entry><entry>Cerebrovascular accident due to occlusion of right carotid artery (disorder)</entry></row><row><entry align="center">536</entry><entry>Cerebrovascular accident due to occlusion of left vertebral artery (disorder)</entry></row><row><entry align="center">537</entry><entry>Cerebrovascular accident due to occlusion of right vertebral artery (disorder)</entry></row><row><entry align="center">538</entry><entry>Cerebrovascular accident due to stenosis of left vertebral artery (disorder)</entry></row><row><entry align="center">539</entry><entry>Cerebrovascular accident due to stenosis of right vertebral artery (disorder)</entry></row><row><entry align="center">540</entry><entry>Occlusion of cerebral artery with stroke (disorder)</entry></row><row><entry align="center">541</entry><entry>Stroke co-occurrent with migraine (disorder)</entry></row><row><entry align="center">542</entry><entry>Silent cerebral infarct (disorder)</entry></row><row><entry align="center">543</entry><entry>Cerebrovascular accident during surgery (disorder)</entry></row><row><entry align="center">544</entry><entry>Ischemic stroke (disorder)</entry></row><row><entry align="center">545</entry><entry>Infarction of basal ganglia (disorder)</entry></row><row><entry align="center">546</entry><entry>Neonatal stroke (disorder)</entry></row><row><entry align="center">547</entry><entry>Embolic stroke (disorder)</entry></row><row><entry align="center">548</entry><entry>Thrombotic stroke (disorder)</entry></row><row><entry align="center">549</entry><entry>Extension of cerebrovascular accident (disorder)</entry></row><row><entry align="center">550</entry><entry>Stroke in the puerperium (disorder)</entry></row><row><entry align="center">551</entry><entry>Ruptured cerebral aneurysm (disorder)</entry></row><row><entry align="center">552</entry><entry>Stroke of uncertain pathology (disorder)</entry></row><row><entry align="center">553</entry><entry>Cerebrovascular accident due to occlusion of cerebral artery (disorder)</entry></row><row><entry align="center">554</entry><entry>Right sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">555</entry><entry>Left sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">556</entry><entry>Brainstem stroke syndrome (disorder)</entry></row><row><entry align="center">557</entry><entry>Paralytic stroke (disorder)</entry></row><row><entry align="center">558</entry><entry>Nonparalytic stroke (disorder)</entry></row><row><entry align="center">559</entry><entry>Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder)</entry></row><row><entry align="center">560</entry><entry>Progressing stroke (disorder)</entry></row><row><entry align="center">561</entry><entry>Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder)</entry></row><row><entry align="center">562</entry><entry>Completed stroke (disorder)</entry></row><row><entry align="center">563</entry><entry>Anterior choroidal artery syndrome (disorder)</entry></row><row><entry align="center">564</entry><entry>Arthritis (disorder)</entry></row><row><entry align="center">565</entry><entry>Arthritis of right sternoclavicular joint (disorder)</entry></row><row><entry align="center">566</entry><entry>Arthritis of left sternoclavicular joint (disorder)</entry></row><row><entry align="center">567</entry><entry>Primary chronic gout without tophus of shoulder (disorder)</entry></row><row><entry align="center">568</entry><entry>Gout of shoulder caused by drug (disorder)</entry></row><row><entry align="center">569</entry><entry>Transient arthritis (disorder)</entry></row><row><entry align="center">570</entry><entry>Arthritis of wrist (disorder)</entry></row><row><entry align="center">571</entry><entry>Interstitial granulomatous dermatitis with arthritis (disorder)</entry></row><row><entry align="center">572</entry><entry>Immune dysregulation, inflammatory bowel disease, arthritis, recurrent infection syndrome (disorder)</entry></row><row><entry align="center">573</entry><entry>Monoarthritis (disorder)</entry></row><row><entry align="center">574</entry><entry>Inflammation of joint of hand (disorder)</entry></row><row><entry align="center">575</entry><entry>Inflammation of joint of shoulder region (disorder)</entry></row><row><entry align="center">576</entry><entry>Arthritis of elbow (disorder)</entry></row><row><entry align="center">577</entry><entry>Arthritis of acromioclavicular joint (disorder)</entry></row><row><entry align="center">578</entry><entry>Inflammatory polyarthropathy (disorder)</entry></row><row><entry align="center">579</entry><entry>Undifferentiated inflammatory arthritis (disorder)</entry></row><row><entry align="center">580</entry><entry>Synovitis (disorder)</entry></row><row><entry align="center">581</entry><entry>Seronegative arthritis (disorder)</entry></row><row><entry align="center">582</entry><entry>Infective arthritis (disorder)</entry></row><row><entry align="center">583</entry><entry>Suppurative arthritis (disorder)</entry></row><row><entry align="center">584</entry><entry>Arthritis of spine (disorder)</entry></row><row><entry align="center">585</entry><entry>Cricoarytenoid joint arthritis (disorder)</entry></row><row><entry align="center">586</entry><entry>Lower limb joint arthritis (disorder)</entry></row><row><entry align="center">587</entry><entry>Small and large joint arthritis (disorder)</entry></row><row><entry align="center">588</entry><entry>Large joint arthritis (disorder)</entry></row><row><entry align="center">589</entry><entry>Small joint arthritis (disorder)</entry></row><row><entry align="center">590</entry><entry>Asymmetrical arthritis (disorder)</entry></row><row><entry align="center">591</entry><entry>Symmetrical arthritis (disorder)</entry></row><row><entry align="center">592</entry><entry>Cholesterol-related arthritis and periarthritis (disorder)</entry></row><row><entry align="center">593</entry><entry>Oxalate-related arthritis and periarthritis (disorder)</entry></row><row><entry align="center">594</entry><entry>Idiopathic pyrophosphate arthritis (disorder)</entry></row><row><entry align="center">595</entry><entry>Chronic infantile neurological, cutaneous and articular syndrome (disorder)</entry></row><row><entry align="center">596</entry><entry>Arthritis following intestinal bypass (disorder)</entry></row><row><entry align="center">597</entry><entry>Post-immunization arthritis (disorder)</entry></row><row><entry align="center">598</entry><entry>Palindromic rheumatism of the pelvic region and thigh (disorder)</entry></row><row><entry align="center">599</entry><entry>Palindromic rheumatism of the shoulder region (disorder)</entry></row><row><entry align="center">600</entry><entry>Generalized arthritis (disorder)</entry></row><row><entry align="center">601</entry><entry>Erosive osteoarthrosis (disorder)</entry></row><row><entry align="center">602</entry><entry>Arthropathy in Crohn's disease (disorder)</entry></row><row><entry align="center">603</entry><entry>Systemic lupus erythematosus arthritis (disorder)</entry></row><row><entry align="center">604</entry><entry>Arthritis of temporomandibular joint (disorder)</entry></row><row><entry align="center">605</entry><entry>Climacteric arthritis (disorder)</entry></row><row><entry align="center">606</entry><entry>Osteochondritis (disorder)</entry></row><row><entry align="center">607</entry><entry>Rheumatoid arthritis (disorder)</entry></row><row><entry align="center">608</entry><entry>Subacute arthritis (disorder)</entry></row><row><entry align="center">609</entry><entry>Chronic arthritis (disorder)</entry></row><row><entry align="center">610</entry><entry>Acute arthritis (disorder)</entry></row><row><entry align="center">611</entry><entry>Arthritis associated with another disorder (disorder)</entry></row><row><entry align="center">612</entry><entry>Deformity of foot (finding)</entry></row><row><entry align="center">613</entry><entry>Acquired overriding toes of left foot (disorder)</entry></row><row><entry align="center">614</entry><entry>Acquired overriding toes of right foot (disorder)</entry></row><row><entry align="center">615</entry><entry>Deformity of foot due to rheumatoid arthritis (finding)</entry></row><row><entry align="center">616</entry><entry>Putter foot (finding)</entry></row><row><entry align="center">617</entry><entry>Pronation deformity of the foot (finding)</entry></row><row><entry align="center">618</entry><entry>Supination deformity of the foot (finding)</entry></row><row><entry align="center">619</entry><entry>Pronated forefoot (finding)</entry></row><row><entry align="center">620</entry><entry>Supinated forefoot (finding)</entry></row><row><entry align="center">621</entry><entry>Adductus deformity of foot (finding)</entry></row><row><entry align="center">622</entry><entry>Plantarflexion deformity of foot (finding)</entry></row><row><entry align="center">623</entry><entry>Abduction deformity of the foot (finding)</entry></row><row><entry align="center">624</entry><entry>Acquired curly toe (disorder)</entry></row><row><entry align="center">625</entry><entry>Dorsiflexion deformity of foot (finding)</entry></row><row><entry align="center">626</entry><entry>Acquired valgus heel (disorder)</entry></row><row><entry align="center">627</entry><entry>Overriding fifth toe (disorder)</entry></row><row><entry align="center">628</entry><entry>Overriding toe (disorder)</entry></row><row><entry align="center">629</entry><entry>Muscle weakness (finding)</entry></row><row><entry align="center">630</entry><entry>Muscle weakness of limb (finding)</entry></row><row><entry align="center">631</entry><entry>Spastic paresis (finding)</entry></row><row><entry align="center">632</entry><entry>Hand muscle weakness (finding)</entry></row><row><entry align="center">633</entry><entry>Pyramidal type muscle weakness (finding)</entry></row><row><entry align="center">634</entry><entry>Distal muscle weakness (finding)</entry></row><row><entry align="center">635</entry><entry>Proximal muscle weakness (finding)</entry></row><row><entry align="center">636</entry><entry>Truncal muscle weakness (finding)</entry></row><row><entry align="center">637</entry><entry>Weakness of sternomastoid (finding)</entry></row><row><entry align="center">638</entry><entry>Weakness of jaw muscles (finding)</entry></row><row><entry align="center">639</entry><entry>On examination - muscle power reduced (finding)</entry></row><row><entry align="center">640</entry><entry>On examination - paresis (weakness) (finding)</entry></row><row><entry align="center">641</entry><entry>Weakness present (finding)</entry></row><row><entry align="center">642</entry><entry>Pseudoparalysis (finding)</entry></row><row><entry align="center">643</entry><entry>Palatal paresis (finding)</entry></row><row><entry align="center">644</entry><entry>Laryngeal paresis (finding)</entry></row><row><entry align="center">645</entry><entry>Pharyngeal paresis (finding)</entry></row><row><entry align="center">646</entry><entry>Bilateral paresis (finding)</entry></row><row><entry align="center">647</entry><entry>Subjective muscle weakness (finding)</entry></row><row><entry align="center">648</entry><entry>Paresis of lower extremity (finding)</entry></row><row><entry align="center">649</entry><entry>Weakness of face muscles (finding)</entry></row><row><entry align="center">650</entry><entry>Diaphragmatic paresis (finding)</entry></row><row><entry align="center">651</entry><entry>Neurological muscle weakness (finding)</entry></row><row><entry align="center">652</entry><entry>Spinal paraparesis (finding)</entry></row><row><entry align="center">653</entry><entry>Spinal hemiparesis (finding)</entry></row><row><entry align="center">654</entry><entry>Inherited spastic paresis (disorder)</entry></row><row><entry align="center">655</entry><entry>Cerebellar degeneration (disorder)</entry></row><row><entry align="center">656</entry><entry>Acute cerebellar syndrome (disorder)</entry></row><row><entry align="center">657</entry><entry>Secondary cerebellar degeneration (disorder)</entry></row><row><entry align="center">658</entry><entry>Cerebellar deficiency syndrome (disorder)</entry></row><row><entry align="center">659</entry><entry>Posthemiplegic ataxia (disorder)</entry></row><row><entry align="center">660</entry><entry>Primary progressive cerebellar degeneration (disorder)</entry></row><row><entry align="center">661</entry><entry>Juvenile cerebellar degeneration AND myoclonus (disorder)</entry></row><row><entry align="center">662</entry><entry>Olivopontocerebellar degeneration (disorder)</entry></row><row><entry align="center">663</entry><entry>Paramyoclonus multiplex (disorder)</entry></row><row><entry align="center">664</entry><entry>Bailey-Cushing syndrome (disorder)</entry></row><row><entry align="center">665</entry><entry>Jervis' syndrome (disorder)</entry></row><row><entry align="center">666</entry><entry>Roussy-Levy syndrome (disorder)</entry></row><row><entry align="center">667</entry><entry>Corticostriatal-spinal degeneration (disorder)</entry></row><row><entry align="center">668</entry><entry>Hereditary cerebellar degeneration (disorder)</entry></row><row><entry align="center">669</entry><entry>Primary cerebellar degeneration (disorder)</entry></row><row><entry align="center">670</entry><entry>Sporadic cerebellar degeneration (disorder)</entry></row><row><entry align="center">671</entry><entry>Friedreich's ataxia (disorder)</entry></row><row><entry align="center">672</entry><entry>Athetosis with spastic paraplegia (disorder)</entry></row><row><entry align="center">673</entry><entry>Cervical myelopathy (disorder)</entry></row><row><entry align="center">674</entry><entry>Myelopathy co-occurrent and due to spinal stenosis of cervical region (disorder)</entry></row><row><entry align="center">675</entry><entry>Parkinsonism (disorder)</entry></row><row><entry align="center">676</entry><entry>X-linked parkinsonism with spasticity syndrome (disorder)</entry></row><row><entry align="center">677</entry><entry>Hemiparkinsonism hemiatrophy syndrome (disorder)</entry></row><row><entry align="center">678</entry><entry>Autosomal dominant striatal neurodegeneration (disorder)</entry></row><row><entry align="center">679</entry><entry>Functional parkinsonism (disorder)</entry></row><row><entry align="center">680</entry><entry>Parkinsonism due to mass lesion of brain (disorder)</entry></row><row><entry align="center">681</entry><entry>Infection causing parkinsonism (disorder)</entry></row><row><entry align="center">682</entry><entry>Kufor Rakeb syndrome (disorder)</entry></row><row><entry align="center">683</entry><entry>Atypical Parkinsonism (disorder)</entry></row><row><entry align="center">684</entry><entry>Infantile dystonia parkinsonism (disorder)</entry></row><row><entry align="center">685</entry><entry>Adult-onset dystonia parkinsonism (disorder)</entry></row><row><entry align="center">686</entry><entry>Psychosis co-occurrent and due to Parkinson's disease (disorder)</entry></row><row><entry align="center">687</entry><entry>Parkinsonism co-occurrent with dementia of Guadeloupe (disorder)</entry></row><row><entry align="center">688</entry><entry>Rapid onset dystonia parkinsonism (disorder)</entry></row><row><entry align="center">689</entry><entry>Perry syndrome (disorder)</entry></row><row><entry align="center">690</entry><entry>X-linked dystonia parkinsonism (disorder)</entry></row><row><entry align="center">691</entry><entry>On - off phenomenon (disorder)</entry></row><row><entry align="center">692</entry><entry>Symptomatic parkinsonism (disorder)</entry></row><row><entry align="center">693</entry><entry>Secondary parkinsonism (disorder)</entry></row><row><entry align="center">694</entry><entry>Parkinsonian syndrome associated with idiopathic orthostatic hypotension (disorder)</entry></row><row><entry align="center">695</entry><entry>Parkinson-dementia complex of Guam (disorder)</entry></row><row><entry align="center">696</entry><entry>Parkinson's disease (disorder)</entry></row><row><entry align="center">697</entry><entry>Striatonigral degeneration (disorder)</entry></row><row><entry align="center">698</entry><entry>Peripheral nerve disease (disorder)</entry></row><row><entry align="center">699</entry><entry>Paraneoplastic peripheral neuropathy (disorder)</entry></row><row><entry align="center">700</entry><entry>Primary CD59 deficiency (disorder)</entry></row><row><entry align="center">701</entry><entry>Peripheral neuropathy due to and following chemotherapy (disorder)</entry></row><row><entry align="center">702</entry><entry>Morvan syndrome (disorder)</entry></row><row><entry align="center">703</entry><entry>Acquired hypoganglionosis of large intestine (disorder)</entry></row><row><entry align="center">704</entry><entry>Deafness, small bowel diverticulosis, neuropathy syndrome (disorder)</entry></row><row><entry align="center">705</entry><entry>Peripheral neuropathy due to hypervitaminosis B6 (disorder)</entry></row><row><entry align="center">706</entry><entry>Length-dependent peripheral neuropathy (disorder)</entry></row><row><entry align="center">707</entry><entry>Autosomal dominant optic atrophy and peripheral neuropathy syndrome (disorder)</entry></row><row><entry align="center">708</entry><entry>Peripheral neuropathy due to metabolic disorder (disorder)</entry></row><row><entry align="center">709</entry><entry>Small fiber neuropathy (disorder)</entry></row><row><entry align="center">710</entry><entry>Peripheral neuropathy due to inflammation (disorder)</entry></row><row><entry align="center">711</entry><entry>Peripheral neuropathy caused by toxin (disorder)</entry></row><row><entry align="center">712</entry><entry>Neuropathy of lower limb (disorder)</entry></row><row><entry align="center">713</entry><entry>Neuropathy of upper limb (disorder)</entry></row><row><entry align="center">714</entry><entry>Ependymal cyst of spinal nerve (disorder)</entry></row><row><entry align="center">715</entry><entry>Peripheral nerve disorder associated with repair of hernia (disorder)</entry></row><row><entry align="center">716</entry><entry>Facial nerve disorder (disorder)</entry></row><row><entry align="center">717</entry><entry>Abducens nerve disorder (disorder)</entry></row><row><entry align="center">718</entry><entry>Pudendal nerve neuropathy (disorder)</entry></row><row><entry align="center">719</entry><entry>Neuromyotonia (disorder)</entry></row><row><entry align="center">720</entry><entry>Thoracoabdominal neuropathy (disorder)</entry></row><row><entry align="center">721</entry><entry>Long thoracic nerve lesion (disorder)</entry></row><row><entry align="center">722</entry><entry>Disorder of peripheral nerve graft (disorder)</entry></row><row><entry align="center">723</entry><entry>Peripheral nerve decompression injury (disorder)</entry></row><row><entry align="center">724</entry><entry>Intercostal neuropathy (disorder)</entry></row><row><entry align="center">725</entry><entry>Compression neuropathy of trunk (disorder)</entry></row><row><entry align="center">726</entry><entry>Ischemic neuropathy (disorder)</entry></row><row><entry align="center">727</entry><entry>Leprosy neuropathy (disorder)</entry></row><row><entry align="center">728</entry><entry>Peripheral axonal neuropathy (disorder)</entry></row><row><entry align="center">729</entry><entry>Phrenic nerve disorder (disorder)</entry></row><row><entry align="center">730</entry><entry>Peripheral neuritis (disorder)</entry></row><row><entry align="center">731</entry><entry>Mononeuropathy (disorder)</entry></row><row><entry align="center">732</entry><entry>Neoplasm of peripheral nerve (disorder)</entry></row><row><entry align="center">733</entry><entry>Celiac plexus syndrome (disorder)</entry></row><row><entry align="center">734</entry><entry>Perineurial cyst (disorder)</entry></row><row><entry align="center">735</entry><entry>Disorder of glossopharyngeal nerve (disorder)</entry></row><row><entry align="center">736</entry><entry>Disorder of acoustic nerve (disorder)</entry></row><row><entry align="center">737</entry><entry>Brachial plexus neuralgia (disorder)</entry></row><row><entry align="center">738</entry><entry>Disorder of vagus nerve (disorder)</entry></row><row><entry align="center">739</entry><entry>Peripheral nerve injury (disorder)</entry></row><row><entry align="center">740</entry><entry>Nerve root disorder (disorder)</entry></row><row><entry align="center">741</entry><entry>Trigeminal nerve disorder (disorder)</entry></row><row><entry align="center">742</entry><entry>Third cranial nerve disease (disorder)</entry></row><row><entry align="center">743</entry><entry>Polyneuropathy (disorder)</entry></row><row><entry align="center">744</entry><entry>Disorder of hypoglossal nerve (disorder)</entry></row><row><entry align="center">745</entry><entry>Congenital anomaly of peripheral nerve (disorder)</entry></row><row><entry align="center">746</entry><entry>Peripheral demyelinating neuropathy (disorder)</entry></row><row><entry align="center">747</entry><entry>Familial visceral neuropathy (disorder)</entry></row><row><entry align="center">748</entry><entry>Fourth nerve palsy (disorder)</entry></row><row><entry align="center">749</entry><entry>Cerebrovascular accident (disorder)</entry></row><row><entry align="center">750</entry><entry>Cerebellar stroke (disorder)</entry></row><row><entry align="center">751</entry><entry>Cerebrovascular accident due to stenosis of left carotid artery (disorder)</entry></row><row><entry align="center">752</entry><entry>Cerebrovascular accident due to stenosis of right carotid artery (disorder)</entry></row><row><entry align="center">753</entry><entry>Cerebrovascular accident due to occlusion of right cerebellar artery (disorder)</entry></row><row><entry align="center">754</entry><entry>Cerebrovascular accident due to occlusion of left cerebellar artery (disorder)</entry></row><row><entry align="center">755</entry><entry>Cerebrovascular accident due to occlusion of left carotid artery (disorder)</entry></row><row><entry align="center">756</entry><entry>Cerebrovascular accident due to occlusion of right pontine artery (disorder)</entry></row><row><entry align="center">757</entry><entry>Cerebrovascular accident due to occlusion of left pontine artery (disorder)</entry></row><row><entry align="center">758</entry><entry>Cerebrovascular accident due to occlusion of right carotid artery (disorder)</entry></row><row><entry align="center">759</entry><entry>Cerebrovascular accident due to occlusion of left vertebral artery (disorder)</entry></row><row><entry align="center">760</entry><entry>Cerebrovascular accident due to occlusion of right vertebral artery (disorder)</entry></row><row><entry align="center">761</entry><entry>Cerebrovascular accident due to stenosis of left vertebral artery (disorder)</entry></row><row><entry align="center">762</entry><entry>Cerebrovascular accident due to stenosis of right vertebral artery (disorder)</entry></row><row><entry align="center">763</entry><entry>Occlusion of cerebral artery with stroke (disorder)</entry></row><row><entry align="center">764</entry><entry>Stroke co-occurrent with migraine (disorder)</entry></row><row><entry align="center">765</entry><entry>Silent cerebral infarct (disorder)</entry></row><row><entry align="center">766</entry><entry>Cerebrovascular accident during surgery (disorder)</entry></row><row><entry align="center">767</entry><entry>Ischemic stroke (disorder)</entry></row><row><entry align="center">768</entry><entry>Infarction of basal ganglia (disorder)</entry></row><row><entry align="center">769</entry><entry>Neonatal stroke (disorder)</entry></row><row><entry align="center">770</entry><entry>Embolic stroke (disorder)</entry></row><row><entry align="center">771</entry><entry>Thrombotic stroke (disorder)</entry></row><row><entry align="center">772</entry><entry>Extension of cerebrovascular accident (disorder)</entry></row><row><entry align="center">773</entry><entry>Stroke in the puerperium (disorder)</entry></row><row><entry align="center">774</entry><entry>Ruptured cerebral aneurysm (disorder)</entry></row><row><entry align="center">775</entry><entry>Stroke of uncertain pathology (disorder)</entry></row><row><entry align="center">776</entry><entry>Cerebrovascular accident due to occlusion of cerebral artery (disorder)</entry></row><row><entry align="center">777</entry><entry>Right sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">778</entry><entry>Left sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">779</entry><entry>Brainstem stroke syndrome (disorder)</entry></row><row><entry align="center">780</entry><entry>Paralytic stroke (disorder)</entry></row><row><entry align="center">781</entry><entry>Nonparalytic stroke (disorder)</entry></row><row><entry align="center">782</entry><entry>Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder)</entry></row><row><entry align="center">783</entry><entry>Progressing stroke (disorder)</entry></row><row><entry align="center">784</entry><entry>Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder)</entry></row><row><entry align="center">785</entry><entry>Completed stroke (disorder)</entry></row><row><entry align="center">786</entry><entry>Anterior choroidal artery syndrome (disorder)</entry></row><row><entry align="center">787</entry><entry>Basilar artery syndrome (disorder)</entry></row><row><entry align="center">788</entry><entry>Peripheral neuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">789</entry><entry>Peripheral neuropathy co-occurrent and due to type 1 diabetes mellitus (disorder)</entry></row><row><entry align="center">790</entry><entry>Peripheral neuropathy co-occurrent and due to type 2 diabetes mellitus (disorder)</entry></row><row><entry align="center">791</entry><entry>Ophthalmoplegia co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">792</entry><entry>Mononeuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">793</entry><entry>Asymmetric proximal motor neuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">794</entry><entry>Polyneuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">795</entry><entry>Radiculoplexus neuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">796</entry><entry>Symmetric proximal motor neuropathy co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">797</entry><entry>Pseudotabes co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">798</entry><entry>Cobalamin deficiency (disorder)</entry></row><row><entry align="center">799</entry><entry>Fetal or neonatal vitamin B12 deficiency due to maternal vitamin B12 deficiency (disorder)</entry></row><row><entry align="center">800</entry><entry>Vitamin B12 deficiency (non anemic) (disorder)</entry></row><row><entry align="center">801</entry><entry>Acute mastoiditis with labyrinthitis (disorder)</entry></row><row><entry align="center">802</entry><entry>Benign paroxysmal positional vertigo (disorder)</entry></row><row><entry align="center">803</entry><entry>Benign paroxysmal positional vertigo or nystagmus (disorder)</entry></row><row><entry align="center">804</entry><entry>Benign paroxysmal vertigo of childhood (disorder)</entry></row><row><entry align="center">805</entry><entry>Hearing loss (disorder)</entry></row><row><entry align="center">806</entry><entry>Mild to moderate hearing loss (disorder)</entry></row><row><entry align="center">807</entry><entry>Severe hearing loss (disorder)</entry></row><row><entry align="center">808</entry><entry>Aphonia, deafness, retinal dystrophy, bifid halluces, intellectual disability syndrome (disorder)</entry></row><row><entry align="center">809</entry><entry>Acquired hearing loss (disorder)</entry></row><row><entry align="center">810</entry><entry>Oro-facial digital syndrome type 11 (disorder)</entry></row><row><entry align="center">811</entry><entry>Deafness craniofacial syndrome (disorder)</entry></row><row><entry align="center">812</entry><entry>Microcephaly with deafness and intellectual disability syndrome (disorder)</entry></row><row><entry align="center">813</entry><entry>Hearing loss of left ear (disorder)</entry></row><row><entry align="center">814</entry><entry>Hearing loss of right ear (disorder)</entry></row><row><entry align="center">815</entry><entry>Combined visual and hearing impairment (disorder)</entry></row><row><entry align="center">816</entry><entry>Asymmetrical hearing loss (disorder)</entry></row><row><entry align="center">817</entry><entry>Partial deafness (disorder)</entry></row><row><entry align="center">818</entry><entry>On examination - deaf (disorder)</entry></row><row><entry align="center">819</entry><entry>Deafness symptom (disorder)</entry></row><row><entry align="center">820</entry><entry>Chronic deafness (disorder)</entry></row><row><entry align="center">821</entry><entry>On examination - significantly deaf (disorder)</entry></row><row><entry align="center">822</entry><entry>Bilateral deafness (disorder)</entry></row><row><entry align="center">823</entry><entry>Birth trauma deafness (disorder)</entry></row><row><entry align="center">824</entry><entry>Congenital anomaly of ear with impairment of hearing (disorder)</entry></row><row><entry align="center">825</entry><entry>Neonatal hearing loss (disorder)</entry></row><row><entry align="center">826</entry><entry>Bilateral hearing loss (disorder)</entry></row><row><entry align="center">827</entry><entry>Traumatic deafness (disorder)</entry></row><row><entry align="center">828</entry><entry>Sudden hearing loss (disorder)</entry></row><row><entry align="center">829</entry><entry>Noise-induced hearing loss (disorder)</entry></row><row><entry align="center">830</entry><entry>Deaf mutism (disorder)</entry></row><row><entry align="center">831</entry><entry>Sensorineural hearing loss (disorder)</entry></row><row><entry align="center">832</entry><entry>Tone deafness (disorder)</entry></row><row><entry align="center">833</entry><entry>Upper frequency deafness (disorder)</entry></row><row><entry align="center">834</entry><entry>Conductive hearing loss (disorder)</entry></row><row><entry align="center">835</entry><entry>Paradoxic hearing loss (disorder)</entry></row><row><entry align="center">836</entry><entry>Toxic deafness (disorder)</entry></row><row><entry align="center">837</entry><entry>Psychogenic deafness (disorder)</entry></row><row><entry align="center">838</entry><entry>Robinson nail dystrophy-deafness syndrome (disorder)</entry></row><row><entry align="center">839</entry><entry>Complete deafness (disorder)</entry></row><row><entry align="center">840</entry><entry>Meniere's disease (disorder)</entry></row><row><entry align="center">841</entry><entry>Meniere's disease of right inner ear (disorder)</entry></row><row><entry align="center">842</entry><entry>Meniere's disease of left inner ear (disorder)</entry></row><row><entry align="center">843</entry><entry>Familial Ménière disease (disorder)</entry></row><row><entry align="center">844</entry><entry>Vestibular Ménière syndrome (disorder)</entry></row><row><entry align="center">845</entry><entry>Cochlear Meniere syndrome (disorder)</entry></row><row><entry align="center">846</entry><entry>Inactive Meniere's disease (disorder)</entry></row><row><entry align="center">847</entry><entry>Active Meniere's disease (disorder)</entry></row><row><entry align="center">848</entry><entry>Cataract (disorder)</entry></row><row><entry align="center">849</entry><entry>Infantile and/or juvenile cataract (disorder)</entry></row><row><entry align="center">850</entry><entry>Microcornea, rod-cone dystrophy, cataract, posterior staphyloma syndrome (disorder)</entry></row><row><entry align="center">851</entry><entry>Cataract due to pseudohypoparathyroidism (disorder)</entry></row><row><entry align="center">852</entry><entry>Cataract due to idiopathic hypoparathyroidism (disorder)</entry></row><row><entry align="center">853</entry><entry>Cochleosaccular degeneration and cataract syndrome (disorder)</entry></row><row><entry align="center">854</entry><entry>Hyperferritinemia cataract syndrome (disorder)</entry></row><row><entry align="center">855</entry><entry>Immature cataract (disorder)</entry></row><row><entry align="center">856</entry><entry>Presenile cataract (disorder)</entry></row><row><entry align="center">857</entry><entry>Nonsenile cataract (disorder)</entry></row><row><entry align="center">858</entry><entry>Suture tip cataract (disorder)</entry></row><row><entry align="center">859</entry><entry>Mixed type cataract (disorder)</entry></row><row><entry align="center">860</entry><entry>Hypermature cataract (disorder)</entry></row><row><entry align="center">861</entry><entry>Rubella cataract (disorder)</entry></row><row><entry align="center">862</entry><entry>Cataract in systemic disorders (disorder)</entry></row><row><entry align="center">863</entry><entry>Capsular cataract (disorder)</entry></row><row><entry align="center">864</entry><entry>Drug-induced cataract (disorder)</entry></row><row><entry align="center">865</entry><entry>Lamellar zonular cataract (disorder)</entry></row><row><entry align="center">866</entry><entry>Cortical cataract (disorder)</entry></row><row><entry align="center">867</entry><entry>Infantile, juvenile and presenile cataracts (disorder)</entry></row><row><entry align="center">868</entry><entry>On examination - lens - early opacity (disorder)</entry></row><row><entry align="center">869</entry><entry>Partial cataract (disorder)</entry></row><row><entry align="center">870</entry><entry>Adherent cataract (disorder)</entry></row><row><entry align="center">871</entry><entry>Stationary cataract (disorder)</entry></row><row><entry align="center">872</entry><entry>Axial cataract (disorder)</entry></row><row><entry align="center">873</entry><entry>Subcapsular cataract (disorder)</entry></row><row><entry align="center">874</entry><entry>Bilateral cataracts (disorder)</entry></row><row><entry align="center">875</entry><entry>Congenital cataract (disorder)</entry></row><row><entry align="center">876</entry><entry>Cataract with neovascularization (disorder)</entry></row><row><entry align="center">877</entry><entry>Cataract associated with radiation (disorder)</entry></row><row><entry align="center">878</entry><entry>Postoperative cataract syndrome (disorder)</entry></row><row><entry align="center">879</entry><entry>Nuclear cataract (disorder)</entry></row><row><entry align="center">880</entry><entry>Incipient cataract (disorder)</entry></row><row><entry align="center">881</entry><entry>Localized traumatic opacity (disorder)</entry></row><row><entry align="center">882</entry><entry>Punctate cataract (disorder)</entry></row><row><entry align="center">883</entry><entry>Age-related cataract (disorder)</entry></row><row><entry align="center">884</entry><entry>Toxic cataract (disorder)</entry></row><row><entry align="center">885</entry><entry>Traumatic cataract (disorder)</entry></row><row><entry align="center">886</entry><entry>Cataract in inflammatory disorder (disorder)</entry></row><row><entry align="center">887</entry><entry>Coronary cataract (disorder)</entry></row><row><entry align="center">888</entry><entry>Calcified cataract (disorder)</entry></row><row><entry align="center">889</entry><entry>Atopic cataract (disorder)</entry></row><row><entry align="center">890</entry><entry>Mature cataract (disorder)</entry></row><row><entry align="center">891</entry><entry>Glaucoma (disorder)</entry></row><row><entry align="center">892</entry><entry>Glaucoma and sleep apnea syndrome (disorder)</entry></row><row><entry align="center">893</entry><entry>Angle-closure glaucoma (disorder)</entry></row><row><entry align="center">894</entry><entry>Acute-on-chronic glaucoma (disorder)</entry></row><row><entry align="center">895</entry><entry>Glaucoma with intraocular hemorrhage (disorder)</entry></row><row><entry align="center">896</entry><entry>Iatrogenic glaucoma (disorder)</entry></row><row><entry align="center">897</entry><entry>Congenital glaucoma (disorder)</entry></row><row><entry align="center">898</entry><entry>Borderline glaucoma (disorder)</entry></row><row><entry align="center">899</entry><entry>Secondary glaucoma (disorder)</entry></row><row><entry align="center">900</entry><entry>Glaucoma due to combination of mechanisms (disorder)</entry></row><row><entry align="center">901</entry><entry>Open-angle glaucoma (disorder)</entry></row><row><entry align="center">902</entry><entry>Glaucoma of childhood (disorder)</entry></row><row><entry align="center">903</entry><entry>Glaucoma associated with ocular disorder (disorder)</entry></row><row><entry align="center">904</entry><entry>Glaucoma associated with systemic syndromes (disorder)</entry></row><row><entry align="center">905</entry><entry>Low tension glaucoma (disorder)</entry></row><row><entry align="center">906</entry><entry>Anatomical narrow angle glaucoma (disorder)</entry></row><row><entry align="center">907</entry><entry>Hypersecretion glaucoma (disorder)</entry></row><row><entry align="center">908</entry><entry>Glaucoma associated with tumors AND/OR cysts (disorder)</entry></row><row><entry align="center">909</entry><entry>Absolute glaucoma (disorder)</entry></row><row><entry align="center">910</entry><entry>Aphakic glaucoma (disorder)</entry></row><row><entry align="center">911</entry><entry>Glaucomatous atrophy of optic disc (disorder)</entry></row><row><entry align="center">912</entry><entry>Age-related macular degeneration (disorder)</entry></row><row><entry align="center">913</entry><entry>Nonexudative age-related macular degeneration (disorder)</entry></row><row><entry align="center">914</entry><entry>Exudative age-related macular degeneration (disorder)</entry></row><row><entry align="center">915</entry><entry>Drusen plus pigment change stage macular degeneration (disorder)</entry></row><row><entry align="center">916</entry><entry>Fibrovascular macular scar (disorder)</entry></row><row><entry align="center">917</entry><entry>Drusen stage macular degeneration (disorder)</entry></row><row><entry align="center">918</entry><entry>Muscle weakness (finding)</entry></row><row><entry align="center">919</entry><entry>Muscle weakness of limb (finding)</entry></row><row><entry align="center">920</entry><entry>Spastic paresis (finding)</entry></row><row><entry align="center">921</entry><entry>Hand muscle weakness (finding)</entry></row><row><entry align="center">922</entry><entry>Pyramidal type muscle weakness (finding)</entry></row><row><entry align="center">923</entry><entry>Distal muscle weakness (finding)</entry></row><row><entry align="center">924</entry><entry>Proximal muscle weakness (finding)</entry></row><row><entry align="center">925</entry><entry>Truncal muscle weakness (finding)</entry></row><row><entry align="center">926</entry><entry>Weakness of sternomastoid (finding)</entry></row><row><entry align="center">927</entry><entry>Weakness of jaw muscles (finding)</entry></row><row><entry align="center">928</entry><entry>On examination - muscle power reduced (finding)</entry></row><row><entry align="center">929</entry><entry>On examination - paresis (weakness) (finding)</entry></row><row><entry align="center">930</entry><entry>Weakness present (finding)</entry></row><row><entry align="center">931</entry><entry>Pseudoparalysis (finding)</entry></row><row><entry align="center">932</entry><entry>Palatal paresis (finding)</entry></row><row><entry align="center">933</entry><entry>Laryngeal paresis (finding)</entry></row><row><entry align="center">934</entry><entry>Pharyngeal paresis (finding)</entry></row><row><entry align="center">935</entry><entry>Bilateral paresis (finding)</entry></row><row><entry align="center">936</entry><entry>Subjective muscle weakness (finding)</entry></row><row><entry align="center">937</entry><entry>Paresis of lower extremity (finding)</entry></row><row><entry align="center">938</entry><entry>Weakness of face muscles (finding)</entry></row><row><entry align="center">939</entry><entry>Diaphragmatic paresis (finding)</entry></row><row><entry align="center">940</entry><entry>Neurological muscle weakness (finding)</entry></row><row><entry align="center">941</entry><entry>Spinal paraparesis (finding)</entry></row><row><entry align="center">942</entry><entry>Spinal hemiparesis (finding)</entry></row><row><entry align="center">943</entry><entry>Inherited spastic paresis (disorder)</entry></row><row><entry align="center">944</entry><entry>Abnormal gait due to impairment of balance (finding)</entry></row><row><entry align="center">945</entry><entry>Impairment of balance (finding)</entry></row><row><entry align="center">946</entry><entry>Difficulty balancing (finding)</entry></row><row><entry align="center">947</entry><entry>Does not balance (finding)</entry></row><row><entry align="center">948</entry><entry>Unable to balance (finding)</entry></row><row><entry align="center">949</entry><entry>General unsteadiness (finding)</entry></row><row><entry align="center">950</entry><entry>Equilibration disorder, vestibular nerve (disorder)</entry></row><row><entry align="center">951</entry><entry>Unsteady when turning (finding)</entry></row><row><entry align="center">952</entry><entry>Unsteady when standing (finding)</entry></row><row><entry align="center">953</entry><entry>Poor balance (finding)</entry></row><row><entry align="center">954</entry><entry>Keeps losing balance (finding)</entry></row><row><entry align="center">955</entry><entry>Feels as though will fall (finding)</entry></row><row><entry align="center">956</entry><entry>Romberg test positive and direction of fall affected by head turn (finding)</entry></row><row><entry align="center">957</entry><entry>Romberg test evokes stiff fall backward (finding)</entry></row><row><entry align="center">958</entry><entry>Loss of equilibrium (finding)</entry></row><row><entry align="center">959</entry><entry>Visual impairment (disorder)</entry></row><row><entry align="center">960</entry><entry>Bilateral visual impairment (disorder)</entry></row><row><entry align="center">961</entry><entry>Visual impairment co-occurrent with human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">962</entry><entry>Drug related visual impairment (disorder)</entry></row><row><entry align="center">963</entry><entry>Combined visual and hearing impairment (disorder)</entry></row><row><entry align="center">964</entry><entry>Multiple disability visual impairment (disorder)</entry></row><row><entry align="center">965</entry><entry>Mild visual impairment (disorder)</entry></row><row><entry align="center">966</entry><entry>Moderate visual impairment (disorder)</entry></row><row><entry align="center">967</entry><entry>Severe visual impairment (disorder)</entry></row><row><entry align="center">968</entry><entry>Orthostatic hypotension (disorder)</entry></row><row><entry align="center">969</entry><entry>Postural hypotension following exercise (disorder)</entry></row><row><entry align="center">970</entry><entry>Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder)</entry></row><row><entry align="center">971</entry><entry>Postural orthostatic tachycardia syndrome (disorder)</entry></row><row><entry align="center">972</entry><entry>Sympathotonic orthostatic hypotension (disorder)</entry></row><row><entry align="center">973</entry><entry>Chronic orthostatic hypotension (disorder)</entry></row><row><entry align="center">974</entry><entry>Hypoadrenergic postural hypotension (disorder)</entry></row><row><entry align="center">975</entry><entry>Hyperadrenergic postural hypotension (disorder)</entry></row><row><entry align="center">976</entry><entry>Arthritis (disorder)</entry></row><row><entry align="center">977</entry><entry>Arthritis of right sternoclavicular joint (disorder)</entry></row><row><entry align="center">978</entry><entry>Arthritis of left sternoclavicular joint (disorder)</entry></row><row><entry align="center">979</entry><entry>Primary chronic gout without tophus of shoulder (disorder)</entry></row><row><entry align="center">980</entry><entry>Gout of shoulder caused by drug (disorder)</entry></row><row><entry align="center">981</entry><entry>Transient arthritis (disorder)</entry></row><row><entry align="center">982</entry><entry>Arthritis of wrist (disorder)</entry></row><row><entry align="center">983</entry><entry>Interstitial granulomatous dermatitis with arthritis (disorder)</entry></row><row><entry align="center">984</entry><entry>Immune dysregulation, inflammatory bowel disease, arthritis, recurrent infection syndrome (disorder)</entry></row><row><entry align="center">985</entry><entry>Monoarthritis (disorder)</entry></row><row><entry align="center">986</entry><entry>Inflammation of joint of hand (disorder)</entry></row><row><entry align="center">987</entry><entry>Inflammation of joint of shoulder region (disorder)</entry></row><row><entry align="center">988</entry><entry>Arthritis of elbow (disorder)</entry></row><row><entry align="center">989</entry><entry>Arthritis of acromioclavicular joint (disorder)</entry></row><row><entry align="center">990</entry><entry>Inflammatory polyarthropathy (disorder)</entry></row><row><entry align="center">991</entry><entry>Undifferentiated inflammatory arthritis (disorder)</entry></row><row><entry align="center">992</entry><entry>Synovitis (disorder)</entry></row><row><entry align="center">993</entry><entry>Seronegative arthritis (disorder)</entry></row><row><entry align="center">994</entry><entry>Infective arthritis (disorder)</entry></row><row><entry align="center">995</entry><entry>Suppurative arthritis (disorder)</entry></row><row><entry align="center">996</entry><entry>Arthritis of spine (disorder)</entry></row><row><entry align="center">997</entry><entry>Cricoarytenoid joint arthritis (disorder)</entry></row><row><entry align="center">998</entry><entry>Lower limb joint arthritis (disorder)</entry></row><row><entry align="center">999</entry><entry>Small and large joint arthritis (disorder)</entry></row><row><entry align="center">1000</entry><entry>Large joint arthritis (disorder)</entry></row><row><entry align="center">1001</entry><entry>Small joint arthritis (disorder)</entry></row><row><entry align="center">1002</entry><entry>Asymmetrical arthritis (disorder)</entry></row><row><entry align="center">1003</entry><entry>Symmetrical arthritis (disorder)</entry></row><row><entry align="center">1004</entry><entry>Cholesterol-related arthritis and periarthritis (disorder)</entry></row><row><entry align="center">1005</entry><entry>Oxalate-related arthritis and periarthritis (disorder)</entry></row><row><entry align="center">1006</entry><entry>Idiopathic pyrophosphate arthritis (disorder)</entry></row><row><entry align="center">1007</entry><entry>Chronic infantile neurological, cutaneous and articular syndrome (disorder)</entry></row><row><entry align="center">1008</entry><entry>Arthritis following intestinal bypass (disorder)</entry></row><row><entry align="center">1009</entry><entry>Post-immunization arthritis (disorder)</entry></row><row><entry align="center">1010</entry><entry>Palindromic rheumatism of the pelvic region and thigh (disorder)</entry></row><row><entry align="center">1011</entry><entry>Palindromic rheumatism of the shoulder region (disorder)</entry></row><row><entry align="center">1012</entry><entry>Generalized arthritis (disorder)</entry></row><row><entry align="center">1013</entry><entry>Erosive osteoarthrosis (disorder)</entry></row><row><entry align="center">1014</entry><entry>Arthropathy in Crohn's disease (disorder)</entry></row><row><entry align="center">1015</entry><entry>Systemic lupus erythematosus arthritis (disorder)</entry></row><row><entry align="center">1016</entry><entry>Arthritis of temporomandibular joint (disorder)</entry></row><row><entry align="center">1017</entry><entry>Climacteric arthritis (disorder)</entry></row><row><entry align="center">1018</entry><entry>Osteochondritis (disorder)</entry></row><row><entry align="center">1019</entry><entry>Rheumatoid arthritis (disorder)</entry></row><row><entry align="center">1020</entry><entry>Subacute arthritis (disorder)</entry></row><row><entry align="center">1021</entry><entry>Chronic arthritis (disorder)</entry></row><row><entry align="center">1022</entry><entry>Acute arthritis (disorder)</entry></row><row><entry align="center">1023</entry><entry>Arthritis associated with another disorder (disorder)</entry></row><row><entry align="center">1024</entry><entry>Cerebrovascular accident (disorder)</entry></row><row><entry align="center">1025</entry><entry>Cerebellar stroke (disorder)</entry></row><row><entry align="center">1026</entry><entry>Cerebrovascular accident due to stenosis of left carotid artery (disorder)</entry></row><row><entry align="center">1027</entry><entry>Cerebrovascular accident due to stenosis of right carotid artery (disorder)</entry></row><row><entry align="center">1028</entry><entry>Cerebrovascular accident due to occlusion of right cerebellar artery (disorder)</entry></row><row><entry align="center">1029</entry><entry>Cerebrovascular accident due to occlusion of left cerebellar artery (disorder)</entry></row><row><entry align="center">1030</entry><entry>Cerebrovascular accident due to occlusion of left carotid artery (disorder)</entry></row><row><entry align="center">1031</entry><entry>Cerebrovascular accident due to occlusion of right pontine artery (disorder)</entry></row><row><entry align="center">1032</entry><entry>Cerebrovascular accident due to occlusion of left pontine artery (disorder)</entry></row><row><entry align="center">1033</entry><entry>Cerebrovascular accident due to occlusion of right carotid artery (disorder)</entry></row><row><entry align="center">1034</entry><entry>Cerebrovascular accident due to occlusion of left vertebral artery (disorder)</entry></row><row><entry align="center">1035</entry><entry>Cerebrovascular accident due to occlusion of right vertebral artery (disorder)</entry></row><row><entry align="center">1036</entry><entry>Cerebrovascular accident due to stenosis of left vertebral artery (disorder)</entry></row><row><entry align="center">1037</entry><entry>Cerebrovascular accident due to stenosis of right vertebral artery (disorder)</entry></row><row><entry align="center">1038</entry><entry>Occlusion of cerebral artery with stroke (disorder)</entry></row><row><entry align="center">1039</entry><entry>Stroke co-occurrent with migraine (disorder)</entry></row><row><entry align="center">1040</entry><entry>Silent cerebral infarct (disorder)</entry></row><row><entry align="center">1041</entry><entry>Cerebrovascular accident during surgery (disorder)</entry></row><row><entry align="center">1042</entry><entry>Ischemic stroke (disorder)</entry></row><row><entry align="center">1043</entry><entry>Infarction of basal ganglia (disorder)</entry></row><row><entry align="center">1044</entry><entry>Neonatal stroke (disorder)</entry></row><row><entry align="center">1045</entry><entry>Embolic stroke (disorder)</entry></row><row><entry align="center">1046</entry><entry>Thrombotic stroke (disorder)</entry></row><row><entry align="center">1047</entry><entry>Extension of cerebrovascular accident (disorder)</entry></row><row><entry align="center">1048</entry><entry>Stroke in the puerperium (disorder)</entry></row><row><entry align="center">1049</entry><entry>Ruptured cerebral aneurysm (disorder)</entry></row><row><entry align="center">1050</entry><entry>Stroke of uncertain pathology (disorder)</entry></row><row><entry align="center">1051</entry><entry>Cerebrovascular accident due to occlusion of cerebral artery (disorder)</entry></row><row><entry align="center">1052</entry><entry>Right sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">1053</entry><entry>Left sided cerebral hemisphere cerebrovascular accident (disorder)</entry></row><row><entry align="center">1054</entry><entry>Brainstem stroke syndrome (disorder)</entry></row><row><entry align="center">1055</entry><entry>Paralytic stroke (disorder)</entry></row><row><entry align="center">1056</entry><entry>Nonparalytic stroke (disorder)</entry></row><row><entry align="center">1057</entry><entry>Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder)</entry></row><row><entry align="center">1058</entry><entry>Progressing stroke (disorder)</entry></row><row><entry align="center">1059</entry><entry>Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder)</entry></row><row><entry align="center">1060</entry><entry>Completed stroke (disorder)</entry></row><row><entry align="center">1061</entry><entry>Anterior choroidal artery syndrome (disorder)</entry></row><row><entry align="center">1062</entry><entry>Urinary incontinence (finding)</entry></row><row><entry align="center">1063</entry><entry>Urinary incontinence due to benign prostatic hypertrophy (finding)</entry></row><row><entry align="center">1064</entry><entry>Urinary incontinence co-occurrent and due to prolapse of female genital organ (disorder)</entry></row><row><entry align="center">1065</entry><entry>Intermittent urinary incontinence (finding)</entry></row><row><entry align="center">1066</entry><entry>Urinary incontinence due to urethral sphincter incompetence (finding)</entry></row><row><entry align="center">1067</entry><entry>Total urinary incontinence (finding)</entry></row><row><entry align="center">1068</entry><entry>Double incontinence (finding)</entry></row><row><entry align="center">1069</entry><entry>Urinary incontinence of non-organic origin (finding)</entry></row><row><entry align="center">1070</entry><entry>Parkinson's disease (disorder)</entry></row><row><entry align="center">1071</entry><entry>Sporadic Parkinson disease (disorder)</entry></row><row><entry align="center">1072</entry><entry>Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder)</entry></row><row><entry align="center">1073</entry><entry>Autosomal dominant late onset Parkinson disease (disorder)</entry></row><row><entry align="center">1074</entry><entry>Young onset Parkinson disease (disorder)</entry></row><row><entry align="center">1075</entry><entry>Juvenile Parkinson's disease (disorder)</entry></row><row><entry align="center">1076</entry><entry>Dementia (disorder)</entry></row><row><entry align="center">1077</entry><entry>Primary degenerative dementia (disorder)</entry></row><row><entry align="center">1078</entry><entry>Dementia with behavioral disturbance (disorder)</entry></row><row><entry align="center">1079</entry><entry>Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments (disorder)</entry></row><row><entry align="center">1080</entry><entry>Subcortical dementia (disorder)</entry></row><row><entry align="center">1081</entry><entry>Dementia following injury caused by exposure to ionizing radiation (disorder)</entry></row><row><entry align="center">1082</entry><entry>Dementia caused by heavy metal exposure (disorder)</entry></row><row><entry align="center">1083</entry><entry>Delirium co-occurrent with dementia (disorder)</entry></row><row><entry align="center">1084</entry><entry>Rapidly progressive dementia (disorder)</entry></row><row><entry align="center">1085</entry><entry>Dementia caused by toxin (disorder)</entry></row><row><entry align="center">1086</entry><entry>Parkinsonism co-occurrent with dementia of Guadeloupe (disorder)</entry></row><row><entry align="center">1087</entry><entry>Dementia co-occurrent with human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">1088</entry><entry>Dementia in remission (disorder)</entry></row><row><entry align="center">1089</entry><entry>Dementia of frontal lobe type (disorder)</entry></row><row><entry align="center">1090</entry><entry>Senile and presenile organic psychotic conditions (disorder)</entry></row><row><entry align="center">1091</entry><entry>Patchy dementia (disorder)</entry></row><row><entry align="center">1092</entry><entry>Semantic dementia (disorder)</entry></row><row><entry align="center">1093</entry><entry>Dementia associated with another disease (disorder)</entry></row><row><entry align="center">1094</entry><entry>Drug-induced dementia (disorder)</entry></row><row><entry align="center">1095</entry><entry>Parkinson-dementia complex of Guam (disorder)</entry></row><row><entry align="center">1096</entry><entry>General paresis - neurosyphilis (disorder)</entry></row><row><entry align="center">1097</entry><entry>Alzheimer's disease (disorder)</entry></row><row><entry align="center">1098</entry><entry>Senile dementia (disorder)</entry></row><row><entry align="center">1099</entry><entry>Presenile dementia (disorder)</entry></row><row><entry align="center">1100</entry><entry>Dialysis dementia (disorder)</entry></row><row><entry align="center">1101</entry><entry>Impaired cognition (finding)</entry></row><row><entry align="center">1102</entry><entry>Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder)</entry></row><row><entry align="center">1103</entry><entry>Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">1104</entry><entry>Cognitive deficit in attention (finding)</entry></row><row><entry align="center">1105</entry><entry>Depressed mood in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1106</entry><entry>Delusions in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1107</entry><entry>Cognitive changes due to organic disorder (finding)</entry></row><row><entry align="center">1108</entry><entry>Early onset Alzheimer's disease with behavioral disturbance (disorder)</entry></row><row><entry align="center">1109</entry><entry>Altered behavior in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1110</entry><entry>Dementia due to multiple sclerosis with altered behavior (disorder)</entry></row><row><entry align="center">1111</entry><entry>Altered behavior in dementia due to Huntington chorea (disorder)</entry></row><row><entry align="center">1112</entry><entry>Hallucinations co-occurrent and due to late onset dementia (disorder)</entry></row><row><entry align="center">1113</entry><entry>Cognitive impairment due to toxicity of substance (disorder)</entry></row><row><entry align="center">1114</entry><entry>Impaired executive functioning (finding)</entry></row><row><entry align="center">1115</entry><entry>Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder)</entry></row><row><entry align="center">1116</entry><entry>Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder)</entry></row><row><entry align="center">1117</entry><entry>Severe cognitive impairment (finding)</entry></row><row><entry align="center">1118</entry><entry>Moderate cognitive impairment (finding)</entry></row><row><entry align="center">1119</entry><entry>Memory impairment (finding)</entry></row><row><entry align="center">1120</entry><entry>Impaired environmental interpretation syndrome (finding)</entry></row><row><entry align="center">1121</entry><entry>Disturbance of cognitive learning (finding)</entry></row><row><entry align="center">1122</entry><entry>Lack of thinking ability (finding)</entry></row><row><entry align="center">1123</entry><entry>Minimal cognitive impairment (finding)</entry></row><row><entry align="center">1124</entry><entry>Age-related cognitive decline (finding)</entry></row><row><entry align="center">1125</entry><entry>Diabetes mellitus (disorder)</entry></row><row><entry align="center">1126</entry><entry>Atypical diabetes mellitus (disorder)</entry></row><row><entry align="center">1127</entry><entry>Diabetes mellitus due to pancreatic injury (disorder)</entry></row><row><entry align="center">1128</entry><entry>Erectile dysfunction co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1129</entry><entry>Acute complication co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1130</entry><entry>Metabolic acidosis co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1131</entry><entry>Lactic acidosis co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1132</entry><entry>Alaninuria, microcephaly, dwarfism, enamel hypoplasia, diabetes mellitus syndrome (disorder)</entry></row><row><entry align="center">1133</entry><entry>Diabetic mastopathy (disorder)</entry></row><row><entry align="center">1134</entry><entry>Pancreatic hypoplasia, diabetes mellitus, congenital heart disease syndrome (disorder)</entry></row><row><entry align="center">1135</entry><entry>Gingival disease co-occurrent with diabetes mellitus (disorder)</entry></row><row><entry align="center">1136</entry><entry>Diabetes mellitus in remission (disorder)</entry></row><row><entry align="center">1137</entry><entry>Diabetes mellitus due to genetic defect in insulin action (disorder)</entry></row><row><entry align="center">1138</entry><entry>Diabetes mellitus due to genetic defect in beta cell function (disorder)</entry></row><row><entry align="center">1139</entry><entry>Disorder of nervous system co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1140</entry><entry>Peripheral vascular disorder co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1141</entry><entry>Disorder of soft tissue co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1142</entry><entry>Diabetes mellitus during pregnancy, childbirth and the puerperium (disorder)</entry></row><row><entry align="center">1143</entry><entry>Disorder of kidney co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1144</entry><entry>Houssay's syndrome (disorder)</entry></row><row><entry align="center">1145</entry><entry>Diabetes mellitus without complication (disorder)</entry></row><row><entry align="center">1146</entry><entry>Diabetes mellitus type 1 (disorder)</entry></row><row><entry align="center">1147</entry><entry>Diabetes mellitus type 2 (disorder)</entry></row><row><entry align="center">1148</entry><entry>Disorder of eye co-occurrent and due to diabetes mellitus (disorder)</entry></row><row><entry align="center">1149</entry><entry>Secondary diabetes mellitus (disorder)</entry></row><row><entry align="center">1150</entry><entry>Diabetes insipidus (disorder)</entry></row><row><entry align="center">1151</entry><entry>Partial diabetes insipidus (disorder)</entry></row><row><entry align="center">1152</entry><entry>Hypohidrosis-diabetes insipidus syndrome (disorder)</entry></row><row><entry align="center">1153</entry><entry>Nephrogenic diabetes insipidus (disorder)</entry></row><row><entry align="center">1154</entry><entry>Dipsogenic diabetes insipidus (disorder)</entry></row><row><entry align="center">1155</entry><entry>Idiopathic diabetes insipidus (disorder)</entry></row><row><entry align="center">1156</entry><entry>Diabetes mellitus AND insipidus with optic atrophy AND deafness (disorder)</entry></row><row><entry align="center">1157</entry><entry>Neurohypophyseal diabetes insipidus (disorder)</entry></row><row><entry align="center">1158</entry><entry>Familial diabetes insipidus (disorder)</entry></row><row><entry align="center">1159</entry><entry>Polypharmacy (finding)</entry></row><row><entry align="center">1160</entry><entry>Nutraceutical polypharmacy (finding)</entry></row><row><entry align="center">1161</entry><entry>On four or more medications (finding)</entry></row><row><entry align="center">1162</entry><entry>Patient on numerous drugs (finding)</entry></row><row><entry align="center">1163</entry><entry>Loop diuretic overdose (disorder)</entry></row><row><entry align="center">1164</entry><entry>Aminoglycoside (substance)</entry></row><row><entry align="center">1165</entry><entry>Analgesic (substance)</entry></row><row><entry align="center">1166</entry><entry>Medicinal product acting as analgesic agent (product)</entry></row><row><entry align="center">1167</entry><entry>Substance with opioid receptor agonist mechanism of action (substance)</entry></row><row><entry align="center">1168</entry><entry>Antiarrhythmic agent (substance)</entry></row><row><entry align="center">1169</entry><entry>Medicinal product acting as antiarrhythmic agent (product)</entry></row><row><entry align="center">1170</entry><entry>Quaternary ammonium compound with anticholinergic mechanism of action (substance)</entry></row><row><entry align="center">1171</entry><entry>Vasodilator (substance)</entry></row><row><entry align="center">1172</entry><entry>Hypotensive agent (substance)</entry></row><row><entry align="center">1173</entry><entry>Hypotensive agent (product)</entry></row><row><entry align="center">1174</entry><entry>Anti-psychotic agent (substance)</entry></row><row><entry align="center">1175</entry><entry>Medicinal product acting as antipsychotic agent (product)</entry></row><row><entry align="center">1176</entry><entry>Diuretic (substance)</entry></row><row><entry align="center">1177</entry><entry>Medicinal product acting as diuretic (product)</entry></row><row><entry align="center">1178</entry><entry>Loop diuretic (substance)</entry></row><row><entry align="center">1179</entry><entry>Psychoactive substance (substance)</entry></row><row><entry align="center">1180</entry><entry>Antidepressant (substance)</entry></row><row><entry align="center">1181</entry><entry>Medicinal product acting as antidepressant agent (product)</entry></row><row><entry align="center">1182</entry><entry>Anti-psychotic agent (substance)</entry></row><row><entry align="center">1183</entry><entry>Medicinal product acting as antipsychotic agent (product)</entry></row><row><entry align="center">1184</entry><entry>Benzodiazepine (substance)</entry></row><row><entry align="center">1185</entry><entry>History of Falling</entry></row><row><entry align="center">1186</entry><entry>Fall (event)</entry></row><row><entry align="center">1187</entry><entry>Fall into water (event)</entry></row><row><entry align="center">1188</entry><entry>Fall on soft surface (event)</entry></row><row><entry align="center">1189</entry><entry>Fall on hard surface (event)</entry></row><row><entry align="center">1190</entry><entry>Jump from burning structure (event)</entry></row><row><entry align="center">1191</entry><entry>Accidental fall (event)</entry></row><row><entry align="center">1192</entry><entry>Fall in, on, or from train (event)</entry></row><row><entry align="center">1193</entry><entry>Engaged in falling (event)</entry></row><row><entry align="center">1194</entry><entry>Fall on snow (event)</entry></row><row><entry align="center">1195</entry><entry>Falls (finding)</entry></row><row><entry align="center">1196</entry><entry>Falls caused by medication (finding)</entry></row><row><entry align="center">1197</entry><entry>Elderly fall (finding)</entry></row><row><entry align="center">1198</entry><entry>At risk for falls (finding)</entry></row><row><entry align="center">1199</entry><entry>At high risk for fall (finding)</entry></row><row><entry align="center">1200</entry><entry>At moderate risk for fall (finding)</entry></row><row><entry align="center">1201</entry><entry>At low risk for fall (finding)</entry></row><row><entry align="center">1202</entry><entry>Secondary Diagnosis</entry></row><row><entry align="center">1203</entry><entry>Diagnosis (observable entity)</entry></row><row><entry align="center">1204</entry><entry>Fetal diagnosis (observable entity)</entry></row><row><entry align="center">1205</entry><entry>New diagnosis (observable entity)</entry></row><row><entry align="center">1206</entry><entry>Ambulatory aid</entry></row><row><entry align="center">1207</entry><entry>Ability to walk (observable entity)</entry></row><row><entry align="center">1208</entry><entry>Ability to walk on uneven surface (observable entity)</entry></row><row><entry align="center">1209</entry><entry>Ability to walk backward pulling large toy (observable entity)</entry></row><row><entry align="center">1210</entry><entry>Ability to walk carrying large toy (observable entity)</entry></row><row><entry align="center">1211</entry><entry>Ability to walk heel to toe (observable entity)</entry></row><row><entry align="center">1212</entry><entry>Ability to walk on a narrow line (observable entity)</entry></row><row><entry align="center">1213</entry><entry>Ability to start and stop walking spontaneously (observable entity)</entry></row><row><entry align="center">1214</entry><entry>Ability to stop walking (observable entity)</entry></row><row><entry align="center">1215</entry><entry>Ability to initiate walking (observable entity)</entry></row><row><entry align="center">1216</entry><entry>Ability to walk down hill (observable entity)</entry></row><row><entry align="center">1217</entry><entry>Ability to walk up hill (observable entity)</entry></row><row><entry align="center">1218</entry><entry>Ability to walk down a slope (observable entity)</entry></row><row><entry align="center">1219</entry><entry>Ability to walk up a slope (observable entity)</entry></row><row><entry align="center">1220</entry><entry>Ability to walk on the flat (observable entity)</entry></row><row><entry align="center">1221</entry><entry>Finding of walking aid use (finding)</entry></row><row><entry align="center">1222</entry><entry>Uses two walking sticks (finding)</entry></row><row><entry align="center">1223</entry><entry>Uses two crutches for walking (finding)</entry></row><row><entry align="center">1224</entry><entry>Uses single crutch for walking (finding)</entry></row><row><entry align="center">1225</entry><entry>Uses single walking stick (finding)</entry></row><row><entry align="center">1226</entry><entry>Uses zimmer frame (finding)</entry></row><row><entry align="center">1227</entry><entry>Tripod/quadrupod: walking (finding)</entry></row><row><entry align="center">1228</entry><entry>Stick only for walking (finding)</entry></row><row><entry align="center">1229</entry><entry>No aid for walking (finding)</entry></row><row><entry align="center">1230</entry><entry>Dependence on walking stick (finding)</entry></row><row><entry align="center">1231</entry><entry>Cane, device (physical object)</entry></row><row><entry align="center">1232</entry><entry>Long cane (physical object)</entry></row><row><entry align="center">1233</entry><entry>Wheelchair crutch/walking stick holder (physical object)</entry></row><row><entry align="center">1234</entry><entry>Gait</entry></row><row><entry align="center">1235</entry><entry>Gait normal (finding)</entry></row><row><entry align="center">1236</entry><entry>On examination - gait normal (finding)</entry></row><row><entry align="center">1237</entry><entry>Mental Status</entry></row><row><entry align="center">1238</entry><entry>Orientated (finding)</entry></row><row><entry align="center">1239</entry><entry>Oriented to person (finding)</entry></row><row><entry align="center">1240</entry><entry>Oriented to place (finding)</entry></row><row><entry align="center">1241</entry><entry>Oriented to time (finding)</entry></row><row><entry align="center">1242</entry><entry>Oriented to person, time and place (finding)</entry></row><row><entry align="center">1243</entry><entry>Disorientated (finding)</entry></row><row><entry align="center">1244</entry><entry>On examination - disorientated (finding)</entry></row><row><entry align="center">1245</entry><entry>Impaired environmental interpretation syndrome (finding)</entry></row><row><entry align="center">1246</entry><entry>Spatial disorientation (finding)</entry></row><row><entry align="center">1247</entry><entry>Disorientated in place (finding)</entry></row><row><entry align="center">1248</entry><entry>Disorientation as to self (finding)</entry></row><row><entry align="center">1249</entry><entry>Disorientation for person (finding)</entry></row><row><entry align="center">1250</entry><entry>Disorientation as to people, time and place (finding)</entry></row><row><entry align="center">1251</entry><entry>Disorientated in time (finding)</entry></row><row><entry align="center">1252</entry><entry>Right-left disorientation (finding)</entry></row><row><entry align="center">1253</entry><entry>Impaired cognition (finding)</entry></row><row><entry align="center">1254</entry><entry>Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder)</entry></row><row><entry align="center">1255</entry><entry>Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">1256</entry><entry>Cognitive deficit in attention (finding)</entry></row><row><entry align="center">1257</entry><entry>Depressed mood in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1258</entry><entry>Delusions in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1259</entry><entry>Cognitive changes due to organic disorder (finding)</entry></row><row><entry align="center">1260</entry><entry>Early onset Alzheimer's disease with behavioral disturbance (disorder)</entry></row><row><entry align="center">1261</entry><entry>Altered behavior in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1262</entry><entry>Dementia due to multiple sclerosis with altered behavior (disorder)</entry></row><row><entry align="center">1263</entry><entry>Altered behavior in dementia due to Huntington chorea (disorder)</entry></row><row><entry align="center">1264</entry><entry>Hallucinations co-occurrent and due to late onset dementia (disorder)</entry></row><row><entry align="center">1265</entry><entry>Cognitive impairment due to toxicity of substance (disorder)</entry></row><row><entry align="center">1266</entry><entry>Impaired executive functioning (finding)</entry></row><row><entry align="center">1267</entry><entry>Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder)</entry></row><row><entry align="center">1268</entry><entry>Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder)</entry></row><row><entry align="center">1269</entry><entry>Severe cognitive impairment (finding)</entry></row><row><entry align="center">1270</entry><entry>Moderate cognitive impairment (finding)</entry></row><row><entry align="center">1271</entry><entry>Memory impairment (finding)</entry></row><row><entry align="center">1272</entry><entry>Impaired environmental interpretation syndrome (finding)</entry></row><row><entry align="center">1273</entry><entry>Disturbance of cognitive learning (finding)</entry></row><row><entry align="center">1274</entry><entry>Lack of thinking ability (finding)</entry></row><row><entry align="center">1275</entry><entry>Minimal cognitive impairment (finding)</entry></row><row><entry align="center">1276</entry><entry>Age-related cognitive decline (finding)</entry></row><row><entry align="center">1277</entry><entry>At risk for cognitive impairment (finding)</entry></row><row><entry align="center">1278</entry><entry>At risk of confusion (finding)</entry></row><row><entry align="center">1279</entry><entry>At risk for delirium (finding)</entry></row><row><entry align="center">1280</entry><entry>Wheelchair bound (finding)</entry></row><row><entry align="center">1281</entry><entry>Dependent on helper pushing wheelchair (finding)</entry></row><row><entry align="center">1282</entry><entry>Minimal help in wheelchair (finding)</entry></row><row><entry align="center">1283</entry><entry>Independent in wheelchair (finding)</entry></row><row><entry align="center">1284</entry><entry>Elimination, Bowel and Urine</entry></row><row><entry align="center">1285</entry><entry>Incontinence (finding)</entry></row><row><entry align="center">1286</entry><entry>Incontinence without sensory awareness (finding)</entry></row><row><entry align="center">1287</entry><entry>Incontinence due to detrusor instability (finding)</entry></row><row><entry align="center">1288</entry><entry>Neurogenic incontinence (finding)</entry></row><row><entry align="center">1289</entry><entry>Urinary incontinence (finding)</entry></row><row><entry align="center">1290</entry><entry>Incontinence of feces (finding)</entry></row><row><entry align="center">1291</entry><entry>Micturition finding (finding)</entry></row><row><entry align="center">1292</entry><entry>Abnormal urination (finding)</entry></row><row><entry align="center">1293</entry><entry>Vesicovaginal fistula with involvement of urinary continence mechanism following termination of pregnancy procedure (disorder)</entry></row><row><entry align="center">1294</entry><entry>Vesicovaginal fistula with involvement of urinary continence mechanism following obstetric delivery procedure (disorder)</entry></row><row><entry align="center">1295</entry><entry>Vesicovaginal fistula with involvement of urinary continence mechanism due to and following obstructed labor (disorder)</entry></row><row><entry align="center">1296</entry><entry>Vesicovaginal fistula with involvement of urinary continence mechanism following normal delivery (disorder)</entry></row><row><entry align="center">1297</entry><entry>Finding of bladder control (finding)</entry></row><row><entry align="center">1298</entry><entry>Finding of flow of urine (finding)</entry></row><row><entry align="center">1299</entry><entry>Finding related to ability to pass urine (finding)</entry></row><row><entry align="center">1300</entry><entry>Lower urinary tract symptoms (finding)</entry></row><row><entry align="center">1301</entry><entry>Finding of measures of urination (finding)</entry></row><row><entry align="center">1302</entry><entry>Finding of desire for urination (finding)</entry></row><row><entry align="center">1303</entry><entry>Finding of pattern of urination (finding)</entry></row><row><entry align="center">1304</entry><entry>Dysfunctional voiding of urine (finding)</entry></row><row><entry align="center">1305</entry><entry>Incomplete urination (finding)</entry></row><row><entry align="center">1306</entry><entry>On examination - micturition reflex (finding)</entry></row><row><entry align="center">1307</entry><entry>Control of micturition normal (finding)</entry></row><row><entry align="center">1308</entry><entry>Normal micturition (finding)</entry></row><row><entry align="center">1309</entry><entry>Micturition feature (observable entity)</entry></row><row><entry align="center">1310</entry><entry>Urinary elimination status (observable entity)</entry></row><row><entry align="center">1311</entry><entry>Ability to collect and discharge urine (observable entity)</entry></row><row><entry align="center">1312</entry><entry>Ability to maintain urinary continence (observable entity)</entry></row><row><entry align="center">1313</entry><entry>Measure of urination (observable entity)</entry></row><row><entry align="center">1314</entry><entry>Characteristic of desire for urination (observable entity)</entry></row><row><entry align="center">1315</entry><entry>Pattern of urination (observable entity)</entry></row><row><entry align="center">1316</entry><entry>Urinary flow pattern (observable entity)</entry></row><row><entry align="center">1317</entry><entry>Ability to pass urine (observable entity)</entry></row><row><entry align="center">1318</entry><entry>Flow of urine (observable entity)</entry></row><row><entry align="center">1319</entry><entry>Bowel finding (finding)</entry></row><row><entry align="center">1320</entry><entry>Intestinal anastomosis present (finding)</entry></row><row><entry align="center">1321</entry><entry>Bowel problem (finding)</entry></row><row><entry align="center">1322</entry><entry>Aware of passing feces (finding)</entry></row><row><entry align="center">1323</entry><entry>Desire for stool finding (finding)</entry></row><row><entry align="center">1324</entry><entry>Finding of measures of defecation (finding)</entry></row><row><entry align="center">1325</entry><entry>Finding of passage of meconium (finding)</entry></row><row><entry align="center">1326</entry><entry>Finding of quantity of defecation (finding)</entry></row><row><entry align="center">1327</entry><entry>Finding of frequency of defecation (finding)</entry></row><row><entry align="center">1328</entry><entry>Finding of speed of defecation (finding)</entry></row><row><entry align="center">1329</entry><entry>Tympanitic bowel sound (finding)</entry></row><row><entry align="center">1330</entry><entry>Bowel assessment observations (finding)</entry></row><row><entry align="center">1331</entry><entry>Bowel sounds continuous (finding)</entry></row><row><entry align="center">1332</entry><entry>Bowel sounds intermittent (finding)</entry></row><row><entry align="center">1333</entry><entry>Bowel sounds loud (finding)</entry></row><row><entry align="center">1334</entry><entry>Bowel sounds quiet (finding)</entry></row><row><entry align="center">1335</entry><entry>Bowel control - child (finding)</entry></row><row><entry align="center">1336</entry><entry>Bowel sounds tinkling (finding)</entry></row><row><entry align="center">1337</entry><entry>Bowel spasm (finding)</entry></row><row><entry align="center">1338</entry><entry>Unaware of passing feces (finding)</entry></row><row><entry align="center">1339</entry><entry>Constipation alternates with diarrhea (finding)</entry></row><row><entry align="center">1340</entry><entry>Sensation as if diarrhea will start (finding)</entry></row><row><entry align="center">1341</entry><entry>Sensation as if bowel still full (finding)</entry></row><row><entry align="center">1342</entry><entry>Intestinal hurry (finding)</entry></row><row><entry align="center">1343</entry><entry>Finding of large intestine (finding)</entry></row><row><entry align="center">1344</entry><entry>Finding of small intestine (finding)</entry></row><row><entry align="center">1345</entry><entry>Disorder of intestine (disorder)</entry></row><row><entry align="center">1346</entry><entry>Double incontinence (finding)</entry></row><row><entry align="center">1347</entry><entry>Urgent desire for stool (finding)</entry></row><row><entry align="center">1348</entry><entry>Multiple diverticula of intestine (finding)</entry></row><row><entry align="center">1349</entry><entry>Abdominal wind pain (finding)</entry></row><row><entry align="center">1350</entry><entry>Passes stool completely (finding)</entry></row><row><entry align="center">1351</entry><entry>Finding of defecation (finding)</entry></row><row><entry align="center">1352</entry><entry>Defecation reflex finding (finding)</entry></row><row><entry align="center">1353</entry><entry>Finding related to awareness of bowel function (finding)</entry></row><row><entry align="center">1354</entry><entry>Finding of bowel action (finding)</entry></row><row><entry align="center">1355</entry><entry>Finding of bowel continence (finding)</entry></row><row><entry align="center">1356</entry><entry>Soiling (finding)</entry></row><row><entry align="center">1357</entry><entry>Defecation observable (observable entity)</entry></row><row><entry align="center">1358</entry><entry>St. Mark's incontinence score (observable entity)</entry></row><row><entry align="center">1359</entry><entry>Time of last bowel movement (observable entity)</entry></row><row><entry align="center">1360</entry><entry>Bowel elimination status (observable entity)</entry></row><row><entry align="center">1361</entry><entry>Awareness of bowel function (observable entity)</entry></row><row><entry align="center">1362</entry><entry>Feces/motions - symptoms (observable entity)</entry></row><row><entry align="center">1363</entry><entry>Bowel action (observable entity)</entry></row><row><entry align="center">1364</entry><entry>Requires supervision to perform wheelchair transfer (finding)</entry></row><row><entry align="center">1365</entry><entry>Unsteady gait (finding)</entry></row><row><entry align="center">1366</entry><entry>Visual impairment (disorder)</entry></row><row><entry align="center">1367</entry><entry>Bilateral visual impairment (disorder)</entry></row><row><entry align="center">1368</entry><entry>Visual impairment co-occurrent with human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">1369</entry><entry>Drug related visual impairment (disorder)</entry></row><row><entry align="center">1370</entry><entry>Combined visual and hearing impairment (disorder)</entry></row><row><entry align="center">1371</entry><entry>Multiple disability visual impairment (disorder)</entry></row><row><entry align="center">1372</entry><entry>Mild visual impairment (disorder)</entry></row><row><entry align="center">1373</entry><entry>Moderate visual impairment (disorder)</entry></row><row><entry align="center">1374</entry><entry>Severe visual impairment (disorder)</entry></row><row><entry align="center">1375</entry><entry>Disorder of auditory system (disorder)</entry></row><row><entry align="center">1376</entry><entry>Weissenbacher-Zweymuller syndrome (disorder)</entry></row><row><entry align="center">1377</entry><entry>Cogan's syndrome (disorder)</entry></row><row><entry align="center">1378</entry><entry>Auditory system hereditary disorder (disorder)</entry></row><row><entry align="center">1379</entry><entry>Auditory system complication of procedure (disorder)</entry></row><row><entry align="center">1380</entry><entry>Auditory dysfunction (disorder)</entry></row><row><entry align="center">1381</entry><entry>Olivary heterotopia (disorder)</entry></row><row><entry align="center">1382</entry><entry>Olive dysplasia (disorder)</entry></row><row><entry align="center">1383</entry><entry>Hearing disorder (disorder)</entry></row><row><entry align="center">1384</entry><entry>Disorder of ear (disorder)</entry></row><row><entry align="center">1385</entry><entry>Non-awareness of common dangers (finding)</entry></row><row><entry align="center">1386</entry><entry>Not aware of danger from deep water (finding)</entry></row><row><entry align="center">1387</entry><entry>Lack of common sense about danger (finding)</entry></row><row><entry align="center">1388</entry><entry>Not aware of danger from strangers (finding)</entry></row><row><entry align="center">1389</entry><entry>Not aware of danger from traffic (finding)</entry></row><row><entry align="center">1390</entry><entry>Not aware of danger from falling from heights (finding)</entry></row><row><entry align="center">1391</entry><entry>Not aware of danger from sharp objects (finding)</entry></row><row><entry align="center">1392</entry><entry>Not aware of danger from hot objects (finding)</entry></row><row><entry align="center">1393</entry><entry>Lack of self awareness (finding)</entry></row><row><entry align="center">1394</entry><entry>Poor awareness of safety at work (finding)</entry></row><row><entry align="center">1395</entry><entry>Impulsive character (finding)</entry></row><row><entry align="center">1396</entry><entry>Making impulsive remarks (finding)</entry></row><row><entry align="center">1397</entry><entry>On examination - impulsive behavior (finding)</entry></row><row><entry align="center">1398</entry><entry>Explosive personality disorder (disorder)</entry></row><row><entry align="center">1399</entry><entry>Isolated explosive disorder (disorder)</entry></row><row><entry align="center">1400</entry><entry>Cognitive seizure (disorder)</entry></row><row><entry align="center">1401</entry><entry>Cognitive disorder (disorder)</entry></row><row><entry align="center">1402</entry><entry>Neurocognitive disorder (disorder)</entry></row><row><entry align="center">1403</entry><entry>Cognitive disorder in remission (disorder)</entry></row><row><entry align="center">1404</entry><entry>Cognitive developmental delay (disorder)</entry></row><row><entry align="center">1405</entry><entry>Mild cognitive disorder (disorder)</entry></row><row><entry align="center">1406</entry><entry>Language-related cognitive disorder (disorder)</entry></row><row><entry align="center">1407</entry><entry>Age-associated memory impairment (disorder)</entry></row><row><entry align="center">1408</entry><entry>Cognitive dysfunction following surgical procedure (disorder)</entry></row><row><entry align="center">1409</entry><entry>Impaired cognition (finding)</entry></row><row><entry align="center">1410</entry><entry>Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder)</entry></row><row><entry align="center">1411</entry><entry>Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder)</entry></row><row><entry align="center">1412</entry><entry>Cognitive deficit in attention (finding)</entry></row><row><entry align="center">1413</entry><entry>Depressed mood in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1414</entry><entry>Delusions in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1415</entry><entry>Cognitive changes due to organic disorder (finding)</entry></row><row><entry align="center">1416</entry><entry>Early onset Alzheimer's disease with behavioral disturbance (disorder)</entry></row><row><entry align="center">1417</entry><entry>Altered behavior in Alzheimer's disease (disorder)</entry></row><row><entry align="center">1418</entry><entry>Dementia due to multiple sclerosis with altered behavior (disorder)</entry></row><row><entry align="center">1419</entry><entry>Altered behavior in dementia due to Huntington chorea (disorder)</entry></row><row><entry align="center">1420</entry><entry>Hallucinations co-occurrent and due to late onset dementia (disorder)</entry></row><row><entry align="center">1421</entry><entry>Cognitive impairment due to toxicity of substance (disorder)</entry></row><row><entry align="center">1422</entry><entry>Impaired executive functioning (finding)</entry></row><row><entry align="center">1423</entry><entry>Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder)</entry></row><row><entry align="center">1424</entry><entry>Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder)</entry></row><row><entry align="center">1425</entry><entry>Severe cognitive impairment (finding)</entry></row><row><entry align="center">1426</entry><entry>Moderate cognitive impairment (finding)</entry></row><row><entry align="center">1427</entry><entry>Memory impairment (finding)</entry></row><row><entry align="center">1428</entry><entry>Impaired environmental interpretation syndrome (finding)</entry></row><row><entry align="center">1429</entry><entry>Disturbance of cognitive learning (finding)</entry></row><row><entry align="center">1430</entry><entry>Lack of thinking ability (finding)</entry></row><row><entry align="center">1431</entry><entry>Minimal cognitive impairment (finding)</entry></row><row><entry align="center">1432</entry><entry>Age-related cognitive decline (finding)</entry></row><row><entry align="center">1433</entry><entry>At risk for cognitive impairment (finding)</entry></row><row><entry align="center">1434</entry><entry>At risk of confusion (finding)</entry></row><row><entry align="center">1435</entry><entry>At risk for delirium (finding)</entry></row><row><entry align="center">1436</entry><entry><b>PROCEDURES/THERAPIES/PHYSICAL OBJECTS</b></entry></row><row><entry align="center">1437</entry><entry>Analgesic technique (procedure)</entry></row><row><entry align="center">1438</entry><entry>Administration of intravenous antiarrhythmic drug (procedure)</entry></row><row><entry align="center">1439</entry><entry>Diuretic therapy (procedure)</entry></row><row><entry align="center">1440</entry><entry>Antidepressant therapy (procedure)</entry></row><row><entry align="center">1441</entry><entry>Antipsychotic drug therapy (procedure)</entry></row><row><entry align="center">1442</entry><entry>Benzodiazepine therapy (procedure)</entry></row><row><entry align="center">1443</entry><entry>Analgesic technique (procedure)</entry></row><row><entry align="center">1444</entry><entry>Administration of intravenous antiarrhythmic drug (procedure)</entry></row><row><entry align="center">1445</entry><entry>Diuretic therapy (procedure)</entry></row><row><entry align="center">1446</entry><entry>Antidepressant therapy (procedure)</entry></row><row><entry align="center">1447</entry><entry>Antipsychotic drug therapy (procedure)</entry></row><row><entry align="center">1448</entry><entry>Benzodiazepine therapy (procedure)</entry></row><row><entry align="center">1449</entry><entry>Bedrest care (regime/therapy)</entry></row><row><entry align="center">1450</entry><entry>Bedrest (regime/therapy)</entry></row><row><entry align="center">1451</entry><entry>Primary bedrest stabilization of spinal fracture (procedure)</entry></row><row><entry align="center">1452</entry><entry>Primary open reduction spinal fracture and bedrest stabilization (procedure)</entry></row><row><entry align="center">1453</entry><entry>Revision to bedrest stabilization of spinal fracture (procedure)</entry></row><row><entry align="center">1454</entry><entry>Primary closed reduction spinal fracture and bedrest stabilization (procedure)</entry></row><row><entry align="center">1455</entry><entry>Revision to open reduction spinal fracture and bedrest stabilization (procedure)</entry></row><row><entry align="center">1456</entry><entry>Revision to closed reduction spinal fracture and bedrest stabilization (procedure)</entry></row><row><entry align="center">1457</entry><entry>Assistance with mobility (procedure)</entry></row><row><entry align="center">1458</entry><entry>Assistance with mobility in bed (procedure)</entry></row><row><entry align="center">1459</entry><entry>Walking aid (physical object)</entry></row><row><entry align="center">1460</entry><entry>Stick, walking device (physical object)</entry></row><row><entry align="center">1461</entry><entry>Crutches (physical object)</entry></row><row><entry align="center">1462</entry><entry>Walking frame (physical object)</entry></row><row><entry align="center">1463</entry><entry>Tripod (physical object)</entry></row><row><entry align="center">1464</entry><entry>Cane, device (physical object)</entry></row><row><entry align="center">1465</entry><entry>Crutch, device (physical object)</entry></row><row><entry align="center">1466</entry><entry>Cane, device (physical object)</entry></row><row><entry align="center">1467</entry><entry>Long cane (physical object)</entry></row><row><entry align="center">1468</entry><entry>Walking assistive device (physical object)</entry></row><row><entry align="center">1469</entry><entry>Walking stick/Crutches (physical object)</entry></row><row><entry align="center">1470</entry><entry>Walker/Walking frame (physical object)</entry></row><row><entry align="center">1471</entry><entry>Walking aid ice grip (physical object)</entry></row><row><entry align="center">1472</entry><entry>Walking stick holder (physical object)</entry></row><row><entry align="center">1473</entry><entry>Walking aid handgrip (physical object)</entry></row><row><entry align="center">1474</entry><entry>Walking aid tip (physical object)</entry></row><row><entry align="center">1475</entry><entry>Walker (physical object)</entry></row><row><entry align="center">1476</entry><entry>Gait rehabilitation electronic walker (physical object)</entry></row><row><entry align="center">1477</entry><entry>Walking chair, non-foldable (physical object)</entry></row><row><entry align="center">1478</entry><entry>Walking table (physical object)</entry></row><row><entry align="center">1479</entry><entry>Basic walker, non-foldable (physical object)</entry></row><row><entry align="center">1480</entry><entry>Walking chair, foldable (physical object)</entry></row><row><entry align="center">1481</entry><entry>Basic walker, foldable (physical object)</entry></row><row><entry align="center">1482</entry><entry>Bariatric walker, non-foldable (physical object)</entry></row><row><entry align="center">1483</entry><entry>Bariatric walker, foldable (physical object)</entry></row><row><entry align="center">1484</entry><entry>Patient/medical device walker, home-use (physical object)</entry></row><row><entry align="center">1485</entry><entry>Patient/medical device walker (physical object)</entry></row><row><entry align="center">1486</entry><entry>Intravenous therapy/heparin lock</entry></row><row><entry align="center">1487</entry><entry>Heparin lock flush syringe, single-use (physical object)</entry></row><row><entry align="center">1488</entry><entry>Heparin lock flush syringe, reprocessed (physical object)</entry></row><row><entry align="center">1489</entry><entry>Intravenous therapy (regime/therapy)</entry></row><row><entry align="center">1490</entry><entry>Checking intravenous tubing for air bubbles (regime/therapy)</entry></row><row><entry align="center">1491</entry><entry>Changing intravenous infusion line (regime/therapy)</entry></row><row><entry align="center">1492</entry><entry>Administration of sedative (procedure)</entry></row><row><entry align="center">1493</entry><entry>Benzodiazepine therapy (procedure)</entry></row><row><entry align="center">1494</entry><entry>Administration of sedative via rectal route (procedure)</entry></row><row><entry align="center">1495</entry><entry>Induction of minimal sedation (procedure)</entry></row><row><entry align="center">1496</entry><entry>Induction of deep sedation (procedure)</entry></row><row><entry align="center">1497</entry><entry>Induction of conscious sedation (procedure)</entry></row><row><entry align="center">1498</entry><entry>Oral sedation (procedure)</entry></row><row><entry align="center">1499</entry><entry>Sedation with analgesic adjunct (procedure)</entry></row><row><entry align="center">1500</entry><entry>Inhalational sedation (procedure)</entry></row><row><entry align="center">1501</entry><entry>Intramuscular sedation (procedure)</entry></row><row><entry align="center">1502</entry><entry>Intravenous sedation (procedure)</entry></row><row><entry align="center">1503</entry><entry>Induction of sedation (procedure)</entry></row><row><entry align="center">1504</entry><entry>Premedication for anesthetic procedure (procedure)</entry></row><row><entry align="center">1505</entry><entry>Intravenous infusion (procedure)</entry></row><row><entry align="center">1506</entry><entry>Intravenous radionuclide therapy (procedure)</entry></row><row><entry align="center">1507</entry><entry>Infusion of drug or medicament via intravenous route (procedure)</entry></row><row><entry align="center">1508</entry><entry>Resuscitation using intravenous fluid (procedure)</entry></row><row><entry align="center">1509</entry><entry>Diabetes mellitus insulin-glucose infusion in acute myocardial infarction (procedure)</entry></row><row><entry align="center">1510</entry><entry>Continuous infusion of dextrose saline (procedure)</entry></row><row><entry align="center">1511</entry><entry>Continuous infusion of normal saline (procedure)</entry></row><row><entry align="center">1512</entry><entry>Intravenous blood transfusion (procedure)</entry></row><row><entry align="center">1513</entry><entry>Intravenous blood transfusion of platelets (procedure)</entry></row><row><entry align="center">1514</entry><entry>Insertion of pleural tube drain (procedure)</entry></row><row><entry align="center">1515</entry><entry>Opening of chest and insertion of pleural tube drain (procedure)</entry></row><row><entry align="center">1516</entry><entry>Insertion of drainage tube into pleural cavity using ultrasound guidance (procedure)</entry></row><row><entry align="center">1517</entry><entry>Insertion of pleural tube using computed tomography guidance (procedure)</entry></row><row><entry align="center">1518</entry><entry>Thoracentesis with insertion of pleural tube (procedure)</entry></row><row><entry align="center">1519</entry><entry>Insertion of underwater seal chest drain (procedure)</entry></row><row><entry align="center">1520</entry><entry>Tube thoracostomy with water seal (procedure)</entry></row><row><entry align="center">1521</entry><entry>Injection of indwelling catheter (procedure)</entry></row><row><entry align="center">1522</entry><entry>Hickman line injection (procedure)</entry></row><row><entry align="center">1523</entry><entry>Portocath injection (procedure)</entry></row><row><entry align="center">1524</entry><entry>Replacement of indwelling catheter of urinary bladder (procedure)</entry></row><row><entry align="center">1525</entry><entry>Deflating indwelling urethral catheter balloon (procedure)</entry></row><row><entry align="center">1526</entry><entry>Catheterization of bladder by indwelling suprapubic catheter (procedure)</entry></row><row><entry align="center">1527</entry><entry>Therapeutic drainage of amniotic fluid by indwelling catheter (procedure)</entry></row><row><entry align="center">1528</entry><entry>Insertion of tunneled indwelling catheter with cuff into pleura (procedure)</entry></row><row><entry align="center">1529</entry><entry>Insertion of indwelling tunneled catheter with cuff by percutaneous approach using radiologic guidance (procedure)</entry></row><row><entry align="center">1530</entry><entry>Insertion of indwelling catheter into urinary bladder (procedure)</entry></row><row><entry align="center">1531</entry><entry>Indwelling catheter removed (situation)</entry></row><row><entry align="center">1532</entry><entry>Indwelling catheter inserted (situation)</entry></row><row><entry align="center">1533</entry><entry>Intermittent pneumatic compression stockings (physical object)</entry></row><row><entry align="center">1534</entry><entry>Assistance with mobility (procedure)</entry></row><row><entry align="center">1535</entry><entry>Assistance with mobility in bed (procedure)</entry></row><row><entry align="center">1536</entry><entry>Self-care assistance: transfer (procedure)</entry></row><row><entry align="center">1537</entry><entry>Able to transfer location with assistance (finding)</entry></row><row><entry align="center">1538</entry><entry>Ambulation training (procedure)</entry></row><row><entry align="center">1539</entry><entry>Gait training procedure (procedure)</entry></row><row><entry align="center">1540</entry><entry>Ambulation therapy (regime/therapy)</entry></row><row><entry align="center">1541</entry><entry><b>OTHER</b></entry></row><row><entry align="center">1542</entry><entry>Diagnoses/Comorbidities</entry></row><row><entry align="center">1543</entry><entry>Fluids</entry></row><row><entry align="center">1544</entry><entry>Orders</entry></row><row><entry align="center">1545</entry><entry>Family History</entry></row><row><entry align="center">1546</entry><entry>Prior Bed Exits</entry></row><row><entry align="center">1547</entry><entry># of Nurse Calls</entry></row><row><entry align="center">1548</entry><entry>Length of Stay</entry></row><row><entry align="center">1549</entry><entry>Rounding Compliance</entry></row><row><entry align="center">1550</entry><entry>Hospital Unit</entry></row><row><entry align="center">1551</entry><entry><b>RISK INDICATORS</b></entry></row><row><entry align="center">1552</entry><entry>Falls</entry></row><row><entry align="center">1553</entry><entry>Pulmonary</entry></row><row><entry align="center">1554</entry><entry>Skin</entry></row><row><entry align="center">1555</entry><entry>Mobility Score</entry></row><row><entry align="center">1556</entry><entry>Braden Score</entry></row><row><entry align="center">1557</entry><entry><b>RISK SCORES (* = Falls, ** = EWS)</b></entry></row><row><entry align="center">1558</entry><entry>Morse*</entry></row><row><entry align="center">1559</entry><entry>Johns Hopkins (JHFRAT)*</entry></row><row><entry align="center">1560</entry><entry>Hendrich*</entry></row><row><entry align="center">1561</entry><entry>Humpty Dumpty*</entry></row><row><entry align="center">1562</entry><entry>STRATIFY*</entry></row><row><entry align="center">1563</entry><entry>MEWS**</entry></row><row><entry align="center">1564</entry><entry>NEWS**</entry></row><row><entry align="center">1565</entry><entry>PEWS**</entry></row><row><entry align="center">1566</entry><entry>MEOWS**</entry></row><row><entry align="center">1567</entry><entry>SIRS**</entry></row><row><entry align="center">1568</entry><entry>SOFA**</entry></row><row><entry align="center">1569</entry><entry><b>RISK STRATIFICATIONS (High, Medium, Low)</b></entry></row><row><entry align="center">1570</entry><entry>Missing Risk Score/Risk Stratification Parameters</entry></row><row><entry align="center">1571</entry><entry><b>RESPONSES (NOTIFICATIONS AND ACTIONS)</b></entry></row><row><entry align="center">1572</entry><entry><b>RISK CONTEXT (for Patient Deterioration sub-vectors)</b></entry></row><row><entry align="center">1573</entry><entry><b>Respiratory Distress</b></entry></row><row><entry align="center">1574</entry><entry>age >= 70</entry></row><row><entry align="center">1575</entry><entry>60 <= age <= 70</entry></row><row><entry align="center">1576</entry><entry>prior hospitalization within 90 days</entry></row><row><entry align="center">1577</entry><entry>COPD</entry></row><row><entry align="center">1578</entry><entry>morbid obesity</entry></row><row><entry align="center">1579</entry><entry>weight >= 250 lbs & gender = F</entry></row><row><entry align="center">1580</entry><entry>weight >= 300 lbs & gender = M</entry></row><row><entry align="center">1581</entry><entry>abdominal aortic aneurysm surgery</entry></row><row><entry align="center">1582</entry><entry>pneumonia</entry></row><row><entry align="center">1583</entry><entry>albumin < 40</entry></row><row><entry align="center">1584</entry><entry>blood urea nitrogen > 40</entry></row><row><entry align="center">1585</entry><entry>respiratory rate > 30</entry></row><row><entry align="center">1586</entry><entry>respiratory rate < 10</entry></row><row><entry align="center">1587</entry><entry>spo2 < 95</entry></row><row><entry align="center">1588</entry><entry>peripheral edema</entry></row><row><entry align="center">1589</entry><entry>current opioids</entry></row><row><entry align="center">1590</entry><entry>pulmonary consult</entry></row><row><entry align="center">1591</entry><entry>blood transfusion</entry></row><row><entry align="center">1592</entry><entry>decreased loc</entry></row><row><entry align="center">1593</entry><entry>restlessness</entry></row><row><entry align="center">1594</entry><entry>Sepsis</entry></row><row><entry align="center">1595</entry><entry>Acute Kidney Injury</entry></row><row><entry align="center">1596</entry><entry>Hemorrhage</entry></row><row><entry align="center">1597</entry><entry>Congestive Heart Failure</entry></row><row><entry align="center">1598</entry><entry>Respiratory Distress</entry></row></tbody></tgroup></table></tables>

0176In Table 11, the bolded entries in the data elements column are headings or data elements categories and the data elements listed beneath the bolded heading line are the data elements within the bolded category.

0177According to this disclosure, phrases of the form "at least one of A and B" and "at least one of the following: A and B" and similar such phrases, mean "A, or B, or both A and B." Phrases of the form "at least one of A or B" and "at least one of the following: A or B" and similar such phrases, also mean "A, or B, or both A and B."

0178Although certain illustrative embodiments have been described in detail above, many embodiments, variations and modifications are possible.

0179Embodiments of the invention can be described with reference to the following numbered clauses, with preferred features laid out in the dependent clauses: <ol id="ol0001" compact="compact"><li>1. A system for use in a healthcare facility, the system comprising an analytics engine, a plurality of equipment providing data to the analytics engine, the data pertaining to a patient in the healthcare facility, the plurality of equipment including at least one of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, or an incontinence detection pad, wherein the analytics engine analyzes the data from the plurality of equipment to determine in substantially real time at least one of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, and a computer coupled to the analytics engine and coordinating a caregiver rounding interval at which at least one caregiver assigned to the patient is required to check in on the patient, wherein the computer automatically decreases the caregiver rounding interval in response to the at least one of the first, second, or third scores increasing from a first value to a second value and wherein the computer automatically increases the caregiver rounding interval in response to the at least one of the first, second, or third scores decreasing from the second value to the first value.</li><li>2. The system of clause 1, further comprising a plurality of displays communicatively coupled to the analytics engine and operable to display the at least two first, second, and third scores, the plurality of displays comprising at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>3. The system of either clause 1 or clause 2, wherein the plurality of equipment includes at least three of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>4. The system of any preceding clause, wherein the plurality of equipment includes at least four of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>5. The system of any preceding clause, wherein the plurality of equipment includes at least five of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>6. The system of any preceding clause, wherein the plurality of equipment includes all six of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>7. The system of any preceding clause, wherein each of the first, second, and third scores is normalized by the analytics engine so as to have a minimum value and a maximum value that is common to each of the other first, second, and third scores.</li><li>8. The system of clause 7, wherein the minimum value is 0 for each of the first, second, and third scores.</li><li>9. The system of clause 7, wherein the minimum value is 1 for each of the first, second, and third scores.</li><li>10. The system of clause 7, wherein the maximum value is 5 for each of the first, second, and third scores.</li><li>11. The system of any preceding clause, wherein the analytics engine also receives additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>12. The system of any preceding clause, wherein the analytics engine communicates the at least two first, second, and third scores to at least one piece of equipment of the plurality of equipment.</li><li>13. The system of clause 12, wherein the at least one piece of equipment of the plurality of equipment includes a device display and wherein steps for lowering at least one of the first, second, and third scores is displayed on the device display.</li><li>14. The system of any preceding clause, wherein data from the patient support apparatus includes at least one patient vital sign sensed by at least one vital sign sensor integrated into the patient support apparatus.</li><li>15. The system of clause 14, wherein the at least one patient vital sign sensed by the at least one vital sign sensor includes heart rate or respiration rate.</li><li>16. The system of either clause 14 or clause 15, wherein data from the patient support apparatus further includes patient weight.</li><li>17. The system of any preceding clause, wherein data from the patient support apparatus includes patient weight and a position of the patient on the patient support apparatus.</li><li>18. The system of clause 17, wherein data from the patient support apparatus further includes data indicative of an amount of motion by the patient while supported on the patient support apparatus.</li><li>19. The system of any preceding clause, wherein data from the physiological monitor includes one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data.</li><li>20. The system of any preceding clause, wherein the first score is at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.</li><li>21. The system of any preceding clause, wherein the analytics engine initiates a message to a mobile device of the at least one caregiver assigned to the patient if the first, second, or third score increases from a previous value.</li><li>22. The system of any preceding clause, wherein the analytics engine initiates a message to a mobile device of the at least one caregiver assigned to the patient if the first, second, or third score reaches a threshold value.</li><li>23. The system of any preceding clause, wherein the analytics engine also receives additional data relating to at least one wound of the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>24. The system of clause 23, wherein the additional data relating to the at least one wound includes an image of the at least one wound.</li><li>25. The system of any preceding clause, wherein the patient support apparatus comprises a patient bed or a stretcher.</li><li>26. The system of any preceding clause, wherein the analytics engine also receives additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and wherein the analytics engine analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>27. The system of any preceding clause, wherein the physiological monitor comprises at least one of the following: a wireless patch sensor attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer.</li><li>28. The system of any preceding clause, wherein the plurality of equipment further comprises a chair monitor to monitor patient movement while the patient is seated on a chair.</li><li>29. The system of any preceding clause, wherein the plurality of equipment further comprises a toilet monitor to monitor patient movement while the patient is seated on a toilet.</li><li>30. Apparatus for assessing medical risks of a patient, the apparatus comprising an analytics engine, a plurality of equipment providing data to the analytics engine, the plurality of equipment including at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad, wherein the analytics engine analyzes the data from the plurality of equipment to determine at least two of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, and a plurality of displays communicatively coupled to the analytics engine and operable to display the at least two first, second, and third scores, the plurality of displays comprising at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>31. The apparatus of clause 30, wherein the plurality of equipment includes at least three of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>32. The apparatus of clause 30, wherein the plurality of equipment includes at least four of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>33. The apparatus of clause 30, wherein the plurality of equipment includes at least five of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>34. The apparatus of clause 30, wherein the plurality of equipment includes all six of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>35. The apparatus of any one of clauses 30 to 34, wherein each of the first, second, and third scores is normalized so as to have a minimum value and a maximum value that is common to each of the other first, second, and third scores.</li><li>36. The apparatus of clause 35, wherein the minimum value is 0 for each of the first, second, and third scores.</li><li>37. The apparatus of clause 35, wherein the minimum value is 1 for each of the first, second, and third scores.</li><li>38. The apparatus of clause 35, wherein the maximum value is 5 for each of the first, second, and third scores.</li><li>39. The apparatus of any one of clauses 30 to 38, wherein a rounding protocol relating to caregiver rounds is adjusted based on at least one of the first, second and third scores.</li><li>40. The apparatus of clause 39, wherein the rounding protocol that is adjusted includes a rounding time interval relating to when the caregiver is required to check on the patient.</li><li>41. The apparatus of any one of clauses 30 to 40, wherein the analytics engine also receives additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>42. The apparatus of any one of clauses 30 to 41, wherein the analytics engine communicates the at least two first, second, and third scores to the plurality of equipment.</li><li>43. The apparatus of clause 42, wherein at least one piece of equipment of the plurality of equipment includes a device display and wherein steps for lowering at least one of the first, second, and third scores is displayed on the device display.</li><li>44. The apparatus of any one of clauses 30 to 43, wherein data from the patient support apparatus includes at least one patient vital sign sensed by at least one vital sign sensor integrated into the patient support apparatus.</li><li>45. The apparatus of clause 44, wherein the at least one patient vital sign sensed by the at least one vital sign sensor includes heart rate or respiration rate.</li><li>46. The apparatus of either clause 44 or clause 45, wherein data from the patient support apparatus further includes patient weight.</li><li>47. The apparatus of any one of clauses 30 to 46, wherein data from the patient support apparatus includes patient weight and a position of the patient on the patient support apparatus.</li><li>48. The apparatus of clause 47, wherein data from the patient support apparatus further includes data indicative of an amount of motion by the patient while supported on the patient support apparatus.</li><li>49. The apparatus of any one of clauses 30 to 48, wherein the analytics engine analyzes the data from the plurality of equipment in substantially real time and updates the at least two first, second, and third scores in substantially real time.</li><li>50. The apparatus of any one of clauses 30 to 49, wherein data from the physiological monitor includes one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data.</li><li>51. The apparatus of any one of clauses 30 to 50, wherein the first score is at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.</li><li>52. The apparatus of any one of clauses 30 to 51, wherein the analytics engine initiates a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score increases from a previous value.</li><li>53. The apparatus of any one of clauses 30 to 52, wherein the analytics engine initiates a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score reaches a threshold value.</li><li>54. The apparatus of any one of clauses 30 to 53, wherein the analytics engine also receives additional data relating to at least one wound of the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>55. The apparatus of clause 54, wherein the additional data relating to the at least one wound includes an image of the at least one wound.</li><li>56. The apparatus of any one of clauses 30 to 55, wherein the patient support apparatus comprises a patient bed or a stretcher.</li><li>57. The apparatus of any one of clauses 30 to 56, wherein the analytics engine also receives additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and wherein the analytics engine analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>58. The apparatus of any one of clauses 30 to 57, wherein the physiological monitor comprises at least one of the following: a wireless patch sensor attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer.</li><li>59. The apparatus of any one of clauses 30 to 58, wherein the plurality of equipment further comprises a chair monitor to monitor patient movement while the patient is seated on a chair.</li><li>60. The apparatus of any one of clauses 30 to 59, wherein the plurality of equipment further comprises a toilet monitor to monitor patient movement while the patient is seated on a toilet.</li><li>61. Apparatus for assessing medical risks of a patient, the apparatus comprising an analytics engine, a plurality of equipment providing data to the analytics engine, the plurality of equipment including at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad, wherein the analytics engine analyzes the data from the plurality of equipment to determine each of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, and a plurality of displays communicatively coupled to the analytics engine, at least one display of the plurality of displays being operable to display the first, second, and third scores.</li><li>62. The apparatus of clause 61, wherein the at least one display includes at least one of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>63. The apparatus of clause 61, wherein the at least one display includes at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>64. The apparatus of clause 61, wherein the at least one display includes at least three of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>65. The apparatus of clause 61, wherein the at least one display includes all four of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>66. The apparatus of any one of clauses 61 to 65 in combination with the apparatus of any one or more of clauses 30-60.</li><li>67. A method for assessing medical risks of a patient, the method comprising receiving at an analytics engine data from a plurality of equipment, the plurality of equipment including at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad, analyzing with the analytics engine the data from the plurality of equipment to determine at least two of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, and displaying at a plurality of displays communicatively coupled to the analytics engine the at least two of the first, second, and third scores, the plurality of displays comprising at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>68. The method of clause 67, wherein the plurality of equipment includes at least three of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>69. The method of clause 67, wherein the plurality of equipment includes at least four of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>70. The method of clause 67, wherein the plurality of equipment includes at least five of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>71. The method of clause 67, wherein the plurality of equipment includes all six of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.</li><li>72. The method of any one of clauses 67 to 71, further comprising, with the analytics engine, normalizing each of the first, second, and third scores so as to have a minimum value and a maximum value that is common to each of the other first, second, and third scores.</li><li>73. The method of clause 72, wherein the minimum value is 0 for each of the first, second, and third scores.</li><li>74. The method of clause 72, wherein the minimum value is 1 for each of the first, second, and third scores.</li><li>75. The method of clause 72, wherein the maximum value is 5 for each of the first, second, and third scores.</li><li>76. The method of any one of clauses 67 to 75, further comprising adjusting a rounding protocol relating to caregiver rounds based on at least one of the first, second and third scores.</li><li>77. The method of clause 76, wherein the rounding protocol that is adjusted includes a rounding time interval relating to when the caregiver is required to check on the patient.</li><li>78. The method of any one of clauses 67 to 77, further comprising receiving at the analytics engine additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and analyzing with the analytics engine the additional data in connection with determining at least one of the first, second, and third scores.</li><li>79. The method of any one of clauses 67 to 78, further comprising communicating the at least two first, second, and third scores from the analytics engine to the plurality of equipment.</li><li>80. The method of clause 79, wherein at least one piece of equipment of the plurality of equipment includes a device display and further comprising displaying on the device steps for lowering at least one of the first, second, and third scores.</li><li>81. The method of any one of clauses 67 to 80, wherein data from the patient support apparatus includes at least one patient vital sign sensed by at least one vital sign sensor integrated into the patient support apparatus.</li><li>82. The method of clause 81, wherein the at least one patient vital sign sensed by the at least one vital sign sensor includes heart rate or respiration rate.</li><li>83. The method of clause 81, wherein data from the patient support apparatus further includes patient weight.</li><li>84. The method of any one of clauses 67 to 83, wherein data from the patient support apparatus includes patient weight and a position of the patient on the patient support apparatus.</li><li>85. The method of clause 84, wherein data from the patient support apparatus further includes data indicative of an amount of motion by the patient while supported on the patient support apparatus.</li><li>86. The method of any one of clauses 67 to 85, wherein analyzing the data with the analytics engine comprises analyzing the data in substantially real time and further comprising updating the at least two first, second, and third scores in substantially real time.</li><li>87. The method of any one of clauses 67 to 86, wherein data from the physiological monitor includes one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data.</li><li>88. The method of any one of clauses 67 to 87, wherein the first score is at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.</li><li>89. The method of any one of clauses 67 to 88, further comprising initiating with the analytics engine a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score increases from a previous value.</li><li>90. The method of any one of clauses 67 to 89, further comprising initiating with the analytics engine a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score reaches a threshold value.</li><li>91. The method of any one of clauses 67 to 90, further comprising receiving at the analytics engine additional data relating to at least one wound of the patient and analyzing with the analytics engine the additional data in connection with determining at least one of the first, second, and third scores.</li><li>92. The method of clause 91, wherein the additional data relating to the at least one wound includes an image of the at least one wound.</li><li>93. The method of any one of clauses 67 to 92, wherein the patient support apparatus comprises a patient bed or a stretcher.</li><li>94. The method of any one of clauses 67 to 93, further comprising receiving at the analytics engine additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and analyzing with the analytics engine analyzes the additional data in connection with determining at least one of the first, second, and third scores.</li><li>95. The method of any one of clauses 67 to 94, wherein the physiological monitor comprises at least one of the following: a wireless patch sensor attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer.</li><li>96. The method of any one of clauses 67 to 95, wherein the plurality of equipment further comprises a chair monitor to monitor patient movement while the patient is seated on a chair.</li><li>97. The method of any one of clauses 67 to 96, wherein the plurality of equipment further comprises a toilet monitor to monitor patient movement while the patient is seated on a toilet.</li><li>98. A method for assessing medical risks of a patient, the method comprising receiving at an analytics engine data from a plurality of equipment, the plurality of equipment including at least two of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad, analyzing with the analytics engine the data from the plurality of equipment to determine each of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, and displaying on at least one display of a plurality of displays communicatively coupled to the analytics engine the first, second, and third scores.</li><li>99. The method of clause 98, wherein the at least one display includes at least one of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>100. The method of clause 98, wherein the at least one display includes at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>101. The method of clause 98, wherein the at least one display includes at least three of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>102. The method of clause 98, wherein the at least one display includes all four of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.</li><li>103. The method of any one of clauses 98 to 102 in combination with the method of any one or more of clauses 67-97.</li><li>104. A method of assessing medical risks of a patient, the method comprising receiving at an analytics engine patient demographics data of the patient including at least one of age, race, and weight, receiving at the analytics engine comorbidity data of the patient including data indicating that the patient has at least one of the following medical conditions: acquired immunodeficiency syndrome (AIDS), anemia, chronic congestive heart failure, asthma, cancer, chronic obstructive pulmonary disease (COPD), coronary artery disease, cystic fibrosis, dementia, emphysema, alcohol or drug abuse, stroke, pulmonary emboli, a history of sepsis, type 1 diabetes, morbid obesity, neuromuscular disease, prior intubation, scoliosis, smoker, delirium, asplenic, bone marrow transplant, cirrhosis, dialysis, diverticulosis, heart valve disorders, inflammatory bowel disease, joint replacement, leukopenia, malignancy, neoplasm, organ transplant, peripheral vascular disease, renal disease, pressure injury, recent abortion, recent childbirth, seizures, sickle cell anemia, or terminal illness, receiving at the analytics engine physiological data measured by a physiological monitor having at least one sensor coupled to, or in communication with, the patient, the physiological data being dynamic and changing over time while the patient is being monitored by the physiological monitor, and using the analytics engine to calculate a risk score of the patient in substantially real time based on the patient demographics data, the comorbidity data, and the physiological data.</li><li>105. The method of clause 104, further comprising receiving at the analytics engine laboratory data of the patient and using the laboratory data in connection with calculating the risk score.</li><li>106. The method of clause 105, wherein the laboratory data includes data pertaining to one or more of the following: albumin, arterial partial pressure of oxygen (arterial PaO2), partial pressure of carbon dioxide (PCO2), arterial pH, acidosis, brain natriuretic peptide, blood urea nitrogen, cardiac ejection fraction, creatinine, hemoglobin, hematocrit, lactate, pulmonary function test, troponin, bilirubin, C-reactive protein, D-dimer, glucose, bicarbonate (HCO3), hyperlactatemia, international normalization ration (INR) for blood clotting, normal white blood count (WBC) with greater than 10% neutrophils, arterial partial pressure of carbon dioxide (PaCO2), fluid overload, Ph, platelets, procalcitonin, protein in urine, partial thromboplastin time (PTT) or white blood cell count.</li><li>107. The method of any one of clauses 104 to 106, further comprising receiving at the analytics engine patient symptoms data of the patient and using the patient symptoms data in connection with calculating the risk score.</li><li>108. The method of clause 107, wherein the patient symptoms data includes data pertaining to one or more of the following: accessory muscle use, altered mental status, confusion, anxiety, chest pain, cough, cyanosis, diaphoresis, dyspnea, hemoptysis, fatigue, restlessness, sputum production, tachycardia, tachypnea, or lethargy.</li><li>109. The method of any one of clauses 104 to 108, further comprising receiving at the analytics engine clinical examination data and using the clinical examination data in connection with calculating the risk score.</li><li>110. The method of clause 109, wherein the clinical examination data includes data pertaining to one or more of the following: abdominal respirations, abnormal lung sounds, accessory muscle use, capillary refill, chest pressure or pain, abnormal electrocardiograph (ECG), cough, cyanosis, decreased level of consciousness (LOC), agitation, encephalopathy, mottling, need for assistance with activities of daily living (ADLS), orthopnea, peripheral edema, sputum production, delirium, fluid overload, cardiac output, early state warm red skin and late state cool and pale with mottling, fever, headache, stiff neck, hypothermia, ileus, jaundice, meningitis, oliguria, peripheral cyanosis, petechial rash, positive fluid balance, seizures, stupor, or volume depletion.</li><li>111. The method of any one of clauses 104 to 110, further comprising receiving at the analytics engine charted doctor's orders data and using the charted doctor's order data in connection with calculating the risk score.</li><li>112. The method of clause 111, wherein the charted doctor's orders data includes data pertaining to one or more of the following: delivery of breathing air other than with a cannula including with a Venturi, a rebreather, a non-rebreather, a continuous positive airway pressure (CPAP) machine, and a bi-level positive airway pressure (bi-PAP) machine; testing of arterial blood gases; testing of brain natriuretic peptide; breathing treatments; chest x-ray; Doppler echocardiography; high fluid rates or volumes (input and output (I&amp;O)); pulmonary consultation; pulmonary function testing; ventilation-perfusion (VQ) scan; or thoracic computerized tomography (CT) scan.</li><li>113. The method of any one of clauses 104 to 112, further comprising receiving at the analytics engine admission data for the patient and using the admission data in connection with calculating the risk score.</li><li>114. The method of clause 113, wherein the admission data includes data pertaining to one or more of the following: abdominal aortic aneurysm surgery, acute myocardial ischemia, acute pancreatitis, aspiration, asthma, bronchiectasis, atelectasis, bronchitis, burns, cancer, cardiac or thoracic surgery, cardiac valve disorder or valvular insufficiency, chemo therapy, congestive heart failure, COPD exacerbation, deep vein thrombosis, drug overdose, dyspnea at rest, emergency surgery, hemoptysis, interstitial lung disease, lung abscess, neck surgery, neuro surgery, upper abdomen surgery, peripheral vascular surgery, pneumonia, pneumothorax, pulmonary emboli, pulmonary hypertension, pulmonary-renal syndrome, renal failure, sepsis, shock, sleep apnea, smoke inhalation injury, surgery, thoracentesis, trauma, lethargy, delirium, abscess, abdominal pain, abdominal tenderness, acute lung injury, appendicitis, bacteremia, cellulitis, cholangitis, cholecystitis, colitis, cystitis, dehydration, diverticulitis, encephalitis, encephalopathy, endocarditis, fever of unknown origin, gastroenteritis, gastrointestinal bleed, gastrointestinal tract infection, hypotension, infectious process, malaise, osteomyelitis, ostomy, pelvic pain, renal disease, pyelonephritis, respiratory infection, septic arthritis, soft tissue infection, surgical admission, wound, or acute respiratory distress syndrome.</li><li>115. The method of any one of clauses 104 to 114, further comprising receiving at the analytics engine medications data for the patient and using the medications data in connection with calculating the risk score.</li><li>116. The method of clause 115, wherein the medications data includes data pertaining to one or more of the following: anticoagulants including heparin or levenox delivered intravenously (IV) or subcutaneously (SC), bronchodilators, corticosteroids, diuretic use, high fluid rates or volumes or hypertonic fluids, opioids, sedatives, hypnotics, muscle relaxants, fluid overload, antibiotics, or immunosuppressants.</li><li>117. The method of any one of clauses 104 to 116, further comprising determining with the analytics engine that the patient is at risk of developing respiratory distress if the patient is 70 years of age or older and has COPD.</li><li>118. The method of any one of clauses 104 to 116, further comprising determining with the analytics engine that the patient is at risk of developing respiratory distress if the patient has COPD and has been prescribed opioids.</li><li>119. The method of any one of clauses 104 to 116, further comprising determining with the analytics engine that the patient is at risk of developing respiratory distress if the patient is 70 years of age or older and has been prescribed opioids.</li><li>120. The method of any one of clauses 104 to 116, further comprising determining with the analytics engine that the patient is at risk of developing respiratory distress if the patient is 70 years of age or older, has asthma, and has a blood urea nitrogen (BUN) of greater than or equal to 30 milligrams (mg) per 100 milliliters (ml) of blood.</li><li>121. The method of any one of clauses 104 to 120, further comprising determining with the analytics engine that the patient is at risk of developing sepsis if the patient is 65 years of age or older and has cancer.</li><li>122. The method of any one of clauses 104 to 121, further comprising determining with the analytics engine that the patient is at risk of developing sepsis if the patient has a history of developing sepsis.</li><li>123. The method of any one of clauses 104 to 122, wherein the physiological data includes one or more of the following: heartrate, respiration rate, temperature, mean arterial pressure, systolic blood pressure, or pulse oximetry data including peripheral capillary oxygen saturation (SpO2).</li><li>124. A method implemented on at least one computer, the method comprising receiving dynamic clinical variables and vital signs information of a patient, using the vital signs information to develop prior vital signs patterns and current vital signs patterns, comparing the prior vital signs patterns with the current vital signs patterns, receiving one or more of the following: static variables of the patient, subjective complaints of the patient, prior healthcare utilization patterns of the patient, or social determinants of health data of the patient, and using the dynamic clinical variables, the vital signs information, the results of the comparison of the prior vital signs patterns with the current vital signs patterns, and the one or more of the static variables, the subjective complaints, the healthcare utilization patterns, or the social determinants of health data in an algorithm to detect or predict that the patient has sepsis or is likely to develop sepsis.</li><li>125. The method of clause 124, wherein the dynamic clinical variables include point-of-care lab data.</li><li>126. The method of either clause 124 or clause 125, wherein the static variables include comorbidities.</li><li>127. The method of any one of clauses 124 to 126, wherein the static variables include whether the care setting of the patient is a pre-acute care setting, an acute care setting, or a post-acute care setting.</li><li>128. The method of any one of clauses 124 to 127, further comprising receiving historical data of the patient.</li><li>129. The method of any one of clauses 124 to 128, further comprising outputting one or more recommended actions to one or more clinicians of the patient.</li><li>130. The method of clause 129, wherein the one or more recommended actions include sending the patient to an emergency department (ED).</li><li>131. The method of clause 129, wherein the one or more recommended actions includes increasing monitoring of the patient by the one or more clinicians.</li><li>132. The method of clause 129, wherein the one or more recommended actions includes ordering a set of labs for the patient.</li><li>133. The method of any one of clauses 124 to 132, further comprising ranking clinicians of a healthcare facility.</li><li>134. The method of clause 133, wherein ranking the clinicians of the healthcare facility comprises ranking the clinicians by experience.</li><li>135. The method of clause 133, wherein ranking the clinicians of the healthcare facility comprises ranking the clinicians by actions previously taken.</li><li>136. The method of clause 133, wherein ranking the clinicians of the healthcare facility comprises ranking the clinicians by prior patient outcomes.</li><li>137. The method of clause 133, wherein ranking the clinicians of the healthcare facility comprises ranking the clinicians by experience, by actions previously taken, and by prior patient outcomes.</li><li>138. The method of clause 137, wherein the actions having greatest impact on outcomes are used by the at least one computer to inform newer or less experienced clinicians how an experienced clinician would attend to the patient.</li><li>139. The system of any of clauses 1-29, wherein a risk determination is made or one or more of the first, second, or third scores is calculated based on one or more of the data elements listed in Table 11.</li><li>140. The apparatus of any of clauses 30-66, wherein a risk determination is made or one or more of the first, second, or third scores is calculated based on one or more of the data elements listed in Table 11.</li><li>141. The method of any of clauses 67-103, further comprising making a risk determination or calculating one or more of the first, second, or third scores based on one or more of the data elements listed in Table 11.</li><li>142. The method of any of clauses 104-123, further comprising calculating the risk score or making a risk determination based on one or more of the data elements listed in Table 11.</li><li>143. The method of any of clauses 124-138, further comprising calculating a risk score or making a risk determination based on one or more of the data elements listed in Table 11.</li></ol>